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THE RELATIONSHIP OF PHYSICAL FITNESS, DEPRESSION 
AND MORTALITY IN A CARDIAC REHABILITATION COHORT 
SUMMARY 
The study aimed to establish whether levels of fitness and depression, or 
changes in those levels, in coronary heart disease patients are associated 
with survival time. 
The cohort consisted of 2,714 coronary patients who were followed up for 13 
[median 6.4] years after enrolment into a cardiac rehabilitation [CR] 
programme. 
All participants underwent fitness testing and psychological assessment at 
the start of Phase III CR. These tests were repeated approximately 12 
weeks later. Fitness levels were categorised into low, medium and high. 
Depression scores were divided into none, borderline and clinical depression. 
Primary endpoints were all-cause mortality and cardiovascular mortality. 
At the end of the study period 16.6% of the cohort had died. The 
improvement in fitness over the 3 months of physical training was 16.8%. 
Fitness category improved in 33% of the cohort and deteriorated in less than 
1%. Baseline fitness was predictive of all-cause and cardiovascular mortality 
with adjusted hazard ratios [HR] for low fitness of 2.83 [2.02,3.96] (p<0.001) 
and 5.40 [3.36,8.69] (p<0.001) respectively. Low fitness at the end of CR 
was predictive of mortality, HRs 4.23 [2.64,6.79] (p<0.001) and 6.37 
[3.37,12.0] respectively (p<0.001). An increase in fitness amongst the least 
fit at baseline was associated with an 11 % reduction in the risk of 
cardiovascular mortality [0.80,0.98] for each unit increase in fitness of 
1 ml/kg/min. 
Baseline clinical depression was 4.6%. This had reduced to 1.1% by the exit 
assessment. Fitness levels were related to depressions scores; the least fit 
participants were more likely to be depressed. The study showed an 
association between baseline clinical depression and all-cause and 
cardiovascular mortality, before adjusting for fitness, HRs 1.60 and 1.79. 
Initial fitness and baseline depression are associated with prognosis in 
coronary patients who have attended CR. These findings may help target 
patients at risk in order to maximise treatments. 
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Chapter 1 
Development of the Research Question 
1.1 Introduction 
The patient recovering from an acute cardiac illness, for example a 
myocardial infarction', needs help in two areas; the first to recover from the 
physical and psychological effects of the illness, and the second to ensure 
the best possible prognosis. This may be achieved by attending a cardiac 
rehabilitation [CR] programme, which incorporates exercise training together 
with approaches to health education, stress management and relaxation. CR 
programmes confer benefits in several equally important ways. Firstly, by 
providing individualised exercise prescriptions for each patient. Secondly, 
through rigorous management of their coronary risk factors, and thirdly, by 
inviting the patients and their partners to attend health education, stress 
management and relaxation classes during the time they spend in the 
programme. Finally, they are often the starting point for encouraging a 
lifelong adherence to healthier lifestyles and longevity. 
The Basingstoke and Alton Cardiac Rehabilitation Programme was started in 
1976 by Dr. Hugh Bethell, a general practitioner, and was one of the first 
programmes to be established in the United Kingdom. 
myocardial infarction - heart attack 
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The CR programme was conducted in a local community sports centre and 
consisted of three sessions of exercise training each week for patients and 
their partners, supervised by one of the centre's exercise trainers. With 
research grants, charitable and National Health Service [NHS] funding I 
joined the team in 1979, initially on a part-time basis, as a chartered 
physiotherapist. 
In 1992,1 was appointed to a full-time NHS post to manage the CR service 
for Basingstoke District Hospital". Our approach to patient care has 
developed significantly over the years, modelled on schemes operating in 
North America (Wenger et al 1995) and our work has been, and continues to 
be, influential in the national development of secondary prevention 
programmes and rehabilitation services for patients with cardiac illnesses. 
In order to monitor our interventions we routinely document a range of 
baseline assessment findings and outcome measures for all the patients 
during CR (Thompson et al 1997). It was this data, which we collected in the 
early years of our programme that became my inspiration for this thesis. The 
outcomes of one patient who attended CR for 3 months, made a lasting 
impression on me. 
He was a gentleman who was currently being treated medically for clinical 
depression, and who enrolled in CR following his discharge from hospital with 
11 Basingstoke District Hospital - now re-named the Basingstoke and North Hampshire 
Hospital NHS Foundation Trust 
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a diagnosis of a myocardial infarction. He attended the programme regularly 
for 3 months. When he completed his rehabilitation we noted that not only 
had his level of fitness improved but also that he was less depressed than at 
the start of his CR with consequential reduction in antidepressant therapy. 
His case inspired me to look more closely at some of the outcomes we had 
begun to collect during CR and in particular the fitness and psychological 
data. I was curious to know whether initial fitness or changes in fitness as a 
possible result of exercise training, or baseline and changes in psychological 
scores would predict the prognosis of our CR patients. 
In 1993 to facilitate data collection and with help from my family, I devised an 
electronic database for the storage of the patients' medical information, as 
opposed to recording the patient assessment data in paper format, which had 
been our traditional practice. One of my tasks, as clinical manager of the 
programme was, and still is, to ensure that all data collection on a range of 
patient observations was consistently recorded into the database that I had 
begun to develop. The baseline and outcome measures we continue to 
collect include before and after measures of physical fitness, psychological 
state, and coronary heart disease risk factor monitoring such as cholesterol 
levels, body mass index and blood pressure readings. 
We also record occupational status, degree of perceived social support, and 
current medication as well as routine demographic data. Until now, this has 
been a unique activity within the field of CR. Most programmes in the United 
3 
Kingdom have not gathered data as a routine part of clinical practice. For 
instance, in 2000, only 8 out of the 302 programmes in the United Kingdom 
were able to provide outcome results relating to the exercise component of 
their CR programmes (Bethell et al 2004). 
For the purpose of this thesis, the records of the patients with coronary heart 
disease in our database make up a cohort of nearly 3000 males and females 
who were invited to participate in CR between 1" January 1993 and 31st 
December 2002. In spite of the various new treatments that have become 
available during this time, which are discussed in Chapter 2, all of these 
patients have been exposed to a similar level and standard of CR, which has 
been delivered consistently over the ten-year study period. A range of data 
including measures of physical fitness and depression scores, the focus of 
this thesis, has been recorded on each participant. 
The basis for my research on our patients is novel in the CR field for the 
following reasons: 
1. The uniqueness of our patients' records. Our patients have all been 
observed as a part of routine practice in a clinical setting, as opposed 
to being participants in a randomised trial. 
2. The data we have recorded therefore will have high external validity 
(Black 1996). 
3. The participants in this study are the largest fully representative 
coronary heart disease population that has been studied within the 
4 
context of a CR setting to date. The majority of published research 
within the CR environment is concentrated on the younger male 
population with uncomplicated coronary heart disease. 
1.2 Purpose of the study 
Previous studies have found an association between levels of fitness and 
mortality in selected groups of coronary patients (Blair et al 1995; Kavanagh 
et al 2002; Kavanagh et al 2003) and some have also found a relationship 
between depression, coronary heart disease and survival (Ziegelstein 2001). 
Some researchers have looked at baseline fitness levels and depression 
within the context of CR and two studies have examined a change in fitness 
level and related it to survival in patients with pre-existing coronary heart 
disease who participate in CR (Fioretti et al 1988; Vanhees et al 1995). 
However, I have not identified any observational studies that have examined 
the changes in measures of physical fitness or depression scores in large 
numbers of male and female coronary patients, or the effect that these 
changes might have on outcomes from CR or survival of the patients. 
The interaction between physical fitness and depression has also been little 
studied even though we know that treating clinically depressed myocardial 
infarction survivors with antidepressant medication, regardless of their level 
of fitness, does not appear to improve their survival (Strike and Steptoe 
2002). 
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1.3 Study aim and objectives 
The aim of the study is to establish whether levels of fitness and levels of 
depression or changes in these levels of cardiac rehabilitation participants 
are associated with survival time. 
The objectives of this research are to determine if the risk of mortality in our 
participants is predicted by: 
1. A baseline fitness level at the start of CR and/or change in fitness level 
at the end of CR. 
2. A baseline depression score at the start of CR and/or change in 
depression score at the end of CR. 
3. An interaction between fitness baseline levels and depression scores. 
The following chapter describes the background to my research and 
introduces the role that CR plays in treating patients with coronary heart 
disease. 
6 
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Chapter 2 
Background to the study 
2.1 Coronary heart disease 
Cardiovascular diseases, which include diseases of the heart and circulatory 
system, are the leading cause of death in the United Kingdom. There are 
two main categories of cardiovascular disease, and they are coronary heart 
disease', the focus of this study, and stroke. Coronary heart disease is the 
most common cause of death in western societies and a major financial 
burden to health care systems. The United Kingdom has one of the highest 
coronary death rates for its population in the western world. In 2003, 
114,000 people died which represented one in five men and one in six 
women (Petersen 2005). In order to address the national death toll from 
coronary heart disease one of the Department of Health's [DOH] aims was to 
reduce cardiovascular deaths (i. e. deaths from coronary heart disease and 
stroke) in the under-75 year olds by two-fifths by the year 2010 (DOH 1999). 
The annual number of cardiovascular deaths including deaths from coronary 
heart disease has continued to fall year on year over the past decade mainly 
due to an improvement in treatments, and in particular the availability of 
cardio-protective medications such as statins". However, there are 
substantial variations in both the burden of, and premature death rate from, 
coronary heart disease across the United Kingdom. For example, the 
' For clarity throughout this thesis I will use the term coronary heart disease, although the 
same condition can also be referred to as coronary artery disease or ischaemic heart 
disease and the references i have selected may reflect this. 
Statins - cholesterol lowering medications 
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premature death rate from coronary heart disease is far higher in Scotland 
and the North of England than in southern regions, in urban as opposed to 
rural areas, in Asians rather than Caucasians living in the United Kingdom, 
and in those who perform manual work compared with non-manual workers 
(Petersen 2005). 
2.1.1 The aetiology of coronary heart disease 
Most heart disease, but not all, is a complex pathological process caused by 
atheroma, the patchy and gradual furring up of the endothelium"' of the 
coronary arteries in response to endothelial injury and inflammation. The 
formation of atheroma can start very early on in life, with streaks of lipid-rich 
material being deposited within the endothelium. Over time, these fatty 
deposits form into plaques, which encroach on the lumen" of the artery 
reducing its diameter and resulting in a restriction of blood flow. Coronary 
atheroma may predispose to the formation of a thrombus or thrombosis" in 
one or more of the coronary arteries, reducing the lumen size even further. 
A myocardial infarction occurs when the blood supply is severely occluded, 
and the segment of myocardium" fails to receive adequate oxygenated 
blood. The chronic but more stable condition known as angina pectoris"" 
occurs when the coronary arteries are only partially blocked by atheromatous 
111 endothelium - innermost lining of an artery Iv lumen - diameter of an artery V thrombosis - clot of blood 
"'myocardium - heart muscle 
v" angina pectoris - literally means a 'tight chest' 
10 
deposits. This condition gives rise to angina, a so-called strangling pain in 
the chest that is felt when the narrowed coronary artery does not allow 
sufficient oxygen-rich blood to reach the myocardium at any one time and as 
a result the myocardium becomes ischaemic. Angina may occur when the 
demand on the heart increases and the heart rate rises for example in 
response to emotion, physical exertion, in cold weather or after a heavy 
meal. Coronary heart disease can present in a variety of ways; as heart 
failure"i or an acute coronary syndromex, in addition to the terms I have 
already described. 
2.1.2 Risk factors for coronary heart disease 
There is no single cause of atheroma although a cluster of risk factors has 
been identified which it is thought make certain individuals more prone than 
their counterparts to developing it. Some of the risk factors for coronary 
heart disease are unalterable, such as being male as opposed to female or 
inheriting a family history of heart disease, but others, for example being a 
smoker (Holm and Spencer 2000; Silagy 2000a; Silagy 2000b) being 
depressed (Glassman et al 2002), having a raised cholesterol level We 
Lorgeril et al 1997) or leading a sedentary existence (Berlin and Colditz 
1990) can be modified or controlled to improve outcomes for those with 
coronary heart disease. 
"" heart failure occurs when the heart fails to pump an adequate amount of blood around the 
body 
`x acute coronary syndrome commonly refers to cardiac pain such as unstable as opposed to 
stable angina and is usually compatible with a myocardial infarction 
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2.1.3 Exercise and coronary heart disease 
The benefits of keeping active have been advocated for thousands of years. 
Hippocrates and his tutor Herodicus and other philosophers in the 4th and 5th 
centuries BC recommended exercise as a means of living long and healthy 
lives (Thompson 2004). Herodicus could be thought of as the first Sports 
Medicine Physician, allegedly encouraging his patients to eat a healthy diet 
and to keep fit by walking from Athens to Megara; a distance of about 70 
miles. Over the years exercise has also been advocated for those with 
suspected heart disease. For instance in the 17th century the physician 
Heberden recorded that one of his patients was cured of his angina by 
regularly sawing wood for six months (Jay 2000). 
Physical inactivity has therefore been linked to low levels of physical fitness 
and is considered a major risk factor for the development and progression of 
coronary heart disease (Blair et al 1996; Blair et al 1989; Paffenbarger et al 
2001). The more physically active an individual is the greater their degree of 
fitness and the lower the risk for developing coronary heart disease (Berlin 
and Colditz 1990; Blair et al 1989). Moreover, the importance of the 
relationship between physical activity, physical fitness, cardiovascular health 
and survival has been well-established from epidemiological research carried 
out during the last 50 years. For example, studies of British workers (Morris 
et al 1953) compared the occupational activity of sedentary bus drivers 
versus the more physically active bus conductors, and also postmen, who 
spent up to 70% of their working day performing tasks that were aerobic in 
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nature, compared with deskbound telephonists and clerks. The main finding 
from these studies was that workers whose jobs were less physical were 
found to have suffered more heart attacks compared with the workers who 
were more active. However, statistical methods were less sophisticated at 
that time and the influence of confounders such as obesity or pre-existing 
coronary disease was not accounted for in the sedentary groups which may 
have affected the overall results (Batty and Lee 2004). 
Other studies also confirmed that manual workers were less prone than non- 
manual workers to developing coronary heart disease and were also less 
likely to suffer a cardiovascular event. For instance, the heavy manual work 
performed by Californian longshoremen contributed to their longevity when 
compared with a group of office workers (Paffenbarger 1972). Twenty years 
later the relationship of physical activity in leisure time, as opposed to 
occupational exercise, and coronary heart disease was also established 
(Morris et al 1973). Nearly 17,000 male civil servants aged between 40-64 
years who had sedentary jobs were asked to keep a diary of leisure-time 
activity for two days. Activity was considered vigorous if it reached an output 
of 7.5 kilocalories, which corresponded to performing heavy industrial work. 
This study showed that men who had a more active lifestyle and participated 
in vigorous leisure-time exercise at least twice a week reduced their risk of 
developing coronary heart disease by up to a third. Recent 
recommendations regarding the uptake of exercise for protection from 
developing coronary heart disease suggest that adults need only participate 
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in regular physical activity of a modest, rather than vigorous, intensity for 
about 30 minutes, but on most days of the week (Pate 1995). 
Nonetheless the role of exercise as a method of secondary prevention of 
coronary heart disease within CR programmes has developed as a result of 
the findings from the early epidemiological studies. There are several 
reasons why exercise training plays a major part within CR. It enhances 
levels of physical activity, improves physical fitness and may also beneficially 
modify some of the other coronary risk factors, for example by lowering blood 
pressure, and helping with weight loss (Bethell and Mullee 1990; Miller et al 
1997). In addition, it helps to regain self confidence (Marra et al 1985; 
Monpere et al 1988) and increases survival rates (Ades and Coello 2000; 
Pashkow 1993). 
2.1.4 Depression and coronary heart disease 
Depression is generally recognised to be a risk factor for cardiac mortality in 
people with coronary heart disease (Barth et al 2004; Carney et al 2003; 
Frasure-Smith and Lesperance 2005). Several researchers have shown the 
value of regular exercise for reducing depression in coronary patients during 
CR (Blumenthal et al 2004; Milani et al 1996; Turner et al 2002) and also in 
healthy but depressed adults who participate in exercise training 
programmes (Brosse et al 2002). Depression is a common finding within CR 
programmes (Turner et al 2003; Ziegelstein 2001) and its presence can 
complicate the pathway of the CR patient by influencing attendance (Deaner 
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2000; Glazer et al 2002; Larney 2002), compliance with medical treatments 
(DiMatteo et al 2000), and inducing excess fatigue (Beniamini et al 1997; 
McGowan et al 2004). 
2.2 Cardiac Rehabilitation Programmes 
2.2.1 The background and development of cardiac rehabilitation 
At the start of the 20th century Dr. John Garson from Hampshire (Garson 
1909) published a textbook entitled Remedial Gymnastics for Heart 
Affections which encouraged people with heart disease to participate in 
exercise programmes. However, during most of the last century the fashion 
for exercise and beliefs about its benefits changed and patients with coronary 
disease were discouraged from taking any form of exercise for fear of 
provoking a further event or even dying. Patients who were admitted to 
hospital with a myocardial infarction remained in bed for at least six weeks. 
They were kept virtually immobile all day, and had their limbs moved 
passively by nurses and physiotherapists during the day to aid circulation. 
In the 1950s, Levine and Lown invented the Armchair Management of 
patients admitted to hospital following myocardial infarction (Levine and Lown 
1952). Patients were sat out of bed after the first few days in hospital, and 
carefully mobilised around the wards to combat the deleterious effects of 
prolonged bed-rest prior to being discharged home. This was a major 
breakthrough in the convalescence and rehabilitation of patients who had 
suffered an acute coronary event. During the next 10 years physicians in 
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North America (Hellerstein and Ford 1957; Hellerstein et al 1967) and in 
Israel, where CR first evolved, (Brunner 1968; Gottheiner 1968; Kellermann 
et al 1968) developed programmes of exercise rehabilitation specifically for 
restoring the health of coronary heart disease patients. By 1988 medically 
directed exercise was a core component of CR programmes in the United 
States. CR was much slower to develop in the United Kingdom, which has 
lagged behind other countries [Table 2: 1]. However, over the past 35 years 
there has been a steady increase in the number of centres providing CR in 
the United Kingdom; the majority of CR programmes being implemented 
following the British Heart Foundation's pump priming initiative in the early 
eighties. In 1989,99 programmes were reported to be offering 
comprehensive rehabilitation. This figure rose to 151 in 1995,302 in 2000, at 
which time it was established that every acute hospital in the United Kingdom 
was running a programme or had access to a CR programme, and 332 in 
2004 [Figure 2: 1]. 
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Table 2: 1 Key developments by decade in Cardiac Rehabilitation 
Adapted from H. Stokes (Stokes 2000) 
International United Kingdom 
1940s Growing awareness of the Prolonged bedrest & restricted 
dangers of bedrest mobility for cardiac patients 
1950s Early mobility and gradually 
increased physical activity 
Prolonged bedrest & inactivity 
1960s Increasing emphasis on physical 
activity as well as psychosocial 
elements; organised CR; WHO' 
reports 
1970s Research into exercise training, 
psychosocial aspects, patient 
education, return to work, 
compliance. Growth in 
programmes and publications 
Bedrest and slow mobilisation; no 
formal CR programmes in 
existence 
Survey of CR 1970; major 
appraisal of CR by RCP` & 
BCS"; a handful of programmes 
commenced; bedrest still 
recommended 
1980s Meta-analyses of exercise-CR First trials of supervised exercise 
published, professional in the United Kingdom; 46/132 
organisations were formed Health Districts providing CR; 
Pump priming of CR by BHF'iii 
1990s Evidence-based guidelines Less than half of Health Districts 
published; World Council providing CR service; formation of 
formed BACR""; national guidelines & 
audit standards developed 1994- 
1996 
2000s National Service Framework for 
Coronary Heart Disease published 
(DOH 2000). All health districts 
have access CR to service; 302 
programmes registered. 
" World Health Organisation 
A Royal College of Physicians 
X British Cardiac Society 
xiQ British Heart Foundation 
xiv British Association for Cardiac Rehabilitation 
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Figure 2: 1 Growth in number of Cardiac Rehabilitation 
Programmes in UK 
(BHF/BACR Annual Survey, Bethell et al. 2004) 
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Several comprehensive reports and systematic reviews were published 
between 1988 and 1999 (Goble and Worcester 1999; NHS 1998; Thompson 
1995; Thompson et al 1996; Wenger et al 1995), which guided CR 
practitioners at the time in delivering CR services. However, some of the 
research material incorporated into earlier publications, including the 
systematic reviews and meta-analyses, has since been questioned because 
of the poor quality of some of the trials that had been included in the reviews. 
These tended to focus on small numbers of male coronary heart disease 
patients, rather than women, and in younger as opposed to older age groups 
(Ebrahim and Davey Smith 1996; NHS 1998). By the end of the nineties the 
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effectiveness of the various components of CR either singly or in combination 
were still relatively unclear which prompted production of a Cochrane review 
of CR that included an exercise component (Jolliffe et al 2000). 
2.2.2 Systematic reviews on cardiac rehabilitation 
This Cochrane review on CR was updated (Jolliffe et al 2003) and reported 
on the majority of CR studies up to December 31St 1998. It included most of 
the studies from the initial meta-analyses that were performed in the late 
eighties (O'Connor et at 1989; Oldridge et at 1988), and incorporated English 
and non-English trials of exercise only or comprehensive CR lasting at least 
six months that involved either an exercise component, or a combination of 
exercise and psychological intervention - referred to as `Comprehensive' CR. 
The trials were subdivided on the basis of differing interventions. There were 
a total of fifty-one trials involving 8,440 patients included in this review. All 
patients in the studies had suffered an acute myocardial infarction or had 
coronary artery bypass grafts, percutaneous coronary interventions or been 
diagnosed with other forms of coronary heart disease, such as angina. 
Nearly all of those recruited to the studies were middle-aged males, who 
were considered to be at a low risk for sustaining a further cardiac event. 
Females with coronary disease were poorly represented. All-cause and 
coronary mortality, nonfatal myocardial infarction or new cardiovascular 
events, revascularisation and health related quality of life were the main 
outcome measures. Some of the trials did not measure all these outcomes 
of interest, however, the Cochrane review demonstrated that over a three 
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year period cardiac mortality was reduced by 31% for both exercise only or 
comprehensive CR groups [Odds Ratio [OR] 0.69,95% Confidence Interval 
[Cl] 0.51,0.94]. All-cause mortality was reduced by 27% [OR 0.73,95% Cl 
0.54,0.98] in the exercise only group but not in the group that had received 
comprehensive CR [OR 0.87,95% Cl 0.71,1.05]. These findings differed 
from those obtained from the original meta-analyses performed in the late 
eighties (O'Connor et al 1989; Oldridge et al 1988), which had shown 
statistically significant reductions in cardiac and all-cause mortality of 
approximately 20-25% for the patients who had received CR which included 
an exercise component. It was not clear from the Cochrane results whether 
exercise only or comprehensive CR was the more effective intervention. 
Moreover, interpretation of the results is limited by the exclusion of some 
patients from the studies, which may have benefited from participating in CR, 
such as those who were older, had greater co-morbidity or who were female. 
Had these categories of patients been included a more realistic picture of the 
effectiveness of CR in terms of longevity and survival may have resulted. In 
addition, there were no analyses performed relating to the psychological 
components of CR because evidence for the effect of CR on depression, or 
quality of life, was only available from the four studies that had used a variety 
of disease-specific questionnaires. 
However, psychological components of CR are considered an equally 
important part of the rehabilitation process (Lewin et al 1992) and a 
Cochrane review of psychological interventions for coronary heart disease 
20 
has been published which includes outcomes for females, the elderly and 
revascularisation patients in the analyses (Rees et al 2004). The results from 
the thirty-six trials that Rees and colleagues examined showed that 
psychological interventions, at least within the CR environment, had no effect 
on either cardiac or total mortality, although some of the trials did show 
reduced levels of depression after attendance at CR. This review is 
discussed in greater detail in Chapter 7. 
Taylor and colleagues, with support from the Cochrane Heart Group, have 
published a meta-analysis and systematic review of the effectiveness of 
exercise-based CR which updates the earlier Cochrane reviews of CR 
(Jolliffe 2000; Jolliffe 2003). Taylor et al's review included 48 randomised 
controlled trials of CR that were published through to March 2003 [Table 2: 2] 
(Taylor et al 2004). Although the number of studies was less than previously 
reported by the Cochrane reviewers, a greater number of patients were 
represented [8,940 compared to 8,440]. Thirty-two of the forty-eight trials 
focused on myocardial infarction patients, with females accounting for 20% of 
the total percentage of patients that were studied. This was in contrast to the 
Cochrane review where only 4.4% and 11% respectively of female 
participants in the exercise only or comprehensive CR trials had been 
included. The results from Taylor's review suggest that CR is effective in 
reducing all-cause mortality [OR 0.80,95% Cl 0.68,0.93] and cardiac 
mortality [OR 0.74,95% Cl 0.61,0.96] independent of the diagnoses of the 
participants and the type of multi-disciplinary rehabilitation they had received. 
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The reviewers found no difference in mortality between exercise-based CR 
versus comprehensive CR or by the exercise dose - i. e. the type, intensity, 
frequency and duration of sessions. In addition, they reported that the 
attendance rates of the patients at CR did not have any effect on subsequent 
occurrence of nonfatal myocardial infarction. 
Table 2: 2 Selected characteristics of the trials (Taylor et al 2004) 
Characteristic Number (% or Median w range) 
Exercise only trials 19 (39) ' 
Sample size 112 (37-1479 patients) 
Publication date 
1970-1979 
1980-1989 
1990-1999 
2000-2003 
Study location 
Europe 
North America 
Asia/Australia 
2 (4) 
17 (35.5) 
21 (44) 
8 (6.5) 
30 (63) 
13 (27) 
5 (10) 
Sex 
Men only 21 (44) 
Women only 1 (2) 
Both 26 (52) 
Unspecified 1 (2) 
Age, years 55 (48-71) 
Diagnosis 
Post myocardial 32 (67) 
infarction 
Revascularisation only 8 (6.5) 
Both 8 (6.5) 
A major limitation with the research carried out to date is that it continues to 
report mainly on CR following myocardial infarction as opposed to CR as an 
intervention after revascularisation or for those with stable angina. Only some 
of the trials include data on females and the elderly. On the basis of the 
Median of study means 
* 49 trials of which one trial included both exercise only CR and comprehensive CR arms 
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evidence that was produced prior to the publication of the three systematic 
reviews I have discussed above, the National Service Framework for 
Coronary Heart Disease suggests that CR should become an essential and 
integral part of the secondary prevention plan for the majority of coronary 
patients (DOH 2000). 
Evaluation of modern CR interventions indicates that they may provide a 
variety of benefits for attendees, which include physical, psychological and 
prognostic gains as well as reducing long term cardiac morbidity and 
improving survival (AACVPR 1999; Coats et al 1995), although the 
mechanisms responsible for these improvements remain unclear (Stokes 
2004; Taylor et al 2004). The following section explains how CR 
programmes set about achieving these benefits. 
2.2.3 The process of cardiac rehabilitation 
CR is the process by which patients with cardiac disease, in partnership with 
a multi-disciplinary team of health professionals, are encouraged and 
supported to achieve and maintain optimal physical and psychosocial health 
(SIGN 2002). The World Health Organisation describes CR as: 
"The sum of activities required to influence favorably the underlying 
cause of the disease, as well as to ensure the patients the best 
possible physical, mental and social conditions, so that they may, by 
their own efforts, preserve or resume when lost, as normal a place as 
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possible in the life of the community. Rehabilitation cannot be 
regarded as an isolated form of therapy but must be integrated with 
the whole treatment of which it forms only one facet" (WHO 1993). 
The centrepiece of CR is often an exercise programme. The uptake of 
regular aerobic-type exercise, whether supervised or not, has a favourable 
effect on many of the coronary risk factors. For instance it may lower blood 
pressure (Whelton et al 2002), alter cholesterol profiles by raising the levels 
of high-density lipoproteins in the blood, (Kraus et al 2002) reduce obesity 
over time when coupled with sound dietary advice (Ross et al 2000) and 
alleviate stress by reducing anxiety and depression (Rozanski et al 2005). 
CR involves a variety of other interventions as well as exercise: health 
education, stress management and relaxation therapy, counselling, self-help 
manuals, home exercise programmes and risk factor monitoring. The 
medically supervised exercise programme is the backbone of the 
rehabilitation process, striving to turn previously sedentary patients and often 
their partners into habitual exercisers. 
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2.2.4 The evidence for cardiac rehabilitation 
The original CR programmes that developed in the sixties and seventies 
(Bethell et al 1983; Carson et al 1982; Kavanagh and Shephard 1973) 
concentrated on physical fitness and physical activity following myocardial 
infarction, enrolling mainly young white collar males to participate in regular 
supervised exercise sessions to aid their recuperation. Moreover, results 
from the early randomised controlled trials of exercise-based CR sought to 
establish the effectiveness of CR as an intervention for patients who had 
suffered a myocardial infarction (Bobbio 1989; O'Connor et al 1989; Oldridge 
et al 1988). Subsequent systematic reviews and meta-analyses (Jolliffe et al 
2000; Wenger et al 1995) address other components of CR as well as 
exercise training, to include psychological and educational interventions and 
greater numbers of patients with other manifestations of coronary heart 
disease. Two systematic reviews have shown CR is an effective intervention 
for patients with coronary heart disease (Jolliffe et al 2003; Taylor et al 2004). 
2.2.5 The phases of cardiac rehabilitation 
In the United Kingdom the process and time-course of CR has been divided 
into four separate but overlapping phases (Coats et al 1995), although the 
theme of secondary prevention may start with rehabilitation and prevails as a 
continuum throughout all four phases of rehabilitation (Thompson and De Bono 
1999). 
Phase I relates to the period when the patient is in hospital - usually having 
had a myocardial infarction, an episode of unstable angina pectoris, or having 
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undergone revascularisation; either coronary artery bypass grafting [CABG] or 
angioplasty'". Revascularisation is performed to alleviate the symptoms of 
coronary heart disease and to improve quality of life. The first phase of CR 
usually lasts for up to 5 days, but with the advent of earlier investigations during 
an acute cardiac event such as undergoing angiography"', the duration of the 
time in hospital may now only last 1-2 days. Patients and their families are 
given help to understand the nature of their illness by specialist cardiac nurses 
and are given going home advice or a self-help manual to assist 
convalescence. 
Phase II refers to the period immediately after discharge from hospital, when 
the patient returns home and comes under the care of the community's primary 
health care team. The duration of this phase is variable and often lasts for 2-4 
weeks until the exercise component begins. It used to be dependent upon 
several factors which includes: the formation of scar tissue in the myocardium, 
currently not so relevant as new technologies such as rescue or primary 
angioplasty have become available, the healing of the sternum for the surgical 
patients, the patient's ability to reach the rehabilitation centre and the 
availability of hospital transport. The advice received in hospital is put into 
practice and the patient may receive telephone support or a visit from a CR 
team member or the cardiac nurses from the hospital during this time. 
'" angioplasty is a procedure performed to reduce angina/chest pain by opening up the 
lumen of the artery. It is also referred to as 'percutaneous transluminal coronary 
angioplasty'. A stent is inserted to help to maintain the diameter of the newly re-opened 
coronary artery. 
'"' angiography is an invasive procedure which involves the injection of radio-opaque dye into 
the blood stream to show up the coronary arteries 
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Phase III of rehabilitation concentrates on active physical recovery provided 
through an individualised and incremental exercise prescription together with 
continuation of lifestyle advice and the risk factor monitoring which was 
provided in the first two phases. The patient returns to the hospital as an 
outpatient or to a suitably equipped leisure centre or gymnasium in the 
community to participate in an exercise and health education programme. This 
phase usually lasts for between 6-12 weeks in the United Kingdom, although it 
may last for much longer especially for patients who are in heart failure or who 
remain unwell. 
Phase IV involves compliance with a healthy lifestyle and risk factor control in 
the long term. The patients reach this phase when they have achieved their 
personal physical and psychological rehabilitative goals, are asymptomatic and 
confident about being physically active, and independent of medical 
supervision. Potentially they remain in Phase IV for life, unless succumbing to 
further cardiac illness or disability, which requires them to return to one of the 
earlier phases of rehabilitation. 
2.3 Changing recruitment to cardiac rehabilitation 
The type of patients enrolled in CR programmes has changed during the past 
two decades, and there are several reasons that may explain this. The 
definition of an acute myocardial infarction has altered over time. Formerly 
there were three criteria set down by the World Health Organisation that 
confirmed the diagnosis: a rise and fall of cardiac enzyme levels during the 
first three days in hospital, changes on an electrocardiograph [ECG] trace 
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involving development of Q waves'"", and symptoms of chest pain (Tunstall- 
Pedoe et al 1994). These patients were eligible for CR because they had 
suffered a true heart attack and it is these criteria that were used when 
identifying the myocardial infarction patients in this study. 
The term myocardial infarction has been redefined. It was recently realised 
that this definition excluded many patients who had in fact suffered an 
infarction. From 2005 onwards, patients admitted to hospital with symptoms 
of unstable angina, with or without a myocardial infarction, are diagnosed 
with an acute coronary syndrome. An acute coronary syndrome is 
considered to be a spectrum of clinical conditions which includes unstable 
angina, ST segment elevation'"M or non-ST segment elevation myocardial 
infarction and chest pain. Biochemical markers, for example, the cardiac 
enzyme Troponin T or Troponin I are measured to detect the smallest 
amounts of myocardial necrosis (McKenna and Forfar 2002) and thus 
confirm a diagnosis. Troponin concentration is measured in nanograms per 
millilitre [ng/ml] and is not detected in the blood of healthy people. An acute 
coronary syndrome may be diagnosed when the Troponin T level is equal or 
greater than 1. Ong/mI or in the case of Troponin I greater than 0.5ng/mI. 
However, an acute coronary syndrome is not diagnosed on troponin levels 
alone because elevated troponin levels are also seen in pneumonia, 
'"" Q waves - There are five deflections on the familiar Electrocardiograph [ECG] which are 
labelled PQRST. AQ wave indicates a full thickness myocardial infarction xv"' ST segment elevation - When the ST segment of the ECG is elevated it helps to diagnose 
a myocardial infarction 
28 
pulmonary embolus, myopericarditis, myocardial contusions, renal failure and 
arrhythmias. 
Many patients undergo surgical procedures for revascularisation in the form 
of either coronary artery bypass grafts or percutaneous coronary 
interventions such as angioplasty and stenting. In relation to attendance at 
CR the type of procedure that each patient receives is important for several 
reasons. The less invasive procedures enable the exercise component of 
CR to be started sooner, and for some patients a more aggressive approach 
to exercise may be considered than had been possible in previous years. 
Recovery time including a period of convalescence following a less invasive 
intervention should be swifter, although no research published to date 
confirms this. 
Although many patients in this study underwent percutaneous coronary 
interventions, none were treated with the minimal invasive technology 
available for coronary artery bypass patients; this has only recently become 
available to our coronary patients. Most of the patients in this study had 
surgical interventions between one month and up to 2 years after their index 
coronary event. 
With the accessibility of new treatments the prognosis of patients diagnosed 
with coronary heart disease has improved. These innovations include 
medications that help to limit disease progression such as lipid lowering 
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therapy for reducing cholesterol levels, the rigorous use of angiotensin 
converting enzyme inhibitors, post infarction 0 blockade and anti-platelet 
therapy, all of which help the secondary prevention of coronary heart 
disease. As a result of government targets and milestones more patients are 
offered CR programmes and the aftercare in the community has become 
more effective. 
In the randomised controlled trials and meta-analyses of CR performed 
between the 70s and up to the late 80s the focus was mainly on young male 
myocardial infarction patients (O'Connor et al 1989; Oldridge et al 1988). 
Current CR participants are older because life expectancy has increased due 
to improved treatments for their medical conditions and also because the 
need to make CR programmes more accessible to elderly people has been 
recognised. Older people are beginning to be better represented in recent 
studies (Ades 1999; Ahto et al 1997; Austin et al 2005; Fattirolli et al 1998). 
The number of females being recruited into CR has grown due in part to an 
improvement in detecting coronary heart disease in women. Females were 
commonly misdiagnosed in the past because their symptoms were often less 
obvious and not stereotypical (Miller 2002). 
2.4 Summary 
Most published studies of coronary heart disease within the CR population 
have involved small numbers of patients who have sustained uncomplicated 
myocardial infarctions, and for whom the prognosis is good (Jolliffe et al 
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2003). Long term outcome data related to coronary heart disease patients 
who access CR programmes are limited and some data are skewed by 
including these selected patient populations. For example most research in 
this field of medicine has focused on younger, male patients who were 
enrolled in the early CR programmes during the 70s (Carson et al 1982; 
Mayou et al 1981; Oldridge et al 1983). On the other hand, the main strength 
of my observational research lies in the large number of patients studied and 
their wide spread of age, fitness, co-morbidity and cardiac performance. 
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Chapter 3 
Review of the Literature 
Introduction and Methods 
3.1 Structure of the review 
The literature review is divided into 5 chapters of which this chapter provides 
an introduction to the following 4 chapters in my thesis. In this first chapter, I 
describe the search strategy I used to select the studies included in my thesis 
as well as the criteria I adopted to locate the papers and publications that I 
finally chose for inclusion. 
Chapter 4 focuses on what is known about physical fitness and changes in 
physical fitness as predictors of progression in coronary heart disease and 
includes a definition of physical fitness and physical activity. 
In Chapter 51 examine the epidemiology of coronary heart disease 
progression and depression. In this chapter, I define clinical depression and 
focus on the role of depression as a risk factor in coronary heart disease. 
Chapter 6 describes the pathophysiological mechanisms associated with 
coronary heart disease and depression. Finally, in Chapter 71 discuss the 
role of antidepressant therapy and psychological interventions in people with 
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coronary heart disease. This chapter includes a section on the Cochrane 
Review of psychological interventions for coronary heart disease (Rees et al 
2004) and also examines studies of depression and exercise within the CR 
environment. 
My initial searches used the databases illustrated in Table 3: 1. 
Table 3: 1 Databases accessed in my initial searches 
Database Dates Comments 
Dialog-DataStar Access to databases marked 
plus DH data, Kings Fund & 
Allied Health Professionals 
database 
Science Citation Index 1981 to date Covers over 2,500 medical 
journals 
oMedline 1951 to date Bibliographic database of the 
National Library of Medicine 
oPubMed The National Library of 
Medicine's search service of 
which Medline is a part 
°Cinahl 1982 to date Cumulative Index to Nursing 
and Allied Health Literature 
-Embase 1974 to date Biomedical and pharmaceutical 
databases world wide 
DPsychINFO 1806 to date Psychological resources database 
The Cochrane Library Updated evidenced - based 
health care 
TRIP Turning Research into Practice - 
an evidenced base database 
Zetoc 1993 to date Access to the British Library's 
electronic table of contents 
The National Research To locate on-going research 
Register projects 
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The key words used in each electronic database for the searches included 
the following selection: 
Cardiac 
Cardiovascular 
Coronary 
Coronary heart (artery) disease 
Coronary artery bypass graft 
Depression 
Exercise 
Ischaemia 
Ischaemic heart disease 
Longitudinal/cohort studies 
Meta-analysis(es) 
Mortality 
Myocardial infarction 
Percutaneous transluminal coronary angioplasty 
Physical activity 
Physical fitness 
Randomis(z)ed, controlled trial(s) 
Rehabilitation 
Reinfarction 
Revascularisation 
Review 
Secondary prevention 
Survival 
I used these words both singly and in combinations with each other. Wild 
card symbols [*] were used to truncate words that had similar roots but 
different endings - such as 'ischaemic' and 'ischaemia' and also to 
differentiate between words that were spelled in American or English as 
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illustrated in the Table 3: 2. When a search produced too many references 
[over 400 at any one time] I limited the parameters of the searches to 
produce a more manageable selection. 
Table 3: 2 Example of search terms 
Number of references Term 
retrieved for review 1 
Depression+ischaemia+survival 626 
Depression+ischaemia+mortality 1109 
Exercise+ischaemia+survival 1287 
Exercise+ischaemia+mortality 2154 
Cardiac+rehabilitation+fitness 331 
Cardiac+rehabilitation+ myocardial infarction 1688 
Cardiac+rehabilitation+ revascularisation 19 
1 Some references may be duplicated in 2 or more databases 
I located most of my references by utilising the online pre-configured 
connection to a bibliographic software management programme. Retrieving 
references from a remote database such as PubMed was far easier than 
using traditional structured methods of searching. I chose PubMed as my 
main database because access was free and did not require a password. It 
was possible to view publications using a variety of headings, such as 
authors, year, or topics. I then browsed the title of each article and the 
abstract, when available, and downloaded potential references into a library 
created for this thesis. It was possible to obtain full `pdf texts using this 
method from many journals by using the URL link that was displayed. I 
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deleted duplicate and triplicate references from my thesis library on a regular 
basis. 
One source of material was through access to the World Wide Web and the 
Internet. I registered online for notification of newly published journal articles 
relevant to my research, selecting suitable articles which I subsequently 
obtained using my reference manager, as described above. Another source 
of literature was from the journals I subscribe to on a regular basis. These 
are Heart, The Journal of Cardiopulmonary Rehabilitation, The European 
Journal of Cardiovascular Prevention and Rehabilitation and the British 
Journal of Cardiology. Additional references were obtained through hand 
searching papers that I already had prior to starting this research project, and 
by scanning the bibliographies and reference lists of the papers I had 
collected for assessment. I identified key authors and experts in the field of 
my thesis, and approached them in person at conferences or via email to 
request specific papers. All those I approached, without exception, sent me 
a copy of their publications. The final number of references is shown in 
Figure 3: 1. 
All relevant references, together with their abstracts, when available, were 
downloaded from the Internet or transcribed manually into my reference 
manager (Thomson 2002). After removal of all duplicate and triplicate 
entries, a total of 166 unique publications were selected for inclusion in this 
review. 
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3.1.1 Selection of the studies 
I have limited my research to aspects of coronary heart disease. There are 
three reasons for this decision. Firstly, by excluding other manifestations of 
cardiovascular disease, such as peripheral vascular disease or cerebral 
vascular disease, I have been able to concentrate on the vast amount of 
literature that is accessible on coronary disease alone. Secondly, the 
patients in my cohort joined the CR programme because of their coronary 
pathology, although they may also have presented with a significant degree 
of systemic cardiovascular co-morbidity. Thirdly, specific rehabilitation 
techniques used to treat patients with either cerebrovascular or peripheral 
vascular disease are markedly different from the methods we use to 
rehabilitate coronary patients. For example, patients with peripheral vascular 
disease are encouraged to walk through the pain of claudication, felt in their 
calf muscles to stimulate the formation of collateral circulation (Skinner and 
Strandness 1967). For coronary patients it is contraindicated to exercise 
above the ischaemic anginal threshold for fear of making the myocardium 
ischaemic and provoking life-threatening ventricular arrhythmias. 
I used the following criteria to select the publications that were included in 
this literature review: 
Publications were written in English, and 
related to coronary heart disease 
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included physical fitness, and/or depression, and mortality in people 
with pre-existing coronary heart disease 
involved CR as an intervention that addressed either exercise or the 
psychological sequelae of coronary disease 
looked at physical fitness, and/or depression with reference to 
mortality or morbidity as outcome measures 
Therefore the review includes results from research performed within the 
context of CR programmes such as ours; these being likely settings for 
studying fitness and depression in relation to the management of patients 
with coronary disease. It also includes literature from the non-CR 
environment. 
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Chapter 4 
Physical fitness and changes in physical 
fitness as predictors of progression 
in coronary heart disease 
4.1 Introduction 
Epidemiological studies have demonstrated an important association 
between physical activity, physical fitness, cardiovascular health and survival 
(Blair et al 1989; Kavanagh et al 2002; Kavanagh et al 2003; Morris et al 
1973; Morris et al 1953; Morris et al 1966; Paffenbarger 1972). It is well- 
established that regular physical activity increases exercise capacity and 
improves physical fitness and also confers a variety of other health gains, 
such as reducing the risk of stroke (Lee and Paffenbarger 1998; 
Wannamethee and Shaper 1992), some cancers (Giovannucci et al 1995) 
and diabetes (Haapanen et al 1997). The more physically active an 
individual is, the greater their degree of fitness and the lower the risk for 
developing coronary heart disease (Berlin and Colditz 1990; Blair et al 1989). 
Even small improvements in fitness appear to reduce mortality (Erikssen et al 
1998), but more vigorous exercise regimes have a greater effect in 
populations with or without cardiovascular diseases (Blair et al 1996; 
Vanhees et al 1994). The mechanisms through which biological and clinical 
benefits of physical activity and physical fitness are mediated are not clear 
(Vanhees et at 2005) and sometimes seem contradictory (Hambrecht et at 
2000). 
51 
4.2 Physical fitness and physical activity 
Physical fitness and physical activity are significant factors in both the 
prevention and treatment of coronary heart disease. Physical fitness is 
defined as: 
"The capacity to meet the present and potential challenges of life. 
Physical fitness is a set of attributes that persons have or achieve that 
relates to the ability to perform physical activity" (CDC 1996a) 
There are a number of health related components to physical fitness. These 
are flexibility, muscular strength, muscular endurance, explosive strength, 
balance, speed and cardiorespiratory fitness (Vanhees et al 2005). Cardio- 
respiratory fitness, also referred to as exercise capacity, endurance fitness or 
aerobic power, is the ability of the body's circulatory and respiratory systems 
to use oxygen during steady state exercise. Poor cardiorespiratory function 
or low levels of fitness are particular important aspects of total physical 
fitness because they are associated with both the development and 
progression of coronary heart disease. 
Aerobic' exercise and physical activity are associated with physical fitness 
because the uptake of exercise or becoming more active helps to improve 
fitness levels (Thompson et al 2003). Physical activity is: 
Aerobic means with oxygen, and refers to the utilisation of oxygen by muscles to produce 
energy. Aerobic exercise increases stamina - our ability to keep going when performing 
exercise such as brisk walking or jogging, cycling, rowing or swimming. 
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"Bodily movement that is produced by the contraction of skeletal 
muscle and that substantially increases energy expenditure" (CDC 
1996b). 
Examples of physical activity are found in all the routine activities we perform 
daily, for example household jobs, shopping and work 
For health-related fitness, adults should participate in regular physical activity 
of a 'modest' intensity for about 30 minutes on most days of the week (Pate 
1995) although results from the earlier epidemiological studies found that 
vigorous, as opposed to modest exercise, afforded greater cardiac protection 
(Blair et al 1996). High levels of physical fitness are sustained by greater 
levels of physical exertion. Conversely, a reduction in exercise habit for 
whatever reason will decrease levels of physical fitness. Exercise training is 
capable of improving physical fitness in those with or without coronary heart 
disease (Bethell 1987; Dugmore et al 1999; Shoenfeld et al 1980). 
The Health Survey for England (DOH 2004) found that only 37% of males 
and 25% of females reported doing the recommended amount of exercise 
weekly. In the over 75 year old age group the figures were smaller, with only 
7% of males and 4% of females achieving the suggested targets. The earlier 
Allied Dunbar Survey had measured fitness objectively via exercise treadmill 
testing as opposed to questionnaires (The Sports Council 1992). This survey 
found that one third of men and two thirds of women were unable to walk up 
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a 5% gradient at 3.00mph without exceeding 70% of their maximum heart 
rate, which indicated a low level of physical fitness within their sample. 
4.3 Measuring physical fitness and physical activity 
It has been suggested that physical fitness and physical activity should be 
considered as separate and independent characteristics (Myers 2005; 
Williams 2001). They are measured in a variety of ways. Data on physical 
activity is collected from physiological responses to exercise - i. e. heart rate, 
the use of motion sensors such as pedometers and accelerometers, or via 
self-reported diaries or questionnaire surveys. However, these methods are 
difficult to quantify accurately (Haskell and Kiernan 2000). Measuring 
physical/cardiorespiratory fitness, rather than physical activity, may be a 
better marker of cardiovascular state (Myers et al 2002; Vanhees et al 2005). 
The measurement of physical fitness is not straightforward because it 
embraces several components. While some publications refer to 
cardiorespiratory fitness, others use the term physical fitness to describe only 
the cardiorespiratory component of total physical fitness. For the purpose of 
this thesis, I shall refer to cardiorespiratory fitness as physical fitness, unless 
it is important to differentiate between the two terms. 
An integral aspect of clinical assessment at the start of CR is the recording of 
current fitness levels. Various ways of measuring physical fitness are 
available. The most accurate way uses direct measurement of oxygen 
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uptake [V02] by analysis of expired gas. The rate of oxygen consumption 
during maximum exercise [V02max] is the gold standard measure of physical 
fitness, but does require expensive equipment to perform. 
Cycle ergometry, usually used in field tests, or treadmill exercise testing, 
under laboratory conditions (Shephard et al 1968) are two methods for 
determining V02 (Andersen et al 1971). V02 can be predicted from the 
workload performed during cycling or walking on the treadmill and is 
expressed as maximum, peak or symptom limited. In practice, most cardiac 
patients are tested to a level below maximum [sub maximum] because of the 
development of symptoms [symptom limited]. Various protocols have been 
designed and standardised for exercise testing using a treadmill, cycle 
ergometer, step test or shuttle walk. Some researchers express exercise 
rate in watts, [one watt being equivalent to one joule of energy per second], 
whilst others use METS [one metabolic equivalent is the consumption of 3.5 
millilitres of oxygen per kilogram per minute] to reflect the energy 
requirements for certain activities. 
4.4 Strategy for searching and selection of studies 
This chapter focuses on physical fitness and the effects of changes in 
physical fitness in relation to disease progression in people with coronary 
heart disease. To locate the references for this section of my literature 
review, I searched systematically papers on physical fitness and mortality 
and the pathology of cardiovascular, as opposed to coronary heart disease. 
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My inclusion criteria were studies that incorporated a baseline measure of 
cardiorespiratory fitness or reported on changes in levels of physical fitness 
[exercise capacity] in relation to survival, mortality or nonfatal cardiovascular 
events. The studies had at least 50 participants, and had a follow-up period 
of at least 6 months. The databases searched are described in the 
introduction to the literature review [Chapter 3]. My search initially yielded 
161 references dating back to 1953. The following sections review firstly 
observational, and secondly intervention studies, under the three sub- 
headings: 
1. Baseline physical fitness and mortality 
2. Baseline physical fitness and risk of nonfatal cardiovascular 
events 
3. Changes in levels of physical fitness or exercise capacity and 
risk of mortality and nonfatal cardiovascular events. 
4.5 Observational studies 
Seven observational studies focus on the prognostic effect of 
cardiorespiratory fitness on survival in people with established coronary heart 
disease (Awad-Elkarim et al 2003; Fioretti et al 1988; Froelicher 1994; 
Kavanagh et at 2002; Kavanagh et at 2003; Vanhees et at 1995; Vanhees et 
al 1994). Details of these studies are shown in Tables 4: 1 a and 4: 1 b. Five of 
the studies report on the relationship between baseline fitness and survival, 
and two report the effect of changes in exercise capacity on mortality in 
coronary heart disease. 
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4.5.1 Baseline physical fitness and mortality 
The largest cohort study of CR patients followed 12,169 white professional or 
managerial males, in their mid-fifties, who had attended a Canadian CR 
programme and were followed up for between 4 to 29 years with a median 
follow up time of 7.9 years as seen in Tables 4: 1 a and 4: 1b (Kavanagh et al 
2002). Initially 13,131 men were recruited to CR, of whom 154 were 
excluded from the study if they were unable to participate in exercise testing 
which used expired gas analysis, or if they did not have coronary heart 
disease. The remaining patients performed a maximal exercise test, unless 
contra-indicated, on a cycle ergometer at the start of CR to determine a 
baseline level of physical fitness. Repeat exercise testing was carried out 
13.4 ±3.9 weeks after enrolment. Over half the patients had suffered a 
myocardial infarction, a quarter had undergone bypass surgery and the 
remainder had non-specific diagnoses of coronary heart disease. Patient 
data on coronary risk factors such as smoking habit, blood pressure and 
fitness levels at entry to CR were examined for their association with cardiac 
and all-cause mortality and to look for possible predictors of survival. 
Baseline fitness was treated firstly as a continuous variable and also 
categorised into three levels of fitness: low [VO2peak <15mVkg/min], moderate 
[V02peak 15-22 ml/kg/min] and high [V02peak >22m1/kg/min]. The data were 
analysed using a Cox proportional hazards model. 
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During the follow up period, 19.3% of the cohort died. Almost half of the 
deaths were from cardiovascular causes. This study showed baseline fitness 
[VO2peak] to be a powerful predictor of both all-cause and cardiac mortality for 
participants as seen in Table 4: 2. The high fitness category was associated 
with a 55% reduction in the risk of death from all causes and a 61 % reduction 
in the risk of cardiac mortality. The moderate fitness category was 
associated with a 34% reduction in the risk of death from all causes and a 
38% reduction in the risk of cardiac mortality. An important finding from this 
study was the association of a 9% reduction in cardiac mortality [HR 0.91], 
for every one ml/kg/min increment of the initial peak oxygen intake. Being on 
digoxin medication for a cardiac rhythm disturbance (p<0.0001), or a current 
smoker (p<0.0001), or having a diagnosis of diabetes (p<0.0001) were also 
predictive of a higher risk of cardiac mortality. 
Table 4: 2 Predictors of mortality in males attending CR 
(Kavanagh et al 2002) 
High Moderate Low p value 
fitness fitness fitness 
All cause deaths HR 0.45 HR 0.66 HR 1.00 
CI 0.42,0.55 CI 0.59,0.73 <0.0001 
Cardiac deaths HR 0.39 HR 0.62 HR 1.00 
Cl 0.33,0.47 Cl 0.54,0.71 <0.0001 
The researchers also followed up 2,380 females from the same cohort. The 
females were aged 59.7 ±9.5 years (Kavanagh et al 2003). Half the 
participants were enrolled into the study following myocardial infarction, 
nearly a quarter had undergone coronary artery bypass procedures and the 
61 
remainder had other forms of coronary heart disease. Baseline fitness was 
measured in the same way. The baseline fitness levels were treated as a 
continuous variable and also as a binary variable, with the cut off point being 
V02 of 13ml/kg per minute, which equates to a little less than 4 METS. Data 
were analysed using a Cox proportional hazards model. 
At the end of the follow-up period 12.8% of the cohort had died, of which just 
under half had died from cardiac causes. Treating baseline fitness as a 
binary variable, all-cause mortality was reduced by 29% and cardiac mortality 
was reduced by 50% for those with a V02peak>13ml/kg/min [Table 4: 3]. The 
female participants had a 1% lower level of cardiac mortality, compared to 
the males, [HR 0.90,95% Cl 0.85,0.96 (p=0.001)], for every 1 ml/kg/min 
increment in initial VO2peak" Being on digoxin (p=0.005), anti-arrhythmic 
therapy (p=0.0001) or having a diagnosis of diabetes (p=0.0001) was 
predictive of a higher risk of cardiac mortality. 
Table 4: 3 Predictors of mortality in females attending CR 
(Kavanagh et al 2003) 
High Low p value 
fitness fitness 
All cause deaths HR 0.71 HR 1.00 
CI 0.53,0.95 0.0204 
Cardiac deaths 
HR 0.5 HR 1.00 
CI 0.34,0.76 0.001 
There are several interesting points concerning the two studies I have 
described above. Firstly, the baseline measures of fitness were recorded at 
13.4 ±3.9 weeks post cardiac event, which is later than often reported in CR 
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studies (Bethell and Mullee 1990; Carson et al 1982; Dugmore et al 1999). 
In a randomised controlled trial (Bethell and Mullee 1990) participants 
performed exit CR exercise tests at 18 weeks post infarction, which was the 
time that some of Kavanagh's participants were undergoing their pre-CR 
exercise testing. Following myocardial infarction there is tendency towards 
spontaneous recovery with improvement in cardiorespiratory function during 
the first 3 weeks to 6 months post infarction (DeBusk 1977; Franklin et al 
1992; Greenland and Chu 1988; Haskell and DeBusk 1979). Therefore the 
sooner after infarction that exercise capacity is measured the lower it may be. 
Baseline fitness reported for considerably younger male myocardial infarction 
participants who underwent exercise testing post infarct was 23.6m1/kg/min 
(Vanhees et al 1995), whereas Kavanagh's male myocardial infarction 
participants had a mean baseline V02 of 20.5ml/kg/min when assessment 
was several weeks later. 
One limitation of this research is that co-morbidity, complex pathology and 
psychological state were not accounted for with the exception of diabetes. 
Secondly, in addition, the researchers did not explain why some patients 
were unable to perform the exercise tests, although one reason for this may 
have been due to co-morbid illness that limits their ability to participate. It is 
also not clear why the female patients were described as having 
uncomplicated stable coronary disease even though diagnoses were similar 
to those assigned to the male patients. Because the risk of mortality in stable 
coronary heart disease is lower than the risk after acute myocardial infarction 
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or acute coronary syndrome, the outcome for the female cohort may only be 
generalisable to individual women with stable coronary heart disease. 
Finally, the reporting period for both studies spans 30 years, from 1968 - 
1998. During these 30 years treatments changed and survival after a cardiac 
event improved. 
Other researchers have also examined the importance of baseline fitness 
levels. Froelicher and colleagues looked at treadmill exercise testing 
variables as predictors of cardiovascular mortality in a group of 258 patients 
[39 females], under 70 years, who were admitted to hospital following an 
acute myocardial infarction between 1977 and 1980 (Froelicher 1994). Low- 
level exercise treadmill tests were performed on participants with 
uncomplicated pathology before discharge from hospital following the index 
cardiac event. The participants were followed up for 10.6 years at which 
point 27.5 % of the cohort had died, the majority [21.7%] from cardiovascular 
causes. The drop out rate from the study was low at 5%. The researchers 
reported that ST segment elevation, or ST depression on an ECG, and a 
It hypotensive blood pressure response to the exercise testing were predictive 
0 
-b 
of cardiovascular death. However, in this small group of participants baseline 
fitness was not predictive of cardiovascular death [HR 1.6,95% Cl 1.0,6.5] 
and was subsequently excluded from further analyses. 
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4.5.2 Baseline physical fitness, mortality and risk of nonfatal 
cardiovascular events 
A study has been published recently which examined the prognostic value of 
early exercise testing and coronary angiography in young survivors of a 
myocardial infarction (Awad-Elkarim et al 2003). From 255 eligible patients, 
150, including 20 females, were recruited to undergo early exercise testing 
and angiography. Physical fitness was measured and expressed by the 
amount of time endured on treadmill exercise testing, and the participants 
were divided into 2 groups: those who could achieve more than 15 minutes 
of the modified Bruce protocol, which equates to 9 minutes of the full Bruce 
protocol, and those who could not manage 15 minutes of the modified 
protocol. The participants were followed up for 15 years. As well as 
reporting on survival, the study also reported the incidence of nonfatal 
events. During the follow up period there were 44 deaths. One hundred 
percent of the 121 female participants had suffered at least one more 
cardiovascular event. Those who had been able to complete 15 minutes of 
the exercise protocol at the baseline exercise assessment were less likely to 
suffer a recurrent cardiovascular event than those who were unable to do so. 
The hazard ratio for the predicted risk for the participants who were able to 
achieve a treadmill test of 15 minutes or more was 0.56 [Cl 0.38,0.82 (p 
=0.003)]. The event free survival odds ratio was 0.35 [Cl 0.13,0.98 (p = 
0.05)]. 
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This study showed the importance of baseline fitness on survival for 
comparatively young participants from the infarct population. However, the 
number of patients recruited to the study was small, the reported drop out 
rate was 13%, and there were few female participants in the cohort. The 
effect of fitness on other manifestations of coronary heart disease remains 
unclear. 
4.5.3 Changes in levels of physical fitness and risk of mortality 
and nonfatal cardiovascular events 
For coronary patients who have had a recent myocardial infarction, the 
VO2max is 10-30% lower than matched controls without overt coronary heart 
disease (Bruce et al 1974; Sanne 1978). Two observational studies have 
measured change in fitness levels in association with mortality and morbidity 
outcome measures. These studies examined baseline measures and also 
changes in measures of fitness following exercise training as predictors of 
survival (Fioretti et al 1988; Vanhees et at 1995). 
The first study followed a group of low risk male patients, with an age range 
of 24 to 74 years, referred to a CR programme of 3 month's duration 
following myocardial infarction or coronary artery bypass grafting or both, 
between 1978 and 1988 (Vanhees et al 1995). Some of the patients were 
part of the same cohort which the authors had previously described 
(Vanhees et al 1994). Patients were followed up for an average of 6.2 years. 
The drop out rate from the CR component was 17.6% and a further 3.9% of 
participants failed to complete the second exercise test at the end of CR. 
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The remaining 417 patients underwent cycle ergometry exercise testing to 
the point of exhaustion with respiratory gas analysis at the start and end of 
CR. The mean age of the group was 53 years and the co-morbidity 
accounted for included diabetes [3%] and chest pain [24%]. The mean body 
mass index of the patients was 24.8 and the mean V02 before starting CR 
was 23.6m1/kg/min. 
During the CR programme the patients accumulated just under 4 hours of 
exercise training per week. Exercise capacity was expressed as V02peak. 
The improvement in measured V02 following completion of the CR 
programme was significant (p<0.001) with the mean V02 rising to 
30.8ml/kg/min. One patient was lost to follow-up, and therefore survival 
analyses were reported on 416 patients. Single and multiple Cox 
proportional hazards regression models were fitted to calculate the relative 
hazard rate for deaths from cardiovascular and all causes. 
Nearly 9% of participants died during the 10-year follow-up period, of which 
just over half the deaths were attributable to cardiovascular causes. The 
mean increase in V02peak by the end of the CR course was reported as 33%. 
Resting heart rates and heart rates during sub-maximal exercise were also 
lower by the end of the exercise programme indicating improved 
cardiovascular status. The hazard rates for V02peak before and after CR and 
the change in VO2peak were put into a regression model unadjusted and also 
adjusted for age, current smoking, diabetes and hypertension. VO2peak 
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recorded at the end of CR was a better predictor of survival than the baseline 
measures. The relative hazard ratio for the percentage increase in V02peak 
between the start and end of CR was 0.98 (p<0.05). This showed that a1% 
rise in VO2peak at the end of CR was associated with a decrease in 
cardiovascular mortality of 2%. 
The results from this study were limited by several factors. The researchers 
were not able to account for the patients who were not referred to CR, nor for 
those who refused to attend following invitation. The cohort consisted of 
patients who opted into the CR programme. The reported drop out rate was 
17.6%. In addition the authors did not report any co-morbid conditions other 
than diabetes, which suggests that the patients did not have any concomitant 
orthopaedic or musculo-skeletal conditions, often prevalent in non-selected 
CR cohorts. An increase in VO2peak of 33% is uncommon in coronary 
patients who have undergone a short course of CR exercise training, 
although the frequency and dose of weekly supervised exercise at four 
sessions weekly was greater than often reported from CR programmes, 
where one or two sessions are the custom. For instance in a study 
performed in the United Kingdom V02peak measured by expired gas analysis 
increased between 13-15% following an 8 month period of exercise 
(Dugmore et al 1999). Finally, the mean body mass index of the cohort was 
lower than is usually reported in male patients who attend CR programmes. 
The median body mass index of the patients in the cohort that is the subject 
of this thesis was much higher at 27.2kg/m2 (22.0,35.1) for the females and 
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26.8kg/m2 (22.9,32.7) for the males. The participants enrolled in Vanhees' 
study were atypical representatives of people with coronary disease. 
One other small observational study reports on changes in physical fitness 
and mortality after attendance at CR (Fioretti et al 1988). The study aimed to 
establish whether haemodynamic" measurements such as nuclear 
ventriculography"' ejection fraction" and exercise capacity assessed during 
the acute phase of myocardial infarction were predictive of exercise capacity 
at the end of CR and also 1-year mortality. Under half of the patients 
admitted to a coronary care unit [CCU] with a diagnosis of a myocardial 
infarction were selected to undergo haemodynamic investigations as seen in 
Figure 4: 1. 
Haemodynamic refers to the dynamic regulation of blood flow 
'° Nuclear ventriculography involves the use of radioactive tracers which show up the heart 
chambers and blood vessels 
'" Ejection fraction is the amount of blood pumped out of the left ventricle as it contracts 
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Figure 4: 1 Flowchart illustrating study enrolment and outcome 
(Fioretti et al 1988) 
702 eligible participants 
from a 
CCU post MI 
327 selected to 
participate in study 
193 selected to perform 
pre-discharge 
exercise test 
80 low risk participants 
selected to attend CR 
60 low risk participants 
completed CR 
34 CR completers 
had normal 
exercise capacity 
45 deaths in CCU 
30 deaths at follow-up 
20 dropped 
out of study 
26 CR completers 
did not have normal 
exercise capacity 
4 died 
4 cardiac 
complications 
4 non cardiac 
complications 
8 non medical 
reasons 
Only those with complicated infarctions or those taking part in a thrombolytic 
trial were recruited to the study initially. Of these 80 patients were recruited to 
a 3-month long CR programme with supervised exercise sessions lasting 1.5 
hours twice a week and 200 patients were not offered CR. The drop out rate 
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following initial enrolment was 25%. Sixty participants completed a second 
exercise test at the end of CR. The participants were divided into 2 groups 
depending upon the outcome measure of exercise capacity at the end of CR. 
Those with a normal exercise capacity which was measured in watts [ie a 
capacity of 100% or more, as compared with a normal population of the 
same gender, age and height] formed one group, and those with less than 
normal capacity the other. Exercise capacity of those who had completed 
CR increased by 26% (p<0.001) over the 3 months of supervised exercise 
training at CR. One year mortality was reported for 327 patients originally 
selected for the study, of whom 14% died during initial hospital admission 
and 9% died within the year. Baseline exercise capacity but not exercise 
capacity at the end of CR predicted survival for the 60 participants for whom 
a change in fitness result was obtained. This differed from Vanhees and 
colleagues' findings, which showed V02peak at the end of CR to be predictive 
of survival. 
The results from this study are limited for several reasons. The sample size 
was small and predominantly [92%] male. Although the original cohort was 
composed of patients with complicated infarctions, those who attended the 
CR programme were a selected group of patients. They were younger [mean 
age of 51 years], had a greater mean ejection fraction (p=0.05) and less sick 
Killip class (p=0.005) than the patients who were not offered CR. Finally, the 
authors did not account for non-cardiac co-morbidity in the analyses. 
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4.6 Intervention Studies 
4.6.1 Changes in levels of physical fitness and risk of mortality 
Fourteen intervention studies looked at changes in measures of physical 
fitness during exercise programmes and also assessed the risk of mortality. 
Most of these studies involve small numbers of male post myocardial 
infarction patients who have undergone CR. They report on measures of 
physical fitness, all-cause and cardiac mortality and the recurrence of 
nonfatal cardiovascular events. Results have often not reached statistical 
significance. It has been estimated that approximately 4,000 patients would 
be required to achieve significance in this type of research (Greenland and 
Chu 1988; Shephard 1985). The largest trial recruited 733 patients, of whom 
nearly half dropped out (Rechnitzer et al 1983). The main points from these 
studies are summarised in Tables 4: 4a and 4: 4b. The majority of intervention 
studies enrolled male patients who had suffered a myocardial infarction 
(Bethell 1987; Bethell et al 1999; Bethell and Mullee 1990; Carson et al 1982; 
Dorn et al 1999; Dugmore et al 1999; Hedback et al 1993; Kallio et al 1979; 
Marra et al 1985; Rechnitzer et al 1983; Roman et al 1983; Shaw 1981; Stern 
and Cleary 1982; Vermeulen et al 1983; Wilhelmsen et al 1975). Only two 
studies focus on patients who had undergone angioplasty (Belardinelli et al 
2001; Hofman-Bang et al 1999). There were no studies on patients who had 
undergone coronary bypass graft operations. 
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The largest intervention study was performed by the National Exercise Heart 
Disease Project group of researchers (Dorn et al 1999; Shaw 1981; Stern 
and Cleary 1982) who have followed up a group of 651, young, low risk male 
post myocardial infarction patients for up to 19 years, after they were 
randomised to join either supervised exercise programmes or undergo usual 
care which consisted of follow up but without structured exercise. Fitness 
was measured in METS from treadmill exercise testing. The exercise 
capacity of the treatment group improved significantly over the period of the 
intervention which lasted for up to 3 years, and ranged from an 8-14% 
reduction [dependent on the timing of the outcome assessments] in all-cause 
mortality, for every single MET gained in fitness. The control group also 
showed an improvement in exercise capacity and for those who took up 
exercise, reduced mortality. Thirty-one percent of the control group had 
taken up exercise, which may have influenced outcomes. However, the 
reduction in mortality was not significantly different between the two groups 
and diminished over the time of the follow-up period. 
73 
L 
0 E 
ü 
to 
N 
N 
0 
N 
d L 
1 
C 
L 
CU 
0 
04- 
0 
H 
2 L 
N 
ea 
d 
E 
ü d 
ea L 
O 
C. 
L 
O 
V 
C 
d 
ca 
ß 
E 
NO 
(1) 0 
'O O 
O 
( C 
Cßeä 
OE 
CN 
r 
d 
> 
OO 
M 
- _ß 
N 
ea 
cu Ö 
Ga ea 
.DV ßL 
F- 0 
wa 
00 
aw 
-o 
OO 
YV 
C ýL 
Cw 
O ýÜ 
E 
H 
d 
Od 
V ++ 
ýý 
Oý 
H 
I 
Vl 
H 
d 
C 
WA 
y 
w 
C 
C4 a 
a 
0 
öV 
V 1Z3 
Vr 
d a, h 
H "r 
O ed tef N 
en ý 
i+ 
2. 
IUr c 
U U U 
cli cu 
7 c 
Vl N 
i 
NN 
yN l 
IV. aa öö 
UUOU Ic 
O 
E 
F 
F Iý Iý IF 
C C 
Ü 
Mw ýw 
i 
ftl -d 
m" 
25 
°A Y öx 
dZw 
ö x 
dUZ¢ýw 
b9 tu 
n. r N 
g: L. Co - >, 
ut 
N 
g. ZU 
_u u VU 
ö 
ö etw 
ÜGýý 
e 0 
ä 
dO Co 
L 1(ý 
WY 
1 
Ä 
E-ý 
H YO 
'_m In 
WM 
Z 
-0 
C 
ar 
N 
EG 
t- 
N 00 
00 00 
'r 
N 
N 
0 
'1i - M C. 
oa 
I-. 
= ON 4 E-. 
0V. . 
ýý cd 
en 
NF 
"C 
H 
6J jr 
}ten 
üb 
3 
ý"N 
7d 
O 
Oy cry 
ywý H_ 
tÜZW 
r 
vi 
0O 
ýJ F 
2 
b 
OJ1 NN 
x- 
.. WA vivý°: Cýýý"°: 
ýý ý ä. 
ýýM 
T 
Cw 
=0'a 
ýýý 
on 
ü 
3u 
uF 
2y 
7 
O 
ä 
ed 
0 
ýzw 
Ay 
3oM 
E°ä 
n 
bU 
C45 y 
5 
ÜN ^ý ýrý ý3 li 
.SN 4" 
in wl 
" 
E 
0 v - b1 
a 
ü jý 
LN 
b 
ö 
b 
G 
0 v 
b 
u N 
0 
b 
G 
ed 
Lý 
x 
F- ti 
Iwa 
.00 12 
2 
Z,: ö 
= 
y. 
>U 
'U ýU 
YLy 
ýG"! 
"U 
ýTJ"+ 
`ý 
CO 
wV~ 
C 
,yU 
Ir 
N O0 UUUUU 
is C- . tea M 40'ci "5 
jz aý °a m m, g 2- p °'°, OOx 'O 
NOk 'O QpmN 
0 tU -2 U rý 
ZU 'r7 NC 
M. 
LY . 
ZD 
"7 
E 
On 
e=cu '0 'u ED 
'ai 17 
osu s: u 
L 
"ýee 
aUi x7UU ÜÜ vý 
oXi 
nvýv aki ° 
2 
E -u 
2O fUn 00OM0 
ü °ý' :d" L'. 5 i'. 5 Lam' one 
A:, e 
Q CO 02. S O 11 -C t0 cd Oe "C ed 
'O "^ W p, Epýý wc 8oaiý Eoäýý Wýä Euoce 
ýý a. o_ ov 0 cU Z. Uci a`de. ý aý 
r 
N: Wm" 
TJ 
4"' 4U"ß 
w5w QÜZÜ ¢ÜZo ÜZäw äz5w dÜZw 
ö ig myU 
y c0 oL 7. S u t. 1 
oo 
E aä 
öy 
`Q p `Q 
°ý o~ 
UöÖ 
CO 
Nöö 
ý.. 
F ýD i. "V 0. M 4ý "ý 
ýD 
ý-"ý 40. M 0. ý, NZ 
h 
d 
F3g 
3 CA 
KA 
w o% O (59 
9 CO 
> >ý 333 
e4 04 
ECE .C7 bbtu cn o3 ODD EMC . °+ N2 cÖ 
ä"ý vv ce 
.ý . 
ý'ß. iq vP. i0 
Gw 07 axi CLl aka Co 
Cn'' D 
"5 G 
ECG aýi E ý" ßý 
N 
.. 
V0 n°E ce en 00 ýö 
19-2 00 
Q0 
"U äý 
0oc «. «. 
w`. V' M e{ p, 000 eG 
Ü 
00 
CO 
ß. 
.u 
y 
5, 
- 41 
wo 
o- e" or 
YyHy tß/1 rý/f 
ypo 
ä& o fi 
QR 
CD- 
TO T0 M -ýr 
P. 
«- M ýý"r 1- r", "i N N- -ý"+ = elm 00 ON 00 
x 
C) s- >Fö 
py 
y 
.VUl. 
rN W CO "b 
UO5m 
tg 
et 
8oüWö °' c aGi c it ems, 
C7 
°' aýi cu CC9 
"ZP U° 
U 
°' °' UOO ö `O 
U 
i` 
M e'da 'ý- 
ä. FV Wää, "g ""°o abi ýc 
"s 
I- 
w n, oý 
ö3 
L 
i4 tý 
C 
d 
E 
C 
V 
x 
h 
d 
E "ti od v .r 
ö 
aý 
"E w 
ý. 
F 
w 
H 
L' 
a 
e 
cl 
94 
0 
w .. 
8a 
OV 
Lam. i' 
d a. 
T 
.ý 
.ý 
vo .. ý 
N 
H 
ö 
NE 
y` N 
1e. 
O. ý 
2 
ýO 
N 
V 
Aý 
op 
ld 
. "y 
ed 
. 'ý 
wý 'ý iy 
^1 y . 
tom" ßßi 
. 
rte' G 
.. 
0 
5 
y9 
U+ uey 
mXC 4 
5 
2 
.5 
3 ý; ,, ,y .i 
C y[ U U 
ýýÜ w"ý cý aüÜ avU 
O O 
U 
E. ce O IU 
v y Ü Ü 
Co 
F iw 
rn 
y 
Ü 
id vUi vU ý 
' 
CU w 'ci 1 ' ie 'v " ie w ci '. 
i . a v 
. .. 
d V t t V V 
Ü ä Ü 
N >. 
e X a' v ý3 ýa ýa as 
e all 01 ö 3 _. $' 00 °0 F ßo3 0. MývE ä 
0 
i+ N N 
3 0 0 
E 'O C 'ä*, 
3ö 
F ýn -^ vý :. R1 [ý 3 `° rý aki end 
C) 
ee .. 
e 
s 
wu 
Q N h 
u 
iE - 
ýQ L W : 
g -ä ý 
8 v 
10 (Y, ba 
, ry, 
ýcF" ý tea`H 
l 
COQ-l4 =r )_ 
h 
in 
N 
QH 
Ný+ 
E 
. -. O [tl O 
ar OA 
aý. °: pG 
a h 
t- 
on 
y 
äQ 
00 u 
=a 
F'° NN 
ÖCN 
2: 1 U, 
0 b 
0 
id 
C 
G7 
N 
N 
i 0 
N 
ýi 
e+ 
U 
Ir 
U 
a 
ti 
N 
ü 
N 
0 
it 
d 
d 
C, 
E 
0 
I- 
N 
d 
d 
.C ß 
i- 
h 
w 
ii d 
E 
E 
U 
4 
y 
i 
L 
O 
>, 
d ä, 
H 
d 
DD 
I 
d 
d3 
I 
M9 
OV 
C' OW N 
1. V 
e£tl i0 
G. 
ON 
iy ö7 .CN 
O O'ý eyd 
.. 
C) 0 
v 
V1 
GQOUai 
Q T"r C.. 
UUU 
4U. 2. 
r^ 
N y., 
N 
N 
z0 
C 
G . 
E» 0 
GAÜ 
Yaý 
¢zw 
V 
rn 
b 
0 
0 a 2 
0 
c. ýo 
uNy 
ý, y 
U 
ýO 
qO 
«G 
0 
VC 
N C. N °cý. ý8 
ý+ C ed O 
o 
,b0 
wy 
VCO.. r7 O CCv Fj 
CL 0 
co QC ýy ý 
{d C? 
"i+ Cw "Vl 
Eöo.. oý .c 
0 
ö8 
og 
IH 
HO 
Q C3. O 
OÖ "0 
ems, 
ýp °' ä 
IHit 
Oy0C 
VO 
; zz 
ýo[z 
Eoýý22 
fl OU vN 
J 
e~d Ock, ¢UZ w 
ýä 
Q 10 oG 
,yN 
U 
a 
go 
ou 
o ao ö 
U 
ö 
on 
°0ö 
GEn 
-, 
" MN 
öo "vý'i 
! 
ýý. o. Z Eaoi 
10 ;aý. 
C0. CC v3 
ÜUo 
aý 
ö 
aF > 
° 
äbß-Q o 
°o F" vö 
o 
NU bA w cc 
U "U-" 
y> !,. aN 
CJ 
'C 
ý 
'ý V1 UyÖ3 
'z'ow5 ooo 
ý', ý ý' öö 
ewe 
o Ccttýýý 
CHE 
'- 
qUIö 
"N .G 
o X, Qcýzw °ýýy 
0- 
.2u 
N 
co 
y op b _ 2O to, ) CIS pd 
WýV 
Ü 
i 
3 
UU 
UN 
ni "0 
OO 
ÖN 
« w' 
O 
.d Oý G 
^ßaä-öE 
an 
ö'$ 
ö- ö-15 -v N 
QN 
pO 
oA 
U" 
.0N 
> 
C. ýO 
ýN U 
, zb cn z 
> 
"C 
cq 
VV 
CU 
. 
zw 
8 
0 ,v 
3 00 
ä 
C) w 
.y 
Q 
z 
z 
s 
ti N- 
H 
i. d 
E 
E 
U 
w 
h 
0 
(ID 
W1 
O 
QO 
d: ^d 7 
aý°O pa 
Nýö, ö 
= öp u9 
OO 
4) 
y .7 
a 
c 10 
N3 
4) 
FN 
Ü ý) 
00 
Oy 
a. + N 
r 
OA 
i+ 
^nq 
dyý 
cd yV 
. 7w Wý 
V 
o y S. ý Ü 
ý 
7ý 'C 1 äy CY. .ý , 
CZ 
e04! - 10 
N vi 
ýwd b- 
k'.. 
v 
W i° °' c 
m *Z 
u v° 
Q a, h 
cö a"ioý, o OUoG-ýÜý 
0 
0 
E 
N 
U 
. ýi HC 
G 
U 
N 
U 
y 
U 
r. + 
y 
U 
Qý 
b 
OZ 
o 
CCC 
Tf 
y C.? 
OwU 7) 
v O'" O aý 
. 
U. 
y "C 
2yU 
.23: 12 Xc oQU 
c ýyo O0äe 
q 
V 
uy 
Cd U 
I, 7 
NO 
O vi U pp 
ýuäe`b c 
zÜd 
U F+ 
yÜN7 
C) 4NU 
Z V} 
C 
ýýz 
OC 
U 
' 20 O 
OC 
Eovö 
'A QU 
C .ýwo 
dc0 
F 
U 
C4 
I- V 
ý, °' z ¬;  >ýý 
ýy O 
.0 
td 
y- 
N a7 
-ti Q 
0 
Ir 
°C 3 
0 
(° z 
00' 
OC 
a°+ýýW 
y 
u 
u 
ýd ä 
Cy 
pq ý. 
h> 
O 
ö. Ra 
Qd a ýýv ö 
c 
oý~ng 
ý 
zz ö °°a 
ýp 
C 0) td 
U 
cr (U 
0 
ý 
oo ýc 
O 
cd 
LA 
c 
C0 
10 
O 
N 
W 
5 
Ct 
y 
I. r 
bY 
N 
Q`- 
b X. 
y ýýwX 
Qyy 
-Z 
yCO 
67 N 
yMO 
'5 0 -u F ,A '4 ". 00 
cd 73öyvö 
ýZäÄýwo°ýo 
0 
0 
y 
"CO 
0 
.Ao 
ä-y4 °o 
ya 
t 
0 ö 
rE 
OU 
OO 
OyMO 
II 
y ý. 
ýy 
}y +U-" O cýU) 
pýO Gy, of 
0 
y oý.. aoýo 
tb O 
a2 a it r. 
9C 
2L 
V1 
0ý 
bNd V] pw 
V). z. °"bEzß, zu) ý'z z öz" ö 
O 
"ý 
. ed -v 'o O, E Oý+ ww ý-, 11 +E ai ö ßäg 
G~ 
0GQVV 
7VV4EC 
.r cli r- U. y toycý U`- Y'eaý, vxý, YQ; výy 
7U 
týF- 00 
«. ý_ ý 
"5 °ý ý vý 
-°: 
w 
rx 
O 
o$ 
L 
'0 V 
Ö0 
ýU.. 
Ö 
CL 
U 
r ;1N 
t 
ta) "Z O1 
42 
OäU 
!Nbc. 
b2 
""=. TCl Vf 
O ed O 
N 
_2 a 
Qr!... O.. CCo 'O U 
cyN 
f0i 
U 
C7 
CO 
V1 
NO 
tea(z 
O 
ar 
y 
z 'öe 
Zc ön o"C 
aý ý C7 
ý 
C 'ý i r. 
U aU.. 4.. 
C U 
12 "= ;=s 
c ~ 
.i0 v+ C 
y 
LLýý d 
W` 
cu mU (A U ed yf e 
QQ U¢ QU2W 
ý 'ý 
üb 
Jý 
ö° 
8 0? Ö 
00 ti 
d 
E 
E 
0 U 
y 
r. r 
', 
h 
6ý 
V 
', 
f+ 
M 
0 ,2 C 
Öcp 
i 'c7 
Ll 
vi Dv 
*O 
yQ 
NG 4U~re 
id 
C0c0 
N0Oy 
OC 
OU 
Ö q. 
Q. 
Q 
'Ö? 
c 
. SU ooý, y 
yÜýä 
O 
ýeý30 
Ci. 
v' o0 
Ay Ö> 
ob0 
Le 
Gav,. 5 
ö6 
a- 
" 
f> 3äý 
v 
zöý 
. - .-a. 
f 
0 
yaoooo 
tim. 
'V GCC 
ÜNV 
of OXu. Is 
O 
ýh äd C- 
ä 0m02 0 
Q ý1 h Qý  "q 
3 
0 r 
VI 
u 
U 
O 
U 
. AD 
2 
0 
3 
_y 
4? o 
Z m Q 
_y 
o 
w- 
äE 
c 
_o 
0aH 
C ý' oy 
4° 3o 
ö-8 b 
00 c2 Gn Ei 
0 
E 
y 
. 
ý7 
C 
O 
4. r 
O 
M 
rQ 
7O 
O 
0 
E 
b Cli H 
C". 
0 
U 
W 
O 
e 
O 
N 
y 
a 
H 
V 
N 
7 
a 
0 0 
00 
c 0 
d ä 
w 
0 
et 
'g 
UN 
q 
ä ö 
Eö 
VI O. F. 
U 
O 
O 
y. Z5 
OE 
C6 0 'C C1 
yCO 
wö$ö 
C9 
13 - 
výoozvý 
N 
N 
, ti . fi 
o o 
o 
i 
c 
o co o Zr- ý 
äb 
;3e ö 
II u 
1: i. U ß. 
ü 'S 5yö 
öyE 0ý^P-iz 
-2 cm 
" 
++ .. 
ý 
GÜýI. 
N. 
Vb 
Ei 0 
VQ_ V"2 (os 
2 
J -0 U S+' 
e 
c ei 
Co 
c o aý ýzw., aýk Z5w ýýw 
U 
.Z E 
Uv 
U 
. 
U ý °' ý °' ý 
ý. °cý. c°w 
c> ý v2Zý 
wv 
tý`y 
FüN 
¢ "i. ýn 4ý+ 
ö F "S cn e 
rn 
Another large multi-centred randomised controlled trial, the Ontario Exercise 
Collaborative Study, recruited 733 young males post myocardial infarction to 
exercise programmes (Rechnitzer et al 1983). The participants were 
randomised to either high or low intensity exercise groups and joined an 
exercise programme between 2 to 12 months after their index cardiac event. 
The exercise intervention lasted for 4 years, which was the duration of the 
follow up period. Four hundred participants completed the study. Results 
from this study showed that the participants who had undergone high 
intensity exercise training had lower resting heart rates at the end of the 
study period (p=0.001). In spite of this reduction in resting heart rate for the 
intensively trained exercisers and, in common with most of the other 
intervention studies, the researchers found that the difference between the 
high and low intensity exercise groups for fatal or nonfatal re-infarction was 
not significant. The results from this study are limited by its small sample 
size, the high drop out rate of 45% and its focus on young male participants 
whose mean age was 47.5 years. 
The earliest study I found (Wilhelmsen et al 1975) randomised 315 participants 
to comprehensive CR or usual care. Fitness was measured by bicycle testing 
at 12 weeks post myocardial infarction and one year later. The participants 
were followed up over a 4-year period. There was no difference in either all- 
cause mortality or the incidence of nonfatal re-infarction between the 2 groups, 
although the intervention group had higher fitness levels at the end of CR 
(p<0.001). However, the results from this study are limited by the small sample 
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size, high drop out rate of 39%, and preponderance of males in the cohort 
[89%]. In addition, although the participants had been randomised to either 
group via a random letter table system, there were several differences between 
the baseline characteristics of the two groups. For example the control group 
had higher levels of leisure and work-time physical activity pre-infarct, contained 
a larger percentage of hypertensive participants, and more of the controls were 
being treated with digoxin. 
Between 1973 and 1978 Kallio (Kallio et al 1979) conducted a similar study, in 
Finland, on 375 participants post myocardial infarction, who were followed up 
for 3 years. The method of randomisation was not described. Change in 
exercise capacity at the start and end of CR was measured on a bicycle 
ergometer and long term follow-up considered all-cause and cardiac mortality, 
nonfatal re-infarction and the reoccurrence of angina as outcome measures. At 
the end of the study the researchers reported that there was no difference 
between the intervention and control groups for the incidence of nonfatal re- 
infarction, the recurrence of anginal symptoms or changes in exercise capacity. 
However, this study showed a significant reduction in cardiac mortality for the 
intervention group at the end of the 3-year follow-up period, 18.6% for the 
intervention group and 29.4% for the control group (p=0.02). This study had 
two main limitations, the distribution of deaths was not clearly reported and also 
the number of nonfatal re-infarctions at the end of the first year of follow-up was 
not stated. 
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Carson (Carson et al 1982) performed the first randomised controlled trial of CR 
in the United Kingdom in the early eighties. They enrolled 303 male myocardial 
infarction participants to either supervised exercise training or usual care. 
Symptom limited baseline fitness was measured on a bicycle ergometer at 5 
months post event and then yearly for up to 3 years. Outcomes measures 
included all-cause, but not cardiac, mortality, nonfatal re-infarction, and changes 
in exercise capacity. There were no differences in mortality reported between 
the 2 groups at the end of the study period. However, as in other studies, the 
sample involved only a small number of patients, and was further limited by its 
recruitment of young male participants post myocardial infarction and an overall 
drop out rate of 21%. The method of randomisation was not described. 
A small study by Vermeulen (Vermeulen et al 1983) recruited 98 males post 
myocardial infarction to either comprehensive CR or usual care. The mean age 
of the study participants was 49 years. The follow-up period was 5 years. The 
exercise capacity of the participants was measured at 4-6 weeks after the index 
event using expired gas analysis and a bicycle ergometer. However, at the end 
of the follow-up period, the only difference between the 2 groups was a higher 
evidence of progressive disease in the controls than in the intervention group 
(P<0.05). 
In the same year Roman (Roman et al 1983) reported a small controlled trial 
to study survival and the recurrence of coronary events, over a9 year period, 
in a group of patients who had recently suffered an acute myocardial 
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infarction. One hundred and ninety three patients were entered into the 
study. There were 93 patients in the intervention group who underwent 
exercise-based CR. One hundred 100 patients were matched for 
characteristics that might affect outcomes and became the control group and 
did not participate in CR. Baseline fitness was assessed by cycle ergometry 
using expired gas analysis to measure V02max. 
The researchers reported no differences between the 2 groups over the 
study period, with the exception of the recurrence of anginal symptoms. 
There were fewer symptoms of angina per year in the CR group [5.1%] 
versus the controls [10.2%] (p<0.005). Exercise capacity was stated to have 
improved in the CR group, although no p values were reported. The results 
from this study are also limited by its small sample size and by the fact that 
the mainly male participants were not randomised into intervention or control 
groups. 
Similar results were reported from Marra's research, which was published 2 
years later. One hundred and sixty-seven patients diagnosed with an acute 
myocardial infarction, were selected as eligible for this study (Marra et al 
1985). The study participants were randomised into an intervention group 
who underwent exercise training and a control group who were permitted to 
carry out unsupervised spontaneous aerobic type activities at home. All 
participants were exercise tested on a bicycle ergometer between 30-60 days 
post infarction and then annually thereafter for 4.7 years. Although there 
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were no differences between the groups in terms of mortality or nonfatal re- 
infarction rates, at the end of the supervised exercise training programme, 
the intervention group showed a significant improvement in exercise capacity 
(p<0.001) and also a significantly decreased double productix which reflects 
myocardial oxygen consumption at a given work load (p<0.001). There are 
several limitations to this study. For example, 43% of initially eligible patients 
were excluded from the study after their first exercise test, as randomisation 
only took place post exercise testing. The number of females in the study 
was not stated, and the method of randomisation was not described. In 
addition, 8% of the control group became regular exercisers. All these 
factors may have affected the overall results reported in this study. 
The PRECOR group (Precor 1991) of researchers from France studied the 
short and long term benefits of CR on fitness and survival in a group of 182 
young male myocardial infarction survivors who were randomised to receive 
either CR or counselling as an intervention compared with a control group 
who were given usual care. The method of randomisation was not 
described. Baseline fitness level was established from a bicycle test and 
outcome measures obtained at 2,12 and 24 months respectively. All 
participants were followed up for 2 years. Exercise tolerance was greater in 
the CR group at 2 months, compared with the counselling group, or those 
that had received usual care (p<10-8). Although re-infarction rates were 
similar across all 3 groups, all-cause mortality was found to be less in the CR 
'" The double product is the heart rate x systolic blood pressure divided by 100 
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group (p=0.03) compared to the combined counselling and usual care 
groups. This study reinforces the beneficial effect of exercise training in CR 
for young, low risk male myocardial infarction patients when compared with 
counselling or usual care. 
Hedback (Hedback et at 1993) reported similar results from an unrandomised 
controlled study. They recruited a selected sample of 123 participants post 
myocardial infarction to a CR exercise programme lasting 3 months and 
compared them with a group of controls from a neighbouring hospital. The 
participants were mostly males [7% females], and were followed up for 10 
years. Although after 5 years there was no difference seen between the 
intervention and control groups, at the end of the follow-up period all-cause 
mortality (p<0.01) and cardiac mortality (p<0.001) were both less in the 
intervention group. Mean exercise capacity in the intervention group rose 
from 91 watts to 131 watts at a year post event. This study is also limited 
because the participants were not randomised to treatment or control groups. 
Following on from Carson's study, which had been published in the early 
eighties, two more studies were performed during the nineties in the United 
Kingdom, which showed the benefits accrued by attendees of CR exercise 
programmes. Bethell and Mullee (Bethell and Mullee 1990) randomised 200 
male patients under 65 years of age, who were diagnosed with an acute 0 
wave myocardial infarction using the WHO criteria to receive either CR or usual 
care. Baseline fitness levels were estimated from bicycle exercise tests at 6 
85 
weeks post event at the start of CR and repeated after 3 months of CR. 
Significant improvements in exercise capacity were seen for the intervention 
group (p<0.001) at the end of CR training, although the researchers were 
unable to show a significant difference between intervention and control groups 
for either cardiac mortality or rates of nonfatal re-infarction when the cohort was 
followed up over the following 11 years (Bethell et al 1999). All-cause mortality 
was not reported in this study. There were two factors that may have affected 
the outcomes of this study. Firstly, some of the control group members became 
regular exercisers over the timeframe of the study. Secondly, the reported 
numbers of nonfatal re-infarctions may not be truly representative, as these 
were collected via self-reported questionnaires rather than through medical 
channels or the national register of deaths. 
Dugmore and colleagues performed the third British study, matching 124 
myocardial infarction patients of which 2 were female, for the site and severity 
of myocardial infarction (Dugmore et al 1999). All patients had been exercise 
tested using the modified Bruce protocol and expired gas analysis at 3 weeks 
post infarction and were then randomly allocated to join a supervised CR 
programme three times a week for 12 months, or to usual care, which excluded 
formal exercise training. Participants were then allocated into either a good 
prognosis group, which started exercise-based CR at 3 weeks post infarct or a 
poor prognosis group, which started CR at 8 weeks. Group allocation was 
dependent on the severity of the initiating event. Outcome measures included 
changes in fitness levels post CR, mortality and the recurrence of nonfatal re- 
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infarctions. The participants were exercise tested 3 times during the first year. 
Subsequent exercise tests were maximal assessments, and participants were 
followed up by questionnaires for 5 years. 
Results were reported on the good and poor prognosis groups and the 
control group. At the end of the first year there were significant differences 
shown in levels of fitness for both good and poor prognosis groups who had 
increased VO2peak by 13 to 15% compared to the control group. One of the 
criteria for being in the poor prognosis group had been an inability to 
complete 9 minutes of the modified Bruce protocol at the start of this study. 
The researchers reported 5 deaths due to re-infarctions during the 5 years of 
follow up, of which 2 were in the intervention group. Although there were no 
differences in mortality between the groups the intervention group fared 
better. They suffered fewer nonfatal re-infarctions 8% versus 22% (p<0.05- 
0.01) and reported fewer anginal symptoms (p<0.001). This study reinforces 
the benefits accrued through increasing levels of physical fitness. However, 
it is limited by its focus on small numbers of predominantly male patients who 
had suffered a myocardial infarction. 
4.6.2 Changes in levels of physical fitness and risk of nonfatal 
cardiovascular events 
Most of the intervention studies I have discussed have reported the incidence 
of nonfatal re-infarction between groups, although they did not necessarily 
look at the recurrence of cardiovascular events, such as the incidence of 
cerebrovascular accident [stroke], as an outcome measure. Several of the 
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earlier studies report on lower, but non-significantly different rates of nonfatal 
events for the intervention groups (Dugmore et al 1999; Hedback et al 1993; 
Vermeulen et al 1983), whilst others have shown no difference between 
groups for this outcome (Bethell and Mullee 1990; Bethell et al 1999; Marra 
et al 1985; Precor 1991; Rechnitzer et al 1983; Roman et al 1983). 
I found two studies on patients who have undergone angioplasty procedures 
that showed improvements in exercise capacity for the intervention groups. 
The duration of follow-up in both studies was less than 3 years. In the first 
study [Figure: 4.2], (Hofman-Bang et al 1999) a selected group of 46 
participants from an initial cohort of 151 patients, performed a bicycle test, 
and attended a 4-week residential course focusing on multifactorial lifestyle 
behaviour components. At the end of the 2-year study period exercise 
capacity was shown to have improved significantly in the intervention group 
(p<0.05) and overall a smaller proportion of the intervention group had 
hospital admissions in the second year (p<0.05). One control patient died. 
The main limitations with this study were its small sample size, and the 
method of allocation, which required the patients to choose between opting 
into the residential course in the intervention group or to becoming a control 
and receiving usual care. 
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Figure 4: 2 Flowchart illustrating study enrolment to angioplasty study 
(Hoffman-Bang 1999) 
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The second study [The ETICAX trial (Belardinelli et al 2001)] also examined 
the effects of exercise training in patients who had undergone angioplasty. 
One hundred and thirty patients were enrolled in the study after they had 
undergone successful angioplasty and were randomised into 2 matched 
groups. Exclusion criteria were no concomitant co-morbidity, which included 
having a diagnosis of diabetes. Some patients received primary angioplasty 
without thrombolysis following myocardial infarction. None of the patients 
received lipid lowering therapy during the study, as one of the outcomes of 
the study was to assess the effects of exercise training on the lipid profile. 
Half of the participants were randomised to attend an exercise programme 
for 6 months, whereas the controls were advised to be physically active, but 
not to participate in formal exercise training. Exercise testing was carried out 
using cycle ergometry with expired gas analysis. V02peak was recorded from 
the average measurement reached during the last 15 seconds of exercise. 
Results showed a significant difference between groups for the increase in 
fitness. Exercise capacity in the intervention group improved by 26% during 
the study period. Fitness in the intervention group rose from 18.6 to 
23.7ml/kg/min compared with the control group whose fitness decreased 
from 20.5 to 19.4ml/kg/min. The control group also experienced a greater 
number of cardiovascular events and hospital admissions as seen below in 
Table 4: 5. 
" ETICA - Exercise training intervention after coronary angioplasty 
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Table 4: 5 Outcomes between intervention and control groups 
(Belardinelli et al 2001) 
Exercise group Control group p value 
n=59 n=59 
Over 3 years Over 3 years 
Cardiovascular events 7 19 0.0008 
Re-stenosis rate 15 of 52 17 of 52 0.81 
Hospital admissions 6 17 <0.001 
Coronary heart disease progression 7.6% 25% 0.038 
A selection of 52 patients from each group underwent further angiography. A 
significantly lower rate of coronary heart disease progression was seen in the 
exercise group compared with the controls. Because the researchers had 
controlled for the effects of treating other risk factors, such as raised 
cholesterol levels, which had not been controlled by statin therapy, an 
important finding was that exercise component independently predicted 
cardiovascular events (p=0.008) and also coronary heart disease 
progression (p=0.0006). The findings from this study showed that 
improvements in exercise capacity in angioplasty patients were associated 
with a reduction in cardiovascular events and fewer hospital admissions post 
procedures regardless of the rate of re-stenosis. 
4.7 Summary 
All the studies I have described have incorporated a measure of baseline 
fitness and used a variety of methods for determining exercise capacity. It is 
difficult to draw comparisons between these studies for the following reasons. 
The lengths of the exercise interventions varied between the trials and 
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ranged from 6 weeks of supervised exercise to approximately 4 years, 
although the average duration of supervised exercise was about 12 weeks. 
The timing of the exercise assessments also varied from programme to 
programme. In the earlier programmes it is noticeable that the dropout rates 
ranged from 21% to 45.4% or were not reported. Nonetheless, as would be 
expected, outcomes relating to exercise capacity in the majority of 
programmes, including the National Exercise Heart Disease Project, were 
shown to improve significantly in the trained groups when compared to the 
controls (Bethell 1987; Bethell and Mullee 1990; Dugmore et al 1999; 
Hedback et al 1993; Wilhelmsen et al 1975). This improvement in fitness has 
been said to be up to 20% more than that which can occur spontaneously 
(Bethell 1992; Greenland and Chu 1988; Lipkin 1991; Sleight 1992). 
It is clearly evident from most of these studies focusing on younger, male, 
myocardial infarction patients that baseline fitness levels are associated with 
fatal and nonfatal cardiovascular events. The importance of peak exercise 
capacity as a predictor for mortality in patients with other manifestations of 
coronary heart disease has also been well established. Some of the later 
studies have included older patients who have survived an initial infarct, but 
this is not true for most of the earlier research. Moreover, the long term 
effects of fitness levels in people with coronary heart disease who have not 
had a myocardial infarction are still unknown, although some research shows 
that similar beneficial physiological effects can be produced in patients with 
coronary heart disease who undergo exercise training (Engblom et al 1993). 
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For example the recent results from the ETICA trial indicate the importance 
of increasing exercise capacity after undergoing angioplasty procedures and 
its association with fewer cardiovascular events. It would be interesting to 
collect survival data on these patients. 
Vanhees' study is the only study I identified which has shown the predictive 
value of a change in fitness following exercise training on mortality. 
However, his cohort was atypical of the coronary heart disease population, 
being limited to young, relatively slender males, post myocardial infarction or 
after coronary bypass grafting. 
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Chapter 5 
The epidemiology of 
coronary heart disease progression 
and depression 
5.1 Introduction 
It is not clear how depressive symptoms or disorders contribute to the 
progression of coronary atheroma (Levin 2005; Strike and Steptoe 2002). 
Current evidence from epidemiological and clinical studies suggests a 
complex relationship exists between psychosocial factors and coronary heart 
disease. In recent years some researchers have reported that depression is 
an independent risk factor for exacerbating symptoms in those with 
established disease (Carney et al 1999; Frasure-Smith 1995; Frasure-Smith 
and Lesperance 2005). If this association is confirmed, the diagnosis and 
subsequent treatment of depression for those with pre-existing coronary 
heart disease could be of prognostic importance. 
5.1.1 What is depression? 
The definition of depression needs clarifying. There is a clear distinction 
between depressive symptoms, which affect most of us at some time during 
our lives, and depressive disorders, which occur less frequently. ICD-10, 
The World Health Organisation's current system for disease classification, 
uses a list of ten symptoms of depression to distinguish between the different 
types of depressive episodes. 
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5.1.2 Depressive episodes 
There is a cluster of symptoms common to all depressive episodes. These 
are depressed mood, loss of interest and enjoyment of one's normal activities 
(also known as anhedonia), and fatigue. Associated symptoms which are 
also common in depression include poor sleep, reduced ability to 
concentrate, memory impairment, low self-esteem and self-confidence, 
feelings of guilt and unworthiness, pessimism, evidence of self-harm or 
suicidal feelings, and loss of appetite with concomitant weight loss. The 
minimum duration of symptoms consistent with an ICD-10 diagnosis of 
depressive episode is two weeks. The number and intensity of symptoms 
present at the same time, and the extent of impairment in normal, social and 
occupational functioning indicate the severity of depressive episodes. The 
person experiencing a severe depressive episode is unlikely to be working or 
leading a normal social life, whereas someone with a mild depressive 
disorder should be able to carry out regular activities of daily living, albeit with 
limitations. 
The natural history of depression is of a remitting and recurring condition. 
Recurrent depressive disorder is the term used to describe the recurrence of 
a depressive episode, classified in ICD-10 as F33, with recovery being 
defined as the remission of a depressive episode for eight consecutive 
weeks. 
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5.1.3 The diagnosis of depression 
The diagnosis of depressive episodes and disorders in a research setting is 
best reached through the use of structured diagnostic clinical interview 
(Blumenthal and Left 2005). Depressive symptoms on the other hand are 
readily assessed using self-report questionnaires. Two of the most 
commonly used instruments for assessing depressive symptoms are the 
Beck Depression Inventory (BDI) and the Center for Epidemiological Studies 
- Depression scale (CES-D) (Sheps and Rozanski 2005). Issues 
surrounding the value of the different methods for establishing psychological 
state are discussed in Chapter 8 in section 8.3.2. 
5.1.4 The prevalence of depression 
In the United Kingdom, the most recent data on the prevalence of depression 
based on the DSM IV criteria comes from a telephone survey of 4,972 
subjects who were interviewed during 1994. They were asked three series of 
questions which assessed whether they were feeling down or depressed, or 
had feelings of hopelessness, or anhedonia. From this survey the 
researchers found the prevalence of depressive disorders in the general 
population was 5% [95% Cl 4.4,5.6] being lower at 4.2% for males, versus 
5.9% for females (p<0.01) (Ohayon et al 1999) but higher than had 
previously reported at 2.2% for males, 4.9% for females (Bebbington et al 
1991) and 1.7% for mates, 2.5% for females (Lewis et al 1992). This 
' DSM IV is the fourth [1994] of the Diagnostic and Statistical Manual of Mental Disorders. It 
lists different categories of mental disorders. 
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compares with a European prevalence of depressive disorders of 7.9% 
(Lepine et al 1997). The European prevalence of depressive symptoms, 
such as feeling down or depressed, was 9.7%, with a greater proportion of 
females reporting symptoms than males [11.7% versus 7.5%]. 
The current figure for the worldwide prevalence of depression is 10.4% and it 
is predicted that by 2020 depression will become a leading cause of disability 
and impairment worldwide (WHO 2006) and second only to coronary heart 
disease in the western world (Murray and Lopez 1996). The implications of 
early detection of depression and appropriate treatment is therefore of social 
and economic importance. For example several studies have shown that 
depressed patients have significantly greater impairments than the non- 
depressed in terms of social functioning and well-being (Fredman et al 1988; 
Weissman et al 1978; Wells et al 1989) and the global economic burden of 
depression is much higher than in other common illnesses. In 1991 although 
the estimated direct costs of the treatment of depression in the United 
Kingdom was £417 million (Jones and Cockrum 2000) which at that time was 
similar to the cost of treating hypertension at £439 million, (DOH 1996) the 
indirect costs and burden of depression were considerably higher and 
estimated to be £2.97 billion (Jones and Cockrum 2000). 
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5.2 Strategy for searching and selection of studies 
I first carried out a scoping literature search which yielded 853 publications 
on the subject of depression and cardiovascular diseases. After examining 
these papers I decided to limit the search strategy to publications that 
focused on the impact of depression on coronary heart disease progression, 
rather than the spectrum of cardiovascular diseases, since my thesis 
concerns outcomes for patients with a diagnosis of coronary heart disease. 
The timescale for this part of my literature review extends back to the late 
1960s, although nearly all the relevant articles I found have been published 
over the last ten years and in particular since the turn of this century. The 
literature selected as suitable for inclusion in this part of my review is divided 
into three chapters. The next chapter examines the relationship of 
depression to the pathophysiology of coronary heart disease progression and 
the final chapter in my literature review focuses on the role of antidepressant 
therapy and psychosocial interventions in coronary heart disease 
progression. The rest of this chapter focuses on the temporal association 
between depression and coronary heart disease; and whether depression is 
an independent risk factor for, or a consequence of, coronary heart disease. 
Many good systematic reviews have been published which focus on 
depression and its association with coronary heart disease progression. I 
therefore found that it was not necessary to go back to the original cohort 
studies for this part of my literature review. I used criteria adapted from 
Oxman, Cook & Guyatt's article on 'How to use an overview' (Oxman et al 
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1994) to identify five systematic reviews and two observational studies 
published between 1999 and 2005 [Tables 5: 1 and 5: 2] which were relevant 
to this research, because they reported on depression as a risk factor for 
coronary heart disease progression. 
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5.3 Systematic reviews of observational studies 
The earliest review I found reported on five studies which focused on the 
effect of a range of psychosocial factors, including depression, on prognosis 
in coronary heart disease progression (Hemingway and Marmot 1999). The 
sample sizes from these studies ranged from 222 participants (Frasure-Smith 
et al 1995) to 1,250 (Barefoot et al 1996) all of whom had either suffered a 
myocardial infarction or had angiographic evidence of coronary heart 
disease. Depressive disorders were assessed by structured interview and 
depressive symptoms by self-report questionnaires. Two studies used 
standardised interview techniques to assess depression and the others used 
a variety of questionnaires which included the BDI and the Zung 
questionnaire. Mortality was an outcome measure in all studies except one 
in which recurrent angina pectoris was the main outcome (Ladwig et al 
1994). 
Results from three of the five studies, two of which had used structured 
interviews to assess depression, showed a strong prognostic association 
(p<0.05) between depressive disorders, and either morbidity or survival 
(Denollet et al 1996; Frasure-Smith et al 1995; Ladwig et al 1994), although 
the timings of the psychological assessments varied between the three 
studies. 
Only one study had measured depression during hospitalisation (Frasure- 
Smith et al 1995) and this study showed that mortality was greatest in 
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depressed myocardial infarction patients when the number of premature 
ventricular contractions recorded had exceeded 10 per hour [OR 29.1; 95% 
Cl, 6.97,122.07]. The finding that deaths were more common among 
depressed patients for whom more than 10 premature ventricular 
contractions per hour had been recorded was not surprising as it is well- 
known that premature ventricular contractions may provoke fatal cardiac 
rhythms. In Ladwig's study, depression was measured in post infarct 
patients at 3 weeks after hospitalisation. The main outcome measure was 
the new onset of anginal symptoms [RR 2.31 95% Cl 1.58,6.16] (Ladwig 
1994). On the other hand, Denollet assessed depression in patients with 
angiographic evidence of coronary heart disease during an outpatient CR 
programme and reported unadjusted results for cardiovascular mortality [OR 
2.69 95% Cl 1.33,5.45]. This study (Denollet 1996) had a follow up period of 
8 years compared to the other two studies with follow-up of less than 2 years. 
It is clear that in all three studies (Denollet et al 1996; Frasure-Smith et al 
1995; Ladwig et al 1994) depression strongly predicted mortality in patients 
with pre-existing coronary heart disease. However, this was not replicated in 
some of the other studies that followed participants for up to 19 years and 
where the effect of depression on mortality was shown to be weaker [RR 
1.72 (p<0.05)] (Barefoot et al 1996). 
Hemingway and Marmot's review has several limitations. Firstly, not all the 
studies had data on psychological morbidity prior to the index event. 
Secondly, a variety of covariates had been adjusted for in most of the studies 
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but none were common to all; three studies had adjusted for the effect of 
age. Thirdly, most studies reported on the presence of depressive 
symptoms, but not isolated major depressive episodes. Fourthly, depression 
was assessed with a variety of instruments at various stages during the 
recovery period. Finally, females were poorly represented in all the studies. 
For all these reasons it is not possible to draw exact comparisons between 
the studies included in this review. 
One component of a comprehensive systematic review published five years 
later (Wulsin 2004) was an assessment of the strength of epidemiological 
evidence for depressive disorders or depressive symptoms as major 
independent risk factors in coronary heart disease progression. Wulsin's 
review included twenty-seven cohort studies from Europe and North America 
which were published in English over a 30 year period between 1972 and 
2002. Inclusion criteria encompassed a wide range of depressive disorders 
such as bipolar depression and adjustment disorder with depressive mood. 
The main outcome measure relevant to my thesis was depression associated 
with coronary mortality. Depression was assessed in several ways. Twelve 
studies used structured interviews, most commonly the Diagnostic Interview 
Schedule, and the remainder used a selection of self-report questionnaires of 
which the BDI was used in over a third of all the studies. Some studies had 
used both questionnaire and structured interview as assessment tools, which 
were administered consecutively during a single psychological assessment 
(Connerney et al 2001; Lesperance et al 2000; Penninx et al 2001; Romanelli 
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et al 2002). Fifteen studies had controlled for a range of coronary risk factors 
that may have acted as confounders. The follow up period for the studies 
ranged from one month (Silverstone 1990) to 19 years (Barefoot et al 1996). 
The numbers of participants recruited to the studies varied from 52 patients 
post-angiography (Carney et al 1988) to 5,623 case control patients in 
General Practice (Hippisley-Cox et al 1998). 
Between 10-22% of participants, the majority of whom had been diagnosed 
with myocardial infarction, were reported to have depressive disorders at the 
time of the onset of their acute coronary illness. This is over double the rate 
expected to occur within the general population (Lavie et al 1999) but similar 
to levels of depression in coronary patients reported previously by other 
researchers (Frasure-Smith et al 1993; Left et al 2004; Schleifer et al 1989). 
The reported prevalence of depressive disorders and symptoms varied 
between studies. Lesperance et al using the BDI and a structured interview 
found 41.4% of 430 patients who had been admitted to a Canadian hospital 
with unstable angina were suffering from either depressive symptoms or 
disorders (Lesperance et al 2000). On the other hand, Mayou et al using the 
Hospital Anxiety and Depression Scale (HADS) questionnaire in 347 
myocardial infarction survivors in England found only 7.6% of his cohort had 
depressive symptoms at baseline (Mayou et al 2000). 
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The prevalence of depression also varied according to cardiovascular 
diagnosis. For instance, depression was most common in myocardial 
infarction patients [16-22%] and least common in those diagnosed with 
unstable angina [15%]. One study found a 20% prevalence of depressive 
disorders in patients who had undergone coronary artery bypass grafting 
(Connerney et al 2001). 
Lesperance using the BDI (Lesperance et al 2000) and Penninx using 
structured interviews and a self report questionnaire (Penninx et al 2001), 
reported significant differences depending upon how depression had been 
categorised. In the more severely depressed patients Lesperance reported a 
six-fold increase in cardiac mortality [adjusted OR 6.73; 95% Cl 2.43,18.64] 
while Penninx found a three-fold increase in patients with severe depression 
[RR 3.0, Cl 1.1,7.8]. 
Eleven studies looked at the duration of depressive episodes in relation to 
each acute coronary event. Several studies found that post-coronary 
depressive episodes lasted for at least three months and often far longer 
following the index coronary event. Two studies reported the duration of 
depressive symptoms to last between up to one and a half years after an 
infarction; 34% of 70 myocardial infarction survivors were found to be 
depressed at their 12 month follow up (Travella et al 1994) and in an earlier 
study, a similar proportion of 101 post infarction CR attendees continued to 
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be severely depressed when assessed 18 months later (p>0.001) (Kavanagh 
et al 1975). 
Results from Wulsin's review (Wulsin 2004) showed a prognostic effect for 
depression on cardiovascular mortality in 15 out of 25 studies. However, one 
important limitation in this review was that females were poorly represented 
in all the studies. In addition, although the review included two major studies 
which did not find an association between post myocardial infarction 
depression and mortality (Lane et al 2002; Mayou et al 2000), other smaller 
studies with negative outcomes or those published in languages other than 
English may have been omitted. 
Van Melle and co-authors included Japanese studies in a meta-analysis, 
(van Melle et al 2004) which reported on 22 studies of coronary patients who 
underwent psychological assessment during the first three months after their 
index coronary event. Three quarters of study participants were male, and all 
were under 75 years of age. Depression was measured by self-report 
questionnaires and structured psychiatric interviews or a mixture of the two. 
Studies that used non-validated measures of depression were excluded. 
Outcome measures were cardiovascular prognosis and mortality within the 2- 
year period post infarction. At baseline the prevalence of depression ranged 
from 5 to 47 percent. In two studies 45% of myocardial infarction survivors 
were found to have either major [18%] or minor depression [27%] when 
assessed within eight to ten days of their event (Frasure-Smith 1995; 
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Schleifer et al 1989). One reason for this difference in reported rates of 
depression may be due to differences in whether depression was defined 
according to diagnostic criteria, or on the basis of a score on a questionnaire 
designed to elicit depressive symptoms. In some studies, the research 
carried out by Lesperance in 2000, Connerney in 2001, Penninx in 2001 and 
Romanelli in 2002, depressive symptoms and disorders had been assessed 
using both questionnaire and structured interview whereas other studies had 
relied on a variety of different questionnaires, rather than a single instrument. 
Results from van Melle's research showed that patients with post infarct 
depressive disorders assessed at an early stage of coronary illness, were at 
significantly increased risk of death from all causes [OR 2.38,95% Cl 
1.76,3.22 (p<0.00001)] and to a greater extent from cardiac mortality [OR 
2.59,95% Cl 1.77,3.77 (p<0.00001)] during the 2-year follow up period from 
their initial coronary event. Depressed patients also experienced a greater 
number of cardiovascular events during follow-up [OR random 1.95,95% Cl 
1.33,2.85 (p=0.0006)] although this effect was stronger for studies conducted 
before 1992, (old studies versus new p=0.08). One possible explanation for 
this difference in these effects pre and post 1992, is that treatments for 
coronary patients, including CR, have improved in recent years (Blumenthal 
et al 2004). However, a limitation of all the studies was the lack of 
information on any of the patients regarding pre-infarct psychological 
morbidity. There was no way of knowing how many of them already had a 
history of depression prior to their coronary event. 
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In the same year, Barth and colleagues' meta-analysis examined the effect of 
depression on mortality in myocardial infarction survivors and also in patients 
who had undergone recent coronary revascularisation (Barth et al 2004). 
They included papers published between 1980 and 2003 from German as 
well as English databases. Depression was assessed at baseline entry to 
the studies by questionnaires or structured interviews or a combination of the 
two. The minimum follow-up period for each study was 3 months. Twenty 
studies were reviewed. Nine studies reported results that were adjusted for 
potential confounders such as smoking habit, age, gender, hypertension, 
dyslipidaemia", body mass index, previous angina, Killip class"' (Khot et al 
2003) and previous infarction. 
Results from this meta-analysis showed that depressive symptoms increased 
the risk of mortality. In the short term, with follow up over 5 years, 
unadjusted results showed that the participants with depressive symptoms 
were twice as likely to die compared with the non-depressed [OR 2.24,95% 
Cl 1.37,3.60]. However, in the long term beyond a five-year period, the effect 
of depressive symptoms on mortality was lower [OR 1.78,95% Cl 1.12,2.83]. 
Results that were adjusted for the known coronary risk factors also showed 
an effect of depressive symptoms on mortality rates [OR 1.76,95% Cl 
" Dyslipidaemia is a disturbance in the amount of blood lipids 
Killip's class is a risk stratification classification. Class I represents no evidence of heart 
failure. Class II represents symptoms of mild heart failure, roles involving a third or less of 
the posterior lung fields and a systolic blood pressure > 90mmHg. Class III patients have 
overt pulmonary oedema, and class IV patients have cardiogenic shock and a systolic blood 
pressure < 90mm Hg. 
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1.27,2.43]. By contrast, for depressive disorders the effect on mortality was 
non-significant in the first 6 months post event, but became significant over 
the subsequent 18 months [OR 2.61, Cl 1.53,4.47]. Only three studies 
reported adjusted results for depressive disorders [HR 4.29,95% CI 
3.14,5.86]. 
There were several limitations in this review. Firstly, the pre-event 
psychological health of participants was not known. Secondly, a variety of 
instruments had been used in the studies to assess depression. Thirdly, the 
timings of assessments varied depending on whether the entry criteria for the 
study included stable coronary disease, an acute coronary event or a 
revascularisation procedure. Finally, the levels of significance varied in the 
studies depending upon whether the results obtained had been adjusted for 
potential confounders or not. Only nine of the twenty studies reported 
adjusted results. The majority of patients in the studies were male and all 
were under the age of 75 years. These factors make it difficult to compare 
results and therefore to generalise the findings. 
The most recent review of studies on depression and coronary heart disease 
concentrated on research published between 2001 and 2003 (Frasure-Smith 
and Lesperance 2005). Twenty-four prognostic studies from this review were 
relevant to this thesis because they reported mortality as an outcome. All 
these studies have been included in one or more of the reviews I have 
already described. Outcome measures included the presence of anginal 
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symptoms or heart failure, nonfatal cardiovascular events and mortality. 
Results were reported as adjusted or non-adjusted and as significant with ap 
value less than 0.05 or as zero when non-significant. The effect sizes were 
not summarised in this paper. 
The majority of studies had follow up periods of less than 5 years but the 
study with the longest follow up of over 19 years which I have already 
referred to in this chapter, was also included in this review (Barefoot et al 
1996). In 19 studies, the researchers found a significant association (p<0.05) 
between depression and worsening of coronary heart disease. Nine of the 
19 showed a significant effect for depression on mortality. 
There were methodological differences between many of the studies. One of 
several limitations was an inconsistency in the types of instruments used to 
measure depression. In addition, when adjusted results were reported these 
were based on a variety of different covariates, but were commonly the 
coronary risk factors: diabetes, obesity and hypertension. It is difficult to 
compare the adjusted results between each study because the covariates 
were not the same for each study. Other inter-study differences included 
different sample sizes and demographic data, different timings for 
assessment of depression, different definitions of depression and different 
ways of reporting outcomes. Some studies reported multiple outcomes, such 
as mortality and nonfatal events, whereas others had single outcomes and 
only reported on all-cause mortality. Inaccurate certification of deaths and 
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coding errors may also have influenced some of the studies' results. The 
change from ICD-9 to ICD-10 has given rise to a number of ill-defined 
cardiovascular codes which have been reported to be inaccurately assigned 
to ischaemic coronary deaths (Lozano et al 2001). Such discrepancies, 
which I also discuss in Chapter 8 page 210, may affect mortality data 
reporting in the studies that were conducted during the changeover period 
between ICD-9 to ICD-10. This review omitted to include one of the two main 
studies with negative findings (Mayou et al 2000). 
5.4 Observational research published after the systematic 
reviews 
Two observational studies on depression and coronary heart disease were 
not included in the systematic reviews because they have been published 
recently. 
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This first study (Blumenthal et al 2003) was one of a few observational 
studies that looked at survival outcomes and depression after coronary 
bypass graft operations. Patients with severe co-morbid conditions and 
those who were undergoing other cardiac surgery such as valve 
replacements were excluded from the study. In addition, patients who 
refused to complete the questionnaire pre-surgery were also excluded, as 
were those who had a prior diagnosis of psychiatric disorder. A total of 817 
participants [27% females] were enrolled in the study and completed a 
baseline depression assessment. Depression was assessed using the CES- 
D (Radloff 1977) the day before surgery and at six months post surgery. The 
cohort was followed up for 12 years [Figure 5: 1]. 
Figure 5: 1 Study Profile from Blumenthal et al 2003 
1075 258 
enrolled no depression 
data 
817 
baseline 
data 
13 
died before 
6 months 
249 
not re-assessed 
at 6 months 
555 
assessed at 6 
months 
490 alive 205 alive 
65 dead at 44 dead at 
12 years 12 years 
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Survival analyses, which controlled for a number of potential confounders 
such as age, gender, the known coronary risk factors, the number of bypass 
grafts, previous myocardial infarction, and left ventricular ejection fraction 
were performed using a Cox proportional hazards model. Early deaths that 
occurred within 30 days post surgery were excluded from the survival 
analyses. Depressive symptoms were treated initially as a binary variable 
and later assigned into one of four categories: a never depressed category, 
depressive symptoms found at baseline that lasted for less than six months, 
no depression at baseline but new onset of symptoms within six months, and 
persistent symptoms of depression at baseline and beyond a six-month time 
frame. Thirty-four percent of participants did not complete a second 
assessment. 
At baseline 26% of the cohort was found to have moderate or severe 
symptoms of depression and 12% mild symptoms. More females than males 
had reported depressive symptoms (p<0.001). At the end of the follow up 
period 15% of the cohort had died. This study showed that the presence of 
depressive symptoms pre-surgery increased the risk of mortality in the 12 
years post surgery (p=0.001) [adjusted HR 2.4,95% Cl 1.4,4.0]. Those 
whose depressive symptoms persisted beyond the first six months post 
bypass were also at a higher risk of death during the 12 year follow-up period 
[adjusted HR 2.2,95% Cl 1.2,4.2 (p=0.015)]. 
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The main limitation of this study was that only 50% of eligible participants 
attended the follow up assessment at 6 months. One-quarter of patients 
were not enrolled into the study because they were too sick or debilitated to 
take part, although the researchers do not explain how they defined the term 
sick. These findings are therefore not generalisable to all people who have 
undergone coronary bypass procedures. 
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Grace and co-researchers (Grace et al 2005) examined the effect of 
depressive history and symptoms on mortality in an observational study of 
750 participants [35.2% females], mean age 61.6 years, who were assessed 
for depression in a selection of Canadian coronary care units following a 
diagnosis an acute coronary syndrome between 1997 and 1999. Nine 
hundred and ten patients (50.6%) from the initial 1,800 patients who were 
approached to join the study, agreed to participate. Participants were 
followed up for 5 years. 
Information on co-morbidity was provided by a link to a Discharge Abstract 
Database and co-morbidity scores were computed using the Charlson Co- 
morbidity Index (Charlson et al 1987). Depressive symptoms were assessed 
using the BDI questionnaire, administered on one occasion, during the 
hospital stay between day 2 and day 5. Former depressive history, lasting 
for more than two weeks, was established from each participant. Depression 
scores were treated as a binary variable with scores either less than 10 or 10 
and above. Survival analyses were performed using Cox proportional 
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hazards models which were adjusted for age, gender, income, marital status, 
education level, diagnosis, systolic blood pressure, smoking, Killip class, co- 
morbidity, diabetes, myocardial infarction and heart failure. 
The 836 participants finally enrolled in the study were significantly younger 
than the participants in the original cohort, and more likely to be married and 
male (p<0.001). At baseline assessment, 23% of participants reported a 
history of depressed mood prior to hospital admission and 31% had raised 
depression scores at the time of their index event. Fourteen per cent were 
found to be persistently depressed. Females were more likely than males to 
have a raised depression score. Fifteen per cent of the cohort died during 
the 5-year follow up period. Depressive symptoms assessed during the 
hospital stay, defined as a BDI score of >_10, were predictive of mortality at 
two years post event, [adjusted HR 1.90,95% Cl 1.12,3.24] and at 5 years 
[HR 1.53,95% Cl 1.04,2.24]. Those with a previous history of depression 
that did not worsen during the acute illness had the lowest mortality rate. 
This was in contrast to the reported hazard ratio from a new onset of 
depression, reflecting a first episode of depression recorded during the 
hospital stay, which was far greater [HR 4.59,95% Cl 1.62,13.01]. 
This study showed that the onset of depressive symptoms during an acute 
coronary event is of prognostic importance. It also indicated that acute 
coronary syndrome patients with a previous history of depressive symptoms 
which did not worsen whilst they were in hospital fared better than those who 
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experienced a new onset of depression at the time of the event. Two earlier 
studies had also assessed pre-event depressive history and reported similar 
findings (Berkman et al 1992; Bush et al 2001). It is hypothesised that past 
psychiatric history may not be as relevant to survival as the severity of 
depressive symptoms recorded during an acute event. 
Although significantly more men participated in this study [64.8%] (p<0.001) 
there was a better representation of females [35.2%] in this study than in 
many others that have been published. Another feature of the study was that 
Grace et al assessed participants' co-morbid illness using the Charlson 
Comorbidity Index (Charlson et at 1987) and accounted for co-morbid 
conditions in the regression models. This is important because co-morbid 
illness may affect function and survival and may be a confounding factor in 
assessing risk of mortality. The proportion of participants found to be 
depressed at baseline was similar to levels reported by other researchers. 
The proportion of reported deaths from all causes over the follow up period 
was also comparable to the level reported from a study of revascularisation 
patients (Blumenthal et al 2003) although the researchers did not report on 
cardiovascular mortality in this study. The main weakness of this study was 
the loss of over half of potential recruits at the start of the study, which means 
that the results may not be generalisable to all acute coronary syndrome 
patients who undergo psychological assessments during the hospital stay. 
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5.5 Summary 
There is an interesting picture emerging concerning the part depression plays 
as a risk factor in coronary heart disease progression. Nearly all the 
observational studies have shown that the presence of depressive symptoms 
or depressive disorders at the time of an acute coronary episode or coronary 
procedure may adversely affect morbidity and survival. However, there are 
two studies of myocardial infarction survivors with negative outcomes and 
which did not show the presence of in-hospital depression to predict survival 
(Lane et al 2002; Mayou et al 2000). Both these studies, using different 
questionnaires to assess depression, [Mayou had used the HADS and Lane 
the BDI] were performed in the United Kingdom. In some groups of coronary 
patients depression has been shown to predict the recurrence of 
cardiovascular events. 
It is hard to make comparisons between studies and to draw conclusions 
from those that have been published to date. The reasons for this include 
the type and timing of psychological assessment, the way baseline 
prevalence of depression is assessed, and the difference in outcomes 
measured. Table 5: 3 shows a number of the studies mentioned in this 
chapter together with the method used to determine psychological state and 
the differences in some of the other parameters recorded. The odds ratios 
quoted vary from 1.26 [95% Cl 1.07,1.48] (Barefoot et al 1996) to 7.82; [95% 
Cl, 2.42,25.26] (Frasure Smith et al 1995) and were likely to have been 
affected by several factors. These include the length of follow up period of 
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individual studies, whether assessment covered depressive symptoms and/or 
depressive disorders, the outcomes assessed [deaths from all causes, 
cardiovascular deaths or cardiovascular events], and whether the results 
reported were adjusted for potential confounders. Nevertheless, across the 
many different measures in use for diagnosing either depressive symptoms 
or disorders, most studies consistently found the presence of depression to 
be related to worsening of coronary symptoms and increased mortality in 
spite of the variation in instruments used 
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Many of the studies showed that depression occurring at the time of a 
coronary event increases the risk of mortality. Some studies also show that 
the hazard ratio for mortality in patients diagnosed with depression usually 
but not always decreases over time when reported over a2 to 19 year follow- 
up period. 
The risk of death for depressed patients with coronary disease is also 
increased when other factors are taken into account. For example, new 
onset depression is greatest in patients when the number of recorded 
premature ventricular contractions exceeds ten per minute (Frasure-Smith et 
al 1995). In contrast, the risk of death is less when the presence of chronic 
depressive symptoms or disorders exists before the coronary event 
(Berkman et al 1992; Bush et al 2001; Grace et al 2005). 
One difficulty in summarising the research on depression and coronary heart 
disease has been that most of the research carried out prior to 1990 
concentrated on male myocardial infarction survivors. Van Melle (van Melle 
2004) found that the effect of depression on mortality was stronger in the 
earlier studies. Studies published after 1992 have tended to incorporate 
other aspects of both acute and stable coronary heart disease and have 
better representation of females. They may also have been affected by the 
improved access to more effective pharmacology for coronary and 
psychiatric illnesses and in the United Kingdom partly influenced by the 
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Department of Health's publication of the National Service Framework for 
Coronary Heart Disease (DOH 2000). 
However, the exact nature of the biological mechanisms thought to provoke 
coronary heart disease progression in relation to depression remains unclear. 
Many hypotheses have been tested within the last five years that attempt to 
clarify the relationship between depression and the pathophysiology of 
coronary heart disease progression; I examine some of these in the next 
chapter. 
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Chapter 6 
Pathophysiological mechanisms 
associated with coronary heart disease and 
depression 
6.1 Introduction 
Many hypotheses have been proposed to explain observed associations 
between depression and cardiovascular disease. This chapter considers 
studies which have examined the pathophysiological mechanisms of this 
association. 
6.1.1 Lifestyles, behaviour and depression 
There are several lifestyle and behavioural factors associated with symptoms 
of depression or depressive disorders, which have been shown to contribute 
to poor outcomes in coronary patients. Depression and social isolation for 
instance are thought to affect the pathogenesis of atheroma (Rozanski et al 
1999), as both may lead to the adoption of unhealthy behaviours. Other 
behavioural factors associated with depression in the coronary population 
also affect outcomes. Coronary patients who continue to smoke are less 
likely to complete a CR programme (Oldridge et al 1983), more likely to 
continue to smoke post event, and have a higher re-infarction rate (Ladwig et 
al 1994) 
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Depressed patients are less likely to complete CR. In an observational study 
in our CR programme we reported a drop out rate of 12.6% and in common 
with other researchers (Glazer et al 2002), found that patients in our cohort 
who were clinically depressed at the start of Phase III CR were less likely to 
complete CR [OR 1.12,95% Cl 1.08,1.17 (p<0.001)] (Turner et al 2002). 
Depression has also been related to a failure to take up the offer of CR (Ades 
et al 1992) and may be responsible for coronary patients' delayed return to 
work, (Soderman et al 2003) impaired quality of life, (Ladwig et al 1994) as 
well as non-compliance with a range of medical treatments (Carney et al 
1995a; DiMatteo et al 2000) and attendance at CR (Lane et al 2001). 
However, one reason for these poor outcomes may be due to depression 
acting as a marker for more severe cardiac disease. 
6.1.2 Quality and provision of health care and depression 
Depression has been linked to a reduced access to optimal health care, 
which may consequently affect the speed and completeness of recovery from 
an illness. This was illustrated in a retrospective study of hospital records in 
the United States, which examined the uptake of angiography or 
revascularisation procedures in relation to psychological state. A cohort of 
113,653 eligible participants aged 65 years or older, with a confirmed acute 
myocardial infarction were enrolled in the study between February 1994 and 
July 1995 during their hospital stay (Druss et al 2000). At baseline 5% of 
participants were found to have a broad range of co-morbid mental illnesses 
which included mood disorders, depressive symptoms or disorders and 
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schizophrenia. This study showed that the patients with mental disorders 
were less likely to undergo revascularisation procedures (p<0.001) than the 
patients without mental disorders. However, it was not clear whether patient 
or provider factors were responsible for the difference in uptake, which could 
have several causes. Firstly, depressed patients may be less likely to seek 
or attend for treatment. Secondly, health professionals from the provider unit 
may not offer or prioritise treatment for patients with mental disorders. 
Finally, it may be that the treatment of mental illness such as depressive 
symptoms or disorders is given a higher priority than the coronary procedure. 
However, because the researchers had included a wider range of mental 
disorders than simply depressive disorder or symptoms the findings are hard 
to quantify. 
Depressive symptoms have also been shown to influence convalescence in 
coronary heart disease patients (Mallik et at 2005). Over a two-year period 
963 patients were followed up after coronary bypass surgery and were 
assessed for physical function at baseline and at six months, using the 
physical component of the SF36', and the self-report Geriatric Depression 
Scale". At baseline assessment 8% of the cohort scored highly on the 
Geriatric Depression Scale with scores greater than 10, and 17% had 
moderate scores of between 5 and 9. Participants with depressive 
symptoms reported greater co-morbidity and worse physical functioning. At 
the six-month assessment and after adjusting for coronary heart disease 
SF-36 is a 36 - item questionnaire focussing on quality of health 
Geriatric Depression Scale: Range 1-15 representing total number of depressive symptoms 
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severity, baseline SF36 scores and medical history, depressive symptoms 
independently predicted a failure to improve functional capacity (p=0.002), 
during the convalescent period. 
6.1.3 The Inflammatory process, atherosclerosis and depression 
Coronary heart disease is considered to be a chronic inflammatory disease 
(Appels et al 2000; Libby 2002) with endothelial inflammation in the coronary 
arteries as a precursor of atherosclerosis (Annique et al 2005). However, it 
is not clear whether markers of the inflammatory process, such as soluble 
intercellular adhesion molecule 1, interleukin-6 and C-reactive protein are 
raised in coronary heart disease because of coronary plaque instability or 
rupture within the endothelial wall of the coronary artery, or whether the 
inflammatory process provokes the plaque rupture in the first place. When 
coronary patients are treated with anti-inflammatory medication this does not 
seem to reduce the endothelial inflammation. Moreover, the use of the highly 
selective anti-inflammatory drugs known as Cyclo-oxengase [COX] 2 
inhibitors appears to increase cardiovascular risks in some patients 
(Bombardier et al 2000), as demonstrated in the VIGOR"' study. 
The VIGOR study was the first study to question the safety of COX-2 
inhibitors. The researchers examined the upper gastrointestinal toxicity of 
rofecoxib [Vioxx], a COX-2 inhibitor, and naproxen in patients with 
rheumatoid arthritis (Bombardier et al 2000) over a follow-up period of nine 
 VIGOR: Vioxx gastrointestinal outcomes research 
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months. Although the group who received 50mg/day of rofecoxib reported 
50% less gastrointestinal symptoms, they also experienced a greater number 
of cardiovascular events than the naproxen group. The incidence of 
myocardial infarction was noticeably higher in the patients receiving rofecoxib 
when compared to the group who were given 1000mg/day of naproxen [RR 
2.37,95% Cl 1.39,4.06] for rofecoxib versus naproxen. There are two 
possible reasons for this. Firstly, the inhibitory role of COX-2 leaves patients 
more vulnerable to pro-thrombic events. Secondly, rofecoxib may have a 
detrimental effect on blood pressure levels in susceptible patients and thus 
provoke a cardiovascular event. The safety profile of COX-2 inhibitors is not 
fully established. Current practice is to use them with caution in coronary 
patients, whilst further studies and systematic reviews are continuing to 
examine their safety (Juni et al 2004). It has been suggested recently that 
naproxen plus a proton pump inhibitor is a safer anti-inflammatory option 
than the COX-2 inhibitors that are currently available (Graham 2006). 
Several studies have focused on the interaction between the inflammatory 
process and the formation and progression of atheroma. A small study 
(Appels et al 2000) examined the serological nature of endothelial 
inflammation by taking samples from 30 male angioplasty patients who had 
been diagnosed with severe but stable angina but who did not present with 
an overt inflammatory disease at baseline. The researchers used a 
structured interview [the SCID'"] to assess depressive disorders and the 
SCID: a structured interview technique 
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Maastricht Interview [MIVE"] to assess Vital Exhaustion which they thought 
might be linked to depressive symptoms. The study participants were two 
groups. After assessing psychological state, 15 participants formed a group 
who appeared to be suffering from exhaustion and the second group was 
composed of 15 non-exhausted patients. One patient dropped out of the 
study. Results from this study showed that the samples taken from the 
exhausted group had significantly higher levels of two inflammatory markers; 
interleukin -1p (p=0.001) and tumour necrosis factor (p=0.04) than the levels 
in the non-exhausted group. This indicated that the mental state of 
participants was linked to the presence of interleukin -1P and to a lesser 
extent, tumour necrosis factor. It remains unclear, however, whether 
exhaustion with or without depressive symptoms triggers coronary 
endothelial inflammation, or whether an inflammatory process, occurring 
within a coronary artery is responsible for provoking or worsening the 
symptoms of depression. 
Endothelial dysfunction has also been examined by Broadley and co- 
researchers (Broadley et al 2002) in a small group of patients being treated 
with antidepressant therapy. The ten participants were matched to a group 
of 'healthy' controls. Endothelial function was assessed by measuring flow- 
mediated dilation in the brachial artery. This study found that seven of the 
ten participants being treated with antidepressants had impaired arterial 
endothelial function, compared with the control group whose endothelial 
MIVE: a tool for recognising Vital Exhaustion 
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function remained unimpaired (p=0.005). There are two possible 
explanations for these results. Firstly, depressive episodes or depressive 
symptoms may adversely affect the normal condition of the endothelial tissue 
and consequently its function. Secondly, it is possible that the 
antidepressant medication was responsible for either provoking endothelial 
dysfunction or inhibiting the resolution of an on-going endothelial 
inflammatory process. 
I 
Several other researchers have also examined the strength of the 
association between coronary heart disease, depressive symptoms or 
disorders, endothelial dysfunction and inflammatory markers. For example, 
blood samples were collected from 481 patients who were diagnosed with 
depression during hospital admission with an acute coronary syndrome, 
shortly after discharge home (Lesperance et al 2004). Analyses were 
adjusted to account for gender, smoking and having metabolic syndrome"The 
results from this study showed that the group with depressive symptoms 
or disorders had higher levels of the soluble intercellular adhesion molecule 1 
than the group who were not depressed. However, when the researchers 
looked at inflammatory markers in a subset from the same cohort, 46 in the 
non-depressed group and 57 in the depressed group, they were unable to 
find any between group differences. One drawback from this study was that 
50% of eligible patients invited to take part in this study had declined and 
vi metabolic syndrome predisposes to coronary heart disease and features the following 
traits: central obesity, elevated blood fat levels, hypertension, insulin resistance and pro- 
thrombic or pro-inflammatory state 
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therefore the study sample was not necessarily representative of a 
depressed coronary population. 
The studies performed to date that have examined the association between 
depression, coronary disease and inflammatory markers have several 
limitations. Firstly, the size of the samples in most studies apart from one 
(Lesperance et al 2004) was small. Secondly, Lesperance et al were also 
the only researchers to adjust for potential confounders in their analyses, 
although these were limited to gender and smoking and the metabolic 
syndrome. Finally, it is possible that the results from some studies may have 
been influenced by other factors such as the use of statins or other 
medications. For example, Lesperance found that depressed patients not 
taking statin medications had higher levels of the inflammatory marker C- 
reactive protein than the non-depressed (Lesperance et al 2004). The 
available evidence therefore regarding the relationship between inflammatory 
markers and depressive symptoms in coronary patients has yet to be 
clarified. 
6.1.4 Dysregulation of the autonomic nervous system and 
depression 
Dysregulation of the autonomic nervous system may be another mechanism 
responsible for the underlying relationship between coronary heart disease 
and depression. In depressed patients with coronary disease, autonomic 
nervous system dysfunction has been shown to cause abnormalities in 
resting heart rates (Carney et al 1999), heart rate variability (Carney et al 
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1995b) and arrhythmias (Carney et al 1993) but little is known about the 
mechanisms involved in this association. It is speculated that the presence 
of depressive symptoms or depressive disorders gives rise to a reduced 
parasympathetic drive [parasympathetic tone is known to protect against 
arrhythmias] which allows the sympathetic nervous system to dominate 
cardiac innervation and thus give rise to chronically elevated resting heart 
rates. A recent study has focused on the relationship between autonomic 
dysfunction and depression by examining resting heart rates and heart rate 
variability in myocardial infarction survivors. 
A group of 100 participants [23 female] with a mean age of 62 years were 
followed up for 5 years from January to December 1999 in Italy (Drago et al 
2007). Depression was measured by structured interview measuring 
depressive disorder and the BDI assessing depressive symptoms. Heart rate 
variability was monitored by a 24 hour Holter recording. At baseline 15 
patients were found to be suffering from a depressive disorder and 35 had 
mild to moderate depressive symptoms. More females than males had 
depressive disorder (p<0.01). A total of 98 patients was followed up, of 
whom 6% had died during the five years. The patients with depressive 
disorder were found to have higher heart rates (p<0.01) and also lower heart 
rate variability (p<0.01) than the patients without depression. Patients with a 
BDI score greater than 10, an indication of depressive symptoms, had lower 
heart rate variability (p=0.01) but not significantly higher heart rates. 
Statistical analysis included a multiple regression model which adjusted for 
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potential confounders; age, gender, diabetes, dyslipidaemia, previous 
myocardial infarction, anterior myocardial infarction, poor ejection fraction, 
acute thrombolysis, primary angioplasty and heart rate variability. 
Drago's study confirmed that the patients with depressive disorders were at 
greater risk of all-cause mortality [OR 12,95% Cl 2.6,56 (p<0.01)]. It also 
indicated that heart rate variability was predictive of mortality (p<0.01) as has 
been previously reported (Carney et al 2001). The mortality risk was greater 
for the patients with depressive disorders than those with mild or moderate 
depressive symptoms. However, the researchers were unable to show that 
autonomic dysfunction was related to an increased mortality risk for the 
depressed group during the study period. The main limitation of this study 
was its small sample size and low mortality rate. Only 6 deaths were 
reported during the five years of follow up. 
Increased ventricular ectopic activity at rest (Cripps et al 1989) and during 
exercise (Weld et al 1981) are predictors of one-year mortality post 
myocardial infarction. Coronary heart disease may trigger arrhythmias, 
particularly during an evolving myocardial infarction. In a cohort of 103 
patients with angiographic evidence of coronary disease, depression was 
assessed by structured interview and all patients in the group underwent 24 
hour Holter monitoring (Carney et al 1993). Results were adjusted for 
gender, smoking status, ß blocker and nitrate therapy. The researchers 
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found a higher prevalence of ventricular tachycardia" in the 21 depressed 
patients [RR 8.2 95% Cl 2.14,31.7 (p <0.008)] than the non-depressed, 
which was not related to either the severity of coronary disease or to 
ventricular function. There was also no difference in the prevalence of 
ventricular tachycardia between the patients who had met the criteria for 
major depression and those with minor depression. The main limitation with 
this study was its small sample size. 
It is thought that there may be an association between depression, 
arrhythmias and mortality although survival outcomes are not improved by 
arrhythmia treatment. Anti-arrhythmic drugs, with the possible exceptions of 
P blockers (Group 1982) and amiodarone (Farre et al 1999) have not been 
shown to reduce mortality in myocardial infarction patients regardless of 
psychological state (Ruskin 1989). 
6.1.5 Platelet dysfunction and depression 
The role of platelet activation in the progression of acute coronary syndromes 
and acute coronary thrombosis is clear. High levels of platelet activation may 
affect clotting mechanisms and increase the risk of further cardiovascular 
events in depressed coronary patients (Nemeroff and Musselman 2000). 
They have been linked to the evolving of an acute coronary syndrome or 
coronary thrombus. However, increased rates of platelet aggregation are 
found in people with coronary heart disease with or without depressive 
symptoms (Serebruany et al 2003). 
v0 Ventricular tachycardia is a fast, potentially life-threatening arrhythmia 
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The use of the antidepressant medication sertraline, a selective serotonin 
reuptake inhibitor [SSRI] has recently been studied as it is known to inhibit 
platelet activity (Serebruany et al 2003). A substudy from SADHART iii 
(Glassman et al 2002) monitored the effect of antidepressants on platelet 
behaviour (Serebruany et al 2003). Fifty-four recent myocardial infarction 
survivors with diagnoses of depression were recruited to the study and 
randomised to receive sertraline or placebo. The participants were also 
taking standard antiplatelet medication; aspirin or clopidogrel. Blood samples 
were taken at baseline, and at 6 and 16 weeks. The results showed that the 
group treated with sertraline had statistically reduced platelet and endothelial 
activity (p=0.03 and p=0.04) compared with the group who had received the 
placebo. It was not known, however, whether the treatment impacted on 
physical or psychological outcomes as these had not been assessed. 
6.2 Summary 
This chapter has given a brief overview of the potential pathophysiological 
mechanisms that may link coronary heart disease and depression. Despite 
the use of different approaches to assessing depression in many of the 
studies, it is well established that depression has an adverse effect on 
psychosocial behaviour (Carney et al 2002) and may consequently affect 
morbidity and mortality. Depression is associated with the adoption of 
unhealthy behaviours such as smoking or poor dietary habits or failing to 
Vul SADHART - The Sertraline antidepressant heart attack randomized trial 
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complete a CR programme, which are likely to exacerbate the risk of relapse 
and disease progression (Ladwig et al 1994; Oldridge et al 1983; Rozanski et 
al 1999). However, research by Druss (Druss 2000) was unable to establish 
the extent to which this reflected a lack of service delivery to patients who 
have depression, rather than poor uptake and/or treatment adherence. 
Convalescence also appears to be adversely affected when depressive 
symptoms are present (Mallik et al 2005). 
Although it has been hypothesised that depression is associated with 
inflammation and impaired endothelial function, evidence for this remains 
limited. The studies performed so far have only recruited small numbers of 
patients (Appels et al 2000; Broadley et al 2002) or succeeded in enrolling 
50% of a study population into trials (Lesperance et al 2004). Additional 
research is awaited in this area to determine whether higher levels of 
inflammatory markers may discover a subgroup of depressed coronary 
patients who are at higher risk for succumbing to further coronary events. 
Several studies by Carney et al have shown autonomic nervous system 
dysfunction to cause abnormalities in resting heart rates (Carney et al 1999), 
heart rate variability (Carney et al 1995b) and arrhythmias (Carney et al 
1993) but the mechanisms responsible for this association are not clear. 
Future studies are also needed to focus on this, particularly because survival 
outcomes have not yet been shown to improve by the treatment of 
arrhythmias. 
155 
Platelet activation with increased rates of aggregation is found in coronary 
patients with or without depressive symptoms or disorders and is associated 
with the formation of coronary thrombi and the subsequent evolution of an 
acute coronary syndrome (Nemeroff and Musselman 2000; Serebruany et al 
2003). Clinical depression is also associated with platelet dysfunction. 
SSRIs are known to reduce platelet and endothelial activity in the coronary 
population. Results from recent studies indicate that the use of SSRIs as an 
adjunct to conventional anti-platelet therapy may improve cardiovascular 
outcomes. 
In the final chapter of this literature review I discuss the role of antidepressant 
therapy and psychosocial interventions in coronary heart disease that are 
particularly relevant to the cohort in this study. 
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Chapter 7 
The role of antidepressant therapy and 
psychological interventions in 
coronary heart disease progression 
7.1 Antidepressant therapy 
Few studies have looked specifically at treatments for coronary patients with 
depression although evidence of the prognostic role of depression in 
coronary disease progression is reasonably persuasive. Pharmacological 
treatments for depression are becoming increasingly prevalent in the 
coronary population, and there is preliminary evidence that non- 
pharmacological interventions such as aerobic exercise therapy and 
counselling may also be effective ways of managing coronary patients with 
depressive disorders. 
The use of older tricyclic antidepressants is contraindicated in acute or 
unstable coronary disease because they are cardiotoxic and may provoke 
serious cardiovascular side effects (Serebruany et al 2003). They are known 
to increase heart rates, induce orthostatic hypotension and provoke 
conduction abnormalities (Roose and Spatz 1999). However, several recent 
randomised controlled trials have considered the efficacy and safety of 
SSRIs in patients with coronary heart disease. The majority of these studies 
enrolled small numbers of patients, with one exception. 
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The SADHART multi-centre randomised double-blind trial (Glassman et al 
2002) examined the safety and effectiveness of treating depressed patients 
with unstable coronary heart disease by using SSRIs. This study examined 
the fate of 369 out of 556 eligible patients who had suffered an acute 
coronary syndrome or episode of unstable angina within the previous 30 
days and were currently experiencing a major depressive disorder. They 
were randomised between 1997 and 2001 to receive either treatment with 
the SSRI sertraline or a placebo. Sixty-four percent of participants were 
male, with a mean age of 57 years. 
The primary outcome was change in left ventricular ejection fraction, more 
than 5% being considered significant. The ejection fraction is the percentage 
of the ventricular diastolic volume which is pumped out during systole and is 
usually more than 65% in normal individuals. A reduced ejection fraction is 
the best measure of left ventricular dysfunction and a strong predictor of a 
poor outcome following an acute coronary syndrome. A level below 35% is 
particularly significant. Other outcomes, such as the number of recorded 
adverse cardiovascular events and measures of depression were also 
included. Depressive symptoms were assessed with the BDI and depressive 
disorders by the Diagnostic Interview Schedule. 
At the end of the study period there were no statistically significant 
differences between the sizes of the left ventricular ejection fractions in the 
group who had received sertraline [baseline: 54%, at week 16: 54%] 
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compared with the control group receiving the placebo [baseline: 52%, at 
week 16: 53%]. However, the sertraline group reported a non-significant 
trend, approximately 20% less, towards fewer major cardiovascular events 
such as orthostatic hypotension or conduction abnormalities. Sertraline was 
found to be superior to placebo in its antidepressant efficacy for the patients 
with recurrent depressive disorders who had experienced an acute coronary 
syndrome, but not for the patients whose depression had first occurred at the 
time of their coronary event. However, there were two main limitations with 
this study. Firstly, the sample size was small. It was estimated that 4,000 
patients would need to be recruited to reveal rarer adverse reactions. 
Secondly, treatment was not initiated until 34 days post event being the time 
it took for the participants to undergo a necessary range of safety screens 
before commencing treatment. 
There has been a widespread use of SSRIs since the publication of the 
SADHART study. Other SSRIs such as fluoxetine, paroxetine and citalopram 
have all been studied although sertraline is the only SSRI not to carry a 
cautionary warning for use in cardiac patients. 
Recently the use of various SSRIs preoperatively (Xiong et al 2006) in 
patients undergoing coronary revascularisation in the United States has led 
to higher incidences of rehospitalisation and increased mortality when 
compared to patients not taking SSRIs. This prospective study examined the 
long term outcomes of 5.1% [246] of a cohort of 4,548 pre-surgical coronary 
163 
patients who were taking SSRIs at the time of joining the study, between 
1999 and 2003. The SSRIs examined in this study included fluoxetine, 
paroxetine, citalopram, and sertraline. Patients were followed up initially at 6 
months and then annually with a self-report questionnaire for up to six years. 
The drop out rate from the study was 5%. Depression levels were not 
measured at any time during the study. The control group were the patients 
not taking the SSRIs. At baseline, the group on SSRI therapy had greater 
co-morbid illness with evidence of peripheral vascular disease, previous 
coronary interventions and diabetes. At the end of the follow-up period the 
group taking SSRIs pre-surgically was shown to have increased risks for 
mortality [HR 1.61,95% Cl 1.17,2.21] (p=0.003) and also for re- 
hospitalisation, [HR 1.52 95% Cl 1.30,1.77] (p<0.0001) compared to those 
not taking SSRIs. However, patients requiring SSRIs because they are 
depressed are at greater risk anyway, so it is not clear whether SSRIs add 
that risk or not. 
This study has several limitations. Firstly, the proportion of patients being 
treated with SSRIs at baseline was low at 5.1%. Other researchers have 
reported rates of around 20% in similar patients (Connerney et al 2001). 
Secondly, it was estimated that a further 2.7% of participants were taking 
other antidepressant medications, but rather than exclude these patients, 
they formed part of the control group, which may have biased the results 
obtained. Finally, depression levels were not assessed at any time during 
the study period, therefore it was not possible to ascertain whether any 
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crossover between the groups occurred in terms of increase or reduction in 
depressive symptoms or disorders or use of SSRIs, which may also have 
confounded the results. 
A study has been published recently (van Melle et al 2007) which recruited 
331 participants diagnosed with depression using ICD-10 criteria, from a 
cohort of 2177 myocardial infarction survivors. This multicentre randomised 
controlled trial aimed to compare the effectiveness of antidepressant 
treatments with usual care, using a variety of modalities. The study 
participants were assessed with the BDI during their hospital stay and 3,6,9 
and 12 months after the acute event. Those found to be depressed whilst in 
hospital were also assessed with a structured interview, after 3 months had 
elapsed. The researchers delayed the structured interviews for several 
months to allow for the spontaneous recovery from depression during early 
convalescence. Outcome measures were the presence of continued 
depression and further cardiovascular events occurring over the follow up 
period of 18 months. Patients who were at significant risk for committing 
suicide were excluded, as were patients who had diseases likely to 
unfavourably influence short term survival and those already being treated for 
depression. Co-morbidity was reported using a modified version of the 
Charlson Comorbidity Index (Charlson et al 1987). The researchers 
accounted for the severity of coronary disease amongst participants using a 
variety of risk stratification tools such as Killip class and measurements of left 
ventricular ejection fractions. 
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Treatment for depression for the intervention group [n=209] consisted of 
several options: 
1. A double-blind placebo controlled treatment of mirtazapine with or 
without the addition of an SSRI [citalopram] for those who did not 
respond to the mirtazapine 
2. Pharmacotherapy or psychotherapy at the discretion of a psychiatrist 
with or without a referral to CR 
3. No treatment 
The group randomised to usual care [n=122] were offered a variety of 
treatments such as pharmacotherapy and psychotherapy which were 
provided at the discretion of local clinicians, or did not receive any treatment. 
At baseline three-quarters of participants were male, with a mean age of 58 
years. Most participants in the intervention group received treatment for 
depression. This was in contrast to the usual care group of whom only 7% 
had recorded evidence of treatment with antidepressant pharmacotherapy 
and 10% received non-pharmacological treatment. 
At the end of the study period 66% of the cohort were assessed for long term 
depression. Forty percent were from the intervention group and 26% from 
the group who had usual care. There were no differences between the 
intervention and usual care group in either mean scores from the BDI 
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assessments [11.0 ±7.5 versus 10.2 ±5.1 (p=0.45)], the presence of 
depressive symptoms using the ICD-10 criteria for diagnosis [30.5% versus 
32.1% (p=0.68)] or the occurrence of cardiovascular events [OR 1.07,95% 
Cl 0.57,2.00]. One limitation of the study was its focus on a variety of 
modalities for treating depression, which may have reduced the power of the 
results obtained. Although not all patients in the intervention group were 
offered antidepressant medication as treatment, when the researchers 
performed a secondary analysis comparing patients who had received 
treatment with those who had not, they were still unable to detect a difference 
in the incidence of cardiovascular events between the two groups. 
This study therefore did not provide evidence that treating depression 
improved either long term depression status or coronary outcomes over the 
18 month follow-up period. 
7.2 Psychological interventions for coronary heart disease - 
The Cochrane Review 
Exercise therapy and counselling interventions are also widely used in the 
treatment of patients who suffer from both depression and coronary heart 
disease. However, until recently, little has been known about the effect of 
psychological interventions for depressed coronary heart disease patients. In 
the original Cochrane Review on comprehensive CR there were only four 
studies that had used validated questionnaires to assess depressive 
symptoms. As a result the researchers were unable to perform analyses or 
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report on the effectiveness of the psychological components in CR. 
However, a later systematic review by the Cochrane Collaboration (Rees et 
al 2004) has focused specifically on the effectiveness of psychological 
interventions and stress management training in coronary heart disease and 
summarises this evidence from the randomised controlled trials that were 
published up to December 2001. Therefore, I did not go back to the original 
cohort studies for this part of my review. 
The studies in the Cochrane Review met the following criteria for inclusion: 
they were randomised controlled trials of non-pharmacological psychological 
interventions for participants who had been diagnosed with coronary heart 
disease and they had a minimum follow-up period of 6 months. Clinically 
qualified personnel delivered the interventions. These included single 
interventions, such as stress management or psychological interventions 
incorporated within comprehensive CR. The primary outcome measures 
were all-cause and coronary-related mortality, nonfatal coronary events, 
anxiety and depression. Using these criteria, the researchers identified 36 
trials for inclusion, involving a total of 12,841 patients. Eleven of the trials 
had assessed depression, with a variety of different instruments. Results 
from these studies showed a significant reduction in depression for treated 
patients, with a standard mean difference of -0.3 [95% Cl -0.48, -0.13]. The 
reviewers commented that the quality of many of the trials that were included 
was poor. The combined results from all the trials failed to show any effect 
from psychological interventions on mortality. Although a small reduction in 
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the incidence of nonfatal re-infarctions for the patients who had received 
either comprehensive CR or stress management, [OR 0.78 (0.67,0.90)] was 
reported, this was not seen in the two largest studies (Blumenthal et al 2004; 
Jones and West 1996) which between them had recruited over a third of the 
total number of participants. 
The first of the larger studies evaluated psychological CR in England and 
Wales (Jones and West 1996). Six hospitals enrolled 2,328 patients (73% 
males), of all ages with an acute myocardial infarction. The exclusion criteria 
were a stay in hospital of over 28 days or being discharged to long-stay or 
institutionalised care. Patients were randomised to an intervention group 
who received psychological therapy, consisting of seven 2-hour sessions of 
group or individual counselling. The control group had a normal cardiology 
follow-up, but none of the usual components of comprehensive CR such as 
weight management, dietary and stop smoking advice and supervised or 
home exercise programmes. Outcome measures were total mortality, cardio- 
vascular mortality, revascularisation, nonfatal myocardial infarction and 
measures of anxiety and depression. Depression was assessed by 
administration of the DSSI/sAD [Delusions-Symptoms-States Inventory/ 
states of Anxiety and Depression] within a semi-structured interview at 
baseline and at 6 months to assess psychological parameters. Participants 
were assessed by a second interview at 6 months in their homes, and at 12 
months in the hospital outpatient departments. Outcome measures were 
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total mortality, cardiovascular mortality, revascularisation, nonfatal 
myocardial infarction and measures of anxiety and depression. 
Seventy-three percent of participants attended the rehabilitation course. The 
drop out rate from the study was 6%. At baseline entry to the trial there were 
no differences between the intervention and control groups by age or HADS 
scores. Nineteen percent of participants in both groups had symptoms 
suggestive of depression at baseline, and this percentage remained the 
same at the 6-month assessment. There were no differences reported in 
changes in depression scores between the start and end of CR. At the end 
of the study period 7% of the cohort had died. The researchers were unable 
to show any statistical differences between the 2 groups in terms of either 
clinical outcomes or mortality. 
There are several possible explanations for the null effect obtained from 
psychologically based CR in this study. Firstly, one in four of patients had 
declined to take part in the study due to transport difficulties and an 
ambulance strike. Therefore the final selection of patients enrolled into the 
study did not necessarily represent the total number of patients who were 
eligible. Secondly, the educational programmes attended by the patients 
were of short duration only. CR programmes are usually considered to last 
between 8-12 weeks in the United Kingdom and far longer in most of the 
studies published from North America. This could have affected the intensity 
of all the interventions and consequently the outcomes. Thirdly, the second 
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and final psychological assessment at 6 months post event may not have 
allowed sufficient time for the psychological treatment to show an effect or 
conversely any effect produced during the seven weeks of CR may have 
worn off by then. Finally, it was unclear whether members of the control 
groups had taken up exercise during the period of study, which could also 
have biased findings towards the null. 
The only other large study from the Cochrane Review followed up myocardial 
infarction survivors by using a subset of depressed participants from the 
Enhancing Recovery in Coronary Heart Disease [ENRICHD] randomised 
controlled trial whom they reviewed at six months post event (Blumenthal et 
al 2004). There were 2,078 participants [43.5% females] with a mean age of 
61 years who entered the study following an assessment for the continued 
presence of depression or a reported perception of having low social support. 
Depressive disorder was measured with the Depression Interview and 
Structured Hamilton [DISH] (Freedland et al 2002). The DISH consists of a 
semi-structured interview divided into 3 sections, with open ended questions, 
a section on current depression symptoms and a third part on psychiatric 
history. Depressive symptoms were assessed with the BDI. Exclusion 
criteria included the presence of major psychiatric co-morbidity, patients who 
were thought to be too ill to take part in the study, patients who had possible 
fatal non-cardiac conditions, patients who had undergone revascularisation 
procedures, and failure of patients to be enrolled into the study within a 28 
day period of the acute event. Physical activity was self-reported by use of a 
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single item on an activity questionnaire. The D'Hoore Co-morbidity Index 
(D'Hoore et al 1993) was used to account for non cardiac and non-psychiatric 
co-morbid illness. Participants were randomly assigned to cognitive 
behavioural therapy sessions that were held in groups, or provided on an 
individual basis, or to usual care with all participants being given the 
opportunity to attend CR as part of routine care. Outcome measures 
included self-reported physical activity, depression, all-cause mortality and 
cardiovascular morbidity. Depressive symptoms and data on exercise habits 
were assessed after 6 months and then annually for up to four years. 
During the four-year follow-up period, 9% of the cohort had died. Results 
indicated several differences between the participants who were exercisers 
and the non-exercisers in the uptake of treatments and lifestyle changes. 
Forty-two percent of exercisers had participated in cognitive behavioural 
therapy compared to 28% of non-exercisers. Forty-two percent of exercisers 
also attended CR compared to 13% of non-exercisers. Exercisers were less 
likely to be smokers [16% versus 23%] and to have modified their diets [57% 
versus 78%]. 
Survival analyses using a Cox proportional hazard model were performed 
using a variety of covariates which included smoking habit, co-morbidity, 
baseline depression level, change in depression level and cognitive 
behavioural therapy. The results demonstrated the importance of exercise 
training in reducing mortality in myocardial infarction survivors who were 
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either depressed or who had reported low levels of social support over an 
average follow-up period of two years. However, attendance at cognitive 
behavioural therapy sessions was not shown to be significant in any of the 
regression models. 
There were twice as many deaths (12%) and a greater number of nonfatal 
myocardial infarctions (10.5%) in the non exercisers compared with the group 
who were still exercising regularly at the final follow-up (5.7%, 6.5% 
respectively). The adjusted HR was 0.62, [95% Cl 0.44,0.86 (p=0.004)] for 
fatal events and 0.72, [95% Cl 0.52,0.99 (p=0.044)] for nonfatal myocardial 
infarction. The regular exercisers had lower depression scores (p=0.0004) at 
the start of the study, and a significantly greater decrease from baseline 
depression scores (p <0.0001). However, the effect of self-reported physical 
activity on baseline depression levels and changes in depression scores over 
time was not significant (p=0.672 and p=0.819 respectively). 
There were several weaknesses with the design of this study. The patients 
had only one opportunity during the 6-month period to recall and self-report 
on their exercise habit. There was no way of distinguishing whether those 
who said they were exercisers were exercising because they were less 
depressed or whether they were less depressed because they had become 
regular exercisers. A further limitation was the lack of clarity concerning the 
concept of self-reported 'exercise'. The patients were a self-selected group 
in terms of self-report of exercise behaviour, with only some of those, who 
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professed to be exercisers having had access to CR programmes. Five 
hundred and fifty-four patients from the original ENRICHD cohort had 
attended certain components of CR, of which less than half had participated 
in supervised exercise-based CR. It is difficult to compare these results with 
other CR studies because the timing of the psychological assessments at 6 
months was later than usually reported in CR studies. The results from this 
study, therefore, can only be generalised to myocardial infarction survivors 
who are either lacking in perceived social support, suffering from a form of 
depression or both. 
7.3 Observational studies of exercise and depression in 
coronary heart disease 
Although some studies have been performed which looked at the effect of 
exercise as a treatment for depression in coronary heart disease, few have 
followed up participants in the long term or reported on mortality as a primary 
end point. However, I found one observational study (Milani et al 1996) 
which although it did not collect survival data on participants, did examine the 
efficacy of exercise therapy in a group of 338 coronary heart disease patients 
[22% female] with elevated depression scores. The patients were enrolled 
into the study whilst participating in a CR programme. They had either been 
in hospital with a myocardial infarction or undergone coronary 
revascularisation 4-6 weeks prior to the start of the study. All participants 
were less than 76 years of age. Those taking antidepressant medication or 
lipid lowering drugs were excluded from participation. Depressive symptoms 
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were assessed with a validated, self-report questionnaire (Kellner 1987). 
The participants' cardiorespiratory fitness levels were measured by treadmill 
exercise testing prior to enrolment in an exercise and educational CR 
programme. The CR programme required participants to attend 3 times a 
week for 12 weeks. Fitness and psychological outcomes were reassessed at 
the end of the 3-month period. 
The researchers categorised depression scores into moderate or severe. At 
baseline 69 [20%] of the cohort was found to be depressed with just over 
one-half of this group reporting symptoms of severe depression. The 
depressed group was also younger (p=0.06), reported to be heavier smokers 
(p=0.07) and less fit (p=0.01) when compared to the non-depressed group. 
By the end of the CR programme the percentage of depressed patients had 
fallen significantly to 6.8%, of which 4.14% reported symptoms of severe 
depression and 2.66% symptoms of moderate depression (p<0.0001). The 
change in depression scores was significant in the depressed group between 
the start and completion of CR. (p<0.0001). However, 6% of participants 
from the non-depressed group had developed depressive symptoms by the 
end of CR. 
Exercise capacity was also shown to improve in both depressed and non- 
depressed participants (p<0.001). In depressed participants before CR 
mean exercise capacity was 4.9 ±2.1 METS which rose to 7.4 ±3.5 by the 
end of the programme (p<0.001) and translated into a 51% improvement in 
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fitness. This compared with a mean exercise capacity in the non-depressed 
group of 5.8 ±2.4 at the start of CR and 7.9 ±3.6 at the end of the Phase III 
programme (p<0.001). For the non-depressed group this represented a 36% 
change in exercise capacity 
This study showed that attending 36 sessions of formal educational and 
exercise-based CR increased fitness levels and reduced symptoms of 
depression in depressed coronary heart disease participants who joined a 
CR programme within 6 weeks of their index event or procedure. 
There were several limitations with this study. The study participants were a 
self-selected group who had previously consented to join a CR programme. 
They may therefore not be representative of all coronary heart disease 
patients. It is also not clear how specific or sensitive The Symptom 
Questionnaire (Kellner 1987) is at detecting symptoms of depression in 
coronary patients, although it has been extensively validated and used to 
measure psychological symptoms in heart-lung patients. I was unable to find 
any other studies in the coronary population that had used this questionnaire 
to assess depression. Finally, the follow-up period for this study was short 
and it was not known whether the immediate beneficial effects of CR would 
endure over the passage of time. 
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7.4 Summary 
Depression is gaining recognition as a risk factor in coronary heart disease 
progression and therefore treatment for depressive symptoms or disorders 
may be of prognostic importance. The choice of antidepressant medication 
is also important as many antidepressants have a potential for provoking 
adverse cardiovascular side effects. Results from recent studies indicate that 
the SSRIs are safer than tricyclic antidepressants for treating depression in 
people with coronary disease. SSRIs versus placebo have been found to be 
effective in treating patients with a prior history of depressive disorder and 
recent myocardial infarction or unstable angina, and have also been shown 
to be less likely to provoke cardiovascular events effects (Glassman et al 
2002). Sertraline appears to be the SSRI of choice and is recommended by 
NICE' for use in myocardial infarction patients or patients with unstable 
angina. 
However, a recent study which used a variety of modalities including 
pharmacotherapy and psychotherapy to treat depressed myocardial 
infarction survivors, was unable to provide evidence that treating depression 
at the time of the event improves either depression status or coronary 
outcomes (van Melle et al 2007). Future research needs to explore the role 
of all antidepressant treatments, including pharmacotherapy and 
psychotherapy and their effects in a wide range of coronary heart disease 
patients, as long term data is limited. 
' NICE The National Institute for Clinical Excellence Guideline 
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The effectiveness of psychosocial interventions in the treatment of coronary 
heart disease remains unclear, as the two largest studies were unable to 
show the beneficial effect from either psychological or cognitive behavioural 
therapies (Jones and West 1996; Blumenthal et at 2004). The Cochrane 
reviewers concluded that although psychological interventions did appear to 
alleviate levels of depression, the overall effect of any treatment was small. It 
has been suggested that further research in this area should be directed 
towards explicit psychological interventions for patients attending CR 
programmes which take into account four factors: the timing and duration of 
interventions, the expertise of those that provide them, and the co-morbid 
state of the patients receiving them (Stokes 2004). 
The study by Milani et al (1996) is the only one of which I am aware that 
focused specifically on the role of exercise therapy in treating depressed 
coronary patients and which reported changes of fitness and depression 
levels as outcome measures at the end of a CR programme. The important 
finding from this study was that depressed patients showed greater gains in 
fitness when attending CR compared with those who were not depressed. 
The depressed patients improved their exercise capacity by 51 % compared 
with the gain of 36% for the non depressed patients. There may be many 
reasons that contribute to this benefit. Unfortunately, this study did not report 
survival data as this may have helped to clarify the effects of physical training 
for depressed coronary patients in the longer term. 
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Chapter 8 
Methodological Issues 
8.1 Using a cardiac rehabilitation cohort for research 
Not all cardiac patients have access to rehabilitation and many are denied 
the opportunity to attend a supervised programme. CR appears to be offered 
to a minority of patients who might benefit (Bethell et al 2001; Lewin et at 
1998; Thomas et al 1996) and a significant number who are recruited for 
rehabilitation, fail to complete their programme (Bethell et at 1999). In 
England, for instance, of 131,089 eligible cardiac patients in 2000,45-67% 
were referred to rehabilitation but only 27-41% actually attended (Griebsch et 
at 2004). The situation is similar in North America where a recently published 
longitudinal survey of patients found that approximately half of heart attack 
survivors were participants in rehabilitation in Minnesota during the 16 year 
timeframe of surveillance and that women and the elderly, independently of 
other characteristics were less likely to enrol (Witt et at 2004). 
In a study performed in our programme we found that non-compliance with 
CR was an important risk factor for a poor prognosis (Turner et al 2002). The 
ability to predict which patients were least likely to comply with CR would be 
useful and enable health professionals to focus more effort on such patients 
to encourage their long-term adherence to healthy lifestyle changes. 
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A number of different factors are related to whether a patient starts the CR 
programme and then persists with it. An important factor is whether the 
patient volunteers for CR or is automatically referred. Patients are more 
likely to enrol in CR if encouraged to do so by the cardiologist in charge of 
their care (Horgan et al 1992). One of the milestones for CR in The National 
Service Framework for Coronary Heart Disease (DOH 2000) is to offer CR to 
85% of patients following acute myocardial infarction or after 
revascularisation. 
There is often poor uptake amongst women, ethnic minority groups, those 
patients at high risk of further cardiac problems and the elderly. Many 
researchers have reported that there is a greater likelihood of any of these 
patients dropping out of the programme prior to completion of an exercise- 
based rehabilitation course (Evenson and Fleury 2000; McGee and Horgan 
1992; Pell et al 1996; Romeo and Saccucci 1991; Thow et al 2000). 
The rate of non-completion from short term CR programmes reported over 
the past 30 years is similar to the rate we have reported previously from our 
programme; ranging from 14-20% (Carson et al 1982; Gutin et al 1990; 
Turner et al 2002; Williams et al 1985). It has been suggested that those 
who have the most to gain from rehabilitation are the least likely to be 
enrolled, and are the most likely to fail to attend the CR course (Harlan et al 
1995; Oldridge et al 1978). For instance, non-compliance with CR is greatest 
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amongst inactive smokers who had already suffered a previous myocardial 
infarction (Oldridge et al 1978). Compliance is also affected by age 
(Evenson et al 1998; Pell et al 1996) and gender, with a higher dropout rate 
being observed in females and in the elderly (McGee and Horgan 1992; 
Moore et al 1998; Thow 2000), whilst others have found that the presence of 
anginal symptoms is a significant predictor of non-completion of CR (Oldridge 
et al 1983; van Dixhoorn et al 1990). 
All of this means that a cohort of CR patients such as the one in this study 
may not be representative of people with coronary disease as a whole. 
8.2 Developments in coronary heart disease secondary 
prevention measures 
Secondary prevention for coronary patients has changed over the last 15 
years. The prognosis of the patients diagnosed with coronary heart disease 
has improved as new treatments and interventions such as thrombolysis 
have become available. It is inevitable that during the course of recruitment 
to CR some of the patients in this study were exposed to more effective 
treatment and in particular to more effective drug therapies [Figure 8: 1]. 
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Figure 8: 1 Changes in use of secondary prevention medication at the 
Basingstoke & Alton Cardiac Rehabilitation Programme between 1993 
and 2005 
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For example, the introduction of the routine use of statins was the first 
evidence-based therapy to help limit coronary disease progression (Bowles 
et al 2004). Government targets have encouraged use of all medications that 
are effective in reducing coronary heart disease progression, namely statins, 
aspirin, ß blockers and, more recently, ace inhibitors. The evidence base for 
this combination of medication is well-established (Borg 1967; Ho et al 2004; 
Veverka and Jolly 2004) although not necessarily being met (Lawlor et al 
2004). Lower targets for blood pressure levels to control hypertension have 
also lead to an increased use of cardiovascular drugs. 
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As well as the new drug therapies that have become available there were 
several other important changes in the management of patients during the 
study period. In 1998 the Basingstoke and North Hampshire Foundation 
Trust appointed its first interventional consultant cardiologist, who was joined 
by a second consultant three years later. With the increase in the use of 
percutaneous coronary intervention procedures there has been a reduction in 
bypass grafting but a significant increase in the number of patients enrolled in 
our programme [Figure 8: 2]. 
Furthermore, there have been recent changes in the way a diagnosis of 
myocardial infarction or coronary heart disease is made and there are new 
types of revascularisation procedures available, as I discussed in Chapter 2. 
Such innovations require changes in the organisation of CR to accommodate 
a greater volume of patients with different requirements. We are seeing an 
increasing number of elderly patients, and a greater number of myocardial 
infarction patients who have undergone immediate primary or rescue 
angioplasties. 
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Figure 8: 2 Changes in diagnostic reasons for enrolment to the 
Basingstoke & Alton Cardiac Rehabilitation Programme between 1993 
and 2005 
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8.3 Choice of variables to include in the analysis 
8.3.1 Measuring physical fitness 
It has been possible to assess cardiorespiratory fitness for most of the 
coronary patients who participated in our CR programme. We used two 
methods to achieve this. Patients tested up to 9th August 1995 were 
assessed on a bicycle ergometer. A stepped protocol of 3-minute stages 
was used, with a starting level of 25 or 50 watts, increasing by 25 watts per 
stage. The end point was taken at a perceived exertion rating 6 or 7 out of a 
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range of 1-10 (Borg 1967), unless the test had been stopped by angina, 
arrhythmia, hypotension or maximum heart rate. Peak V02 was thus 
predicted from the known oxygen cost of cycling at the final workload 
attained and divided by the weight of the patient to give a figure in ml/kg/min. 
We acquired an exercise treadmill with an electrocardiograph facility at the 
beginning of August 1995. From 1 0th August that year most new patients 
were assessed on the treadmill with a few exceptions for those who could not 
walk on the treadmill, but could bicycle, usually because they had 
orthopaedic limitations. The Bruce protocol [full Bruce] (Bruce et al 1973) 
was used for most patients, but a modified version [modified Bruce protocol] 
was used for patients whose age and physical condition made it unlikely that 
they would be able to perform at least 3 minutes of the full Bruce protocol 
[Table 8: 11. For the full Bruce protocol, oxygen uptake was estimated as 
3.5ml/kg/min for each full minute performed added to the basal rate of 
3.5ml/kg/min. For the modified Bruce protocol, oxygen uptake was estimated 
as 3.5m1 for each 3-minute stage for the first 3 stages. At the end of the 
exercise programme, everyone who completed the programme was retested 
using the same method and protocol as was used for the initial test. Chapter 
9 includes a description of the protocols we used for exercise testing and 
explains how the data collection was achieved. 
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Table 8: 1 Modified and Full Bruce Protocol 
STAGE SPEED (MPH) 
GRADE 
% 
DURATION 
(mins) 
METS 
Modified Bruce Full Bruce 
1 - 1.7 0 3 
1.7 
2 - 1.7 5 3 
2.9 
3 1 1.7 10 3 4.7 
4 2 2.5 12 3 7.1 
5 3 3.4 14 3 10.2 
6 4 4.2 16 3 13.5 
7 5 5.0 18 3 17.3 
Adapted from 'Principles in Exercise Testing by R. A. Bruce, 1973 
8.3.2 Measuring depression and psychological state 
There are two main ways of assessing psychological state, by standardised 
clinical interviews and by self-report questionnaires. A combination of the 
two methods may be used, as for example in the ENRICHD trial (Blumenthal 
et al 2004). Each method of assessment has its own merits and the choice 
of technique may depend upon factors such as the type of detailed 
information that is required, the funds available for a project, the sample size, 
or the location of the research. 
Standardised clinical interviews may be subdivided into those carried out 
during epidemiological research or probing, in-depth interviews. Lay 
interviewers often conduct the former by reading out standard questions to 
the interviewees and recording their answers. Health professionals, who are 
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required to undergo special training in interviewing skills, carry out probing or 
in-depth interviews. 
In contrast, standardised self-report questionnaires can be easily completed 
during a clinical appointment, or by post or emails, as a part of patient 
assessment. Using this method it is possible to detect depressive symptoms, 
and to differentiate between symptoms suggestive of clinical depression and 
non-depressed states. Self-report questionnaires have several advantages 
over interview techniques. They are quick and cheap to administer, easy to 
score and analyse and give instant results. This was the main reason for 
selecting this type of instrument for regular use in our CR programme. There 
are many psychosocial assessment instruments for CR patients in use and 
there is no general agreement as to which instruments are the most helpful 
and which should be used routinely to ascertain changes in psychosocial 
status during CR (McGee et al 1999). This is an on-going problem for those 
of us measuring the psychological state of our CR patients. 
Interpretation of results is often complicated. The availability of a wide range 
of instruments means it is difficult to compare individual study results, when 
different instruments have been used to measure similar things. The timing 
of assessments also varies between studies. For instance, in research 
carried out specifically on coronary heart disease patients, some researchers 
measure depression in hospital (Lewin et al 1992), whilst others do so at 
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about one month post event (Mayou et al 2002), or, as we did, at the start of 
Phase III, which is about 4-5 weeks after the event. 
The most common questionnaire used to assess psychological state in CR in 
the United Kingdom (Bethell et al 2004) is the HADS (Zigmond and Snaith 
1983). It was designed initially to detect emotional disorders and was used in 
medical outpatient clinics but not necessarily in people with coronary 
disease. It has since been shown to be an acceptable, reliable and valid 
measure with sensitivities and specificities of more than 80% for detecting 
anxiety and depression in physical illness (Herrmann 1997). The BDI is 
another popular instrument available for measuring depression and is also 
widely used in research in coronary heart disease (Beck et al 1961). It is the 
most commonly used instrument for measuring depression in the general 
population in the United Kingdom (Bradford 2005) and has been used in 
widely in studies involving people with coronary disease (Blumenthal et al 
2004; Carney et al 2001; Connerney et al 2001). The BDI consists of 21 
items and is, like the HADS, easy to administer and score. However, in the 
United Kingdom the majority of CR programmes measuring psychological 
state use the HADS as recommended by national CR guidelines (Coats et al 
1995) and the National Service Framework for Coronary Heart Disease 
(DOH 2000). In a survey performed by the BACR/BHF, 52 CR programmes, 
out of the 302, measured the psychological state of their coronary patients. 
Eighty-eight per cent of these programmes were found to be using the HADS 
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(Bethell et al 2000), possibly because the BDI has to be purchased by users, 
while the HADS is a free resource (Bethell et al 2000). 
The HADS consists of 14 questions divided into two subscales, each of 
which includes four possible responses, which are presented in a tick box 
format. The patient is asked to rate each question and tick the box they 
judge best to correspond with their current state of mind. The questions, 
which are weighted 0-3, alternate between measuring traits of either anxiety 
or depression. The minimum score for either trait is zero and the maximum 
21. The clinician adds up the weighted scores separately for the two 
domains, the greater the anxiety or depression, the higher is the score. A 
score of between 8 and 10 indicates borderline anxiety or borderline 
depressive symptoms and above 10 suggests symptoms of clinical anxiety or 
depression. The HADS is easy to apply and rapidly interpreted by clinicians. 
As seen in Figure 8: 3, the numbers in the boxes refer to the weighting of 
each answer; these are masked on the patient's form. 
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Figure 8: 3 HAD Scale - Questions and Scoring 
Instructions: Doctors are aware that emotions play an important part in most 
illnesses. If your doctor knows about these feelings he or she will be able to help 
you more. This questionnaire is designed to help your doctor know how you feel. 
Read each item and place a firm tick in the box opposite the reply which comes 
closest to how you have been feeling in the past week. Don't take too long over your 
replies: your immediate reaction to each item will probably be more accurate than a 
long thought out response. 
I feel tense or'wound up': A I feel as if I am slowed down: D 
Most of the time [-][3 Nearly all of the time 
A lot of the time 2 Very often 
12 
Time to time, occasionally 11 Sometimes D1171 
Not at all Jj Not at all 
0Q 
I still enjoy the things I used to D I get a sort of frightened feeling A 
enjoy: like 'butterflies in the stomach': 
Definitely as much 0Q Not at all 
Q61 
Not quite so much 1QQ Occasionally Q0 
Only a little 2Qý Quite often Q2 
Not at all F-3 ]F Very often 
QW 
I get a sort of frightened feeling A I have lost interest in my D 
like something awful is about to appearance: 
happen: 
Very definitely and quite badly [-IF3 Definitely ýQ 
Yes, but not too badly 2 11M I don't take as much care as I 22 
should 
A little, but it doesn't worry me 1j I may not take quite as much care 11 
Not at all Elo I take just as much care as ever 
10 
I can laugh and see the funny side D I feel restless as if I have to be A 
of things: on the move: 
As much as I always could Q0 F] Very much indeed 
ý3 
Not quite so much now 1Q1-1 Quite a lot 
Q[2] 
Definitely not so much now [ý]P Not very much 
Q1-1-1 
Not al all F3][ 1 Not at all 
Q101 
Worrying thoughts go through my A I look forward with enjoyment to D 
mind: things: 
A great deal of the time [: ]F3 3 A much as I ever did 
1-0 ) 11 
A lot of the time F 2Q Rather less than I used to 
From time to time but not too often 11l Definitely less than I used to 2Qý 
Only occasionally QQ0 Hardly at all 
Wý 
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I feel cheerful: D I get sudden feelings of panic: A 
Not at all LJU Very often indeed L JU 
Not often Quite often Q2 
Sometimes 17171 Not very often 1Q 
Most of the time QE1 Not at all QQ0 
I can sit at ease and feel relaxed: A I can enjoy a good book or radio D 
or TV programme: 
Definitely 0Fo Often 
Usually IF Sometimes 00 
Not often Fý 22 Not often 
Not at all 3] Very seldom 
W3 
Several researchers have used the HADS to detect psychological distress in 
patients who have suffered a myocardial infarction (Barth et al 2004; Budde 
and Keck 2001; Kittel et al 2003; Martin et al 2003; Whitmarsh et al 2003), 
and Martin and colleagues have examined its performance at different stages 
of coronary illness. Martin's research involved 335 myocardial infarction 
patients, who completed the questionnaire on three separate occasions: 
during their stay in the coronary care unit, at 6 weeks and at 6 months. The 
researchers tested the questionnaire for both internal and test-retest 
reliability, for total anxiety and depression scores, and also for scores within 
the subscales. Results from this study showed the HADS to be a reliable 
instrument for detecting psychological state in people with coronary disease. 
8.3.3 Risk stratification 
All patients who are recruited to exercise-based CR undergo risk stratification 
during initial assessment. Exercise testing is a part of this process. Risk 
stratification enables an appropriate and individualised exercise prescription 
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to be planned for patients that reflects the severity of cardiac illness, co- 
morbidity and current medical state. Each patient is assessed and 
categorised into one of three levels of risk of a further cardiac event: high, 
medium, or low. The American Association of Cardiovascular and 
Pulmonary Rehabilitation [AACVPR] [Figure 8: 4] was the first to lay down 
criteria for risk stratification. The index of co-morbidity (Zoghbi et al 2004) 
that I have used in this research are based on these criteria. Current risk 
stratification of CR patients in the United Kingdom is based on similar criteria, 
and a mix of these criteria is widely recommended and used within the CR 
field in this country (AACVPR 1999; BACR 1997; SIGN 2002). 
Figure 8: 4 Risk stratification criteria for cardiac patients (AACVPR 
1999) 
LOW RISK 
Uncomplicated MI, CABG, angioplasty or atherectomy 
Functional capacity equal to or greater than 6 METS 3 or more weeks after clinical event 
No resting or exercise induced myocardial ischaemia manifested as angina and/or ST segment 
displacement 
No resting or exercise-induced complex arrhythmias 
No significant left ventricular dysfunction (Ejection fraction equal to or greater than 50%) 
MODERATE RISK 
Functional capacity less than 5- 6 METS 3 or more weeks after clinical event 
Mild to moderately depressed left ventricular function (Ejection fraction 31-49%) 
Failure to comply with exercise prescription 
Exercise induced ST-segment depression of 1-2mm or reversible ischaemia defects (echocardiography 
or nuclear radiography) 
HIGH RISK 
Severely depressed left ventricular function (Ejection fraction equal to or less than 30%) 
Complex ventricular arrhythmias at rest or appearing or increasing with exercise 
Decrease in systolic blood pressure of>15mmHg during exercise or failure to rise consistent with 
exercise workloads 
MI complicated by Congestive Heart Failure, cardiogenic shock and/or complex arrhythmias 
Patients with severe CHD and marked (>2mm) exercise induced ST-segment depression 
Survivor of a cardiac arrest 
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The principle factors for deciding the risk each patient carries are as follows: 
1. The extent of cardiac muscle damage, causing ventricular dysfunction 
especially of the left ventricle 
2. The presence of residual ischaemia indicating persisting coronary 
narrowing 
3. The provocation of ventricular arrhythmias by exercise. 
Other features of risk stratification for consideration are a history of: 
1. an infarction over the anterior surface of the heart muscle (which is 
generally larger and involves the left as opposed to the right ventricle) 
rather than an inferior infarction, involving the smaller right ventricle 
2. more than one previous infarction 
3. high cardiac enzyme levels at the time of infarction suggestive of 
greater areas of damage to the myocardium/heart muscle 
4. complications such as left ventricular failure or cardiogenic shock 
5. symptoms such as severe breathlessness due to exertion and 
orthopnea (breathlessness when lying down, which can only be 
relieved by sitting upright) 
6. the finding of a large heart or pulmonary venous congestion on the 
chest X-ray and of a low ejection fraction on the echocardiogram 
7. a low capacity on an exercise treadmill test, with significant 
electrocardiographic changes 
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8. a poor heart rate and blood pressure response, for instance heart rate 
rises very rapidly or systolic blood pressure falls with incremental 
exercise which indicates a poor left ventricle 
9. the presence of current angina pectoris, and whether the pattern of the 
angina is predictable or not predictable. 
Adapted from: (BACR 1997) 
8.3.4 Co-morbidity indices 
Any disease that is present, in addition to a primary diagnosis, may be 
referred to as a co-morbid condition. Co-morbidity is important to measure 
because it may be a confounding factor when assessing the risk of mortality. 
For instance, as well as having an initial diagnosis of coronary disease, a 
patient may be suffering from other medical conditions such as gout, 
diabetes, or a skin problem; all of which may be considered to be co-morbid 
illnesses. Moreover, a coronary patient with diabetes can suffer with co- 
morbid diabetic retinopathy or neuropathy. Co-morbid illnesses affect both 
function and survival. For this reason, several researchers have 
experimented with ways of accounting for co-morbidity by categorising and 
weighting certain diseases numerically so that a meaningful figure is obtained 
that relates to disease severity and survival, and is capable of inclusion into 
analyses. In my literature search I found three co-morbidity indices that are 
currently used in a variety of medical settings (Charlson et al 1987; D'Hoore 
et al 1996; Zoghbi et al 2004) 
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The Charlson Comorbidity Index is a validated tool for predicting short term 
and long term mortality from medical records (Charlson et al 1987). As it 
stands today, it consists of 19 categories of co-morbidity that were based on 
ICD-9 for a variety of medical conditions. Each code is weighted and based 
on an adjusted risk of one-year mortality. However, a recent update on the 
Charlson Index from the University of Manitoba (Burchill 2003) cautions 
users about its limitations; the codes in the programme refer to either 
complications or to co-morbidity diagnoses and, when applied, may result in 
an overestimation of co-morbid burden for certain diseases. Several 
researchers have validated the Charlson Index for use to predict mortality 
with coronary heart disease patients (D'Hoore et al 1993; Ghali et al 1996; 
Grace et al 2005; Roos et al 1989) and it has recently been used by Grace 
and colleagues in the study I discussed in Chapter 5. However the lower 
weightings assigned to certain diseases commonly seen in CR settings in the 
Charlson Index, such as peripheral vascular disease or myocardial infarction 
may to be inadequate and inappropriate (Ghali et al 1996). This is another 
problem when using this index to measure co-morbidity in CR programmes. 
An adaptation of the Charlson Index has been developed by D'Hoore 
(D'Hoore et al 1996) which has the main advantage compared with previous 
versions of being simpler to use (Deyo et al 1992; Romano et al 1993) 
because it only uses the first 3 digits of the ICD-9 codes. This makes it 
easier to read and score and also provides a less complex approach to some 
of the diseases. For example it does not differentiate between 
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uncomplicated diabetes and diabetes that presents with complications. This 
makes it a more attractive tool to use in CR settings. It has been validated 
for use with coronary heart disease inpatients as the patients in the study 
used to develop the D'Hoore Index were coded for their co-morbidity during 
their inpatient stay. 
A modification of D'Hoore's Index, The Modified D'Hoore Co-morbidity Index, 
[Table 8: 2] has been developed specifically for use in CR programmes and 
avoids duplications of some of the weightings (Zoghbi et al 2004). This index 
was designed for assessing non-cardiac conditions specifically in the out- 
patient CR environment, as opposed to in the acute setting. It also acted as 
a supplement to the usual AACVPR risk stratification tool, which some 
researchers did not consider capable of accounting for the true burden of co- 
morbid illness in their coronary patients. Zoghbi et al omitted myocardial 
infarction and congestive heart failure from the index because these were 
already included in the AACVPR tool and would otherwise have been 
duplicated within the weightings. Leukaemia, lymphoma and tumours were 
combined into one category labelled malignancy and a diagnosis of 
hemiplegia was assigned a weight of 2 as opposed to other less disabling 
forms of cerebrovascular diseases such as transient ischaemic attacks, 
which were weighted as 1 [Table 8: 2]. 
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Table 8: 2 The Modified D'Hoore Co-morbidity Index 
Weight Condition 
1 Myocardial infarct* 
Congestive heart failure* 
Peripheral vascular disease 
Dementia 
Cerebrovascular diseaset 
Chronic pulmonary disease 
Connective tissue disease 
Ulcer disease 
Mild liver diseases 
2 Hemiplegia$ 
Moderate/severe renal disease (end stage) § 
Diabetes 
Any tumour# 
Leukaemia# 
Lymphoma# 
3 Moderate or severe liver disease 
6 Metastatic solid tumour 
*Myocardial infarct and congestive heart failure were omitted from the index because they 
are included in the AACVPR risk stratification for events. 
tincludes patients with history of stroke or history of cerebrovascular disease. 
tMild liver disease and hemiplegia were omitted from index because it could not be 
quantified in Zoghbi database 
§Includes patients with end stage renal disease 
#Labelled as one category (malignancy) 
Source: (Zoghbi et al 2004) 
In Zoghbi's study the 490 participants [mean age 60.1 ±11.6 years, 35.5% 
females, ] were categorised into low, medium or high risk groups using the 
AACVPR risk stratification. A co-morbidity score was then computed for 
each participant. 
The researchers found a high prevalence of co-morbidity in the study 
participants at baseline. About 40% of participants not classed as high risk 
using the AACVPR tool were classified as high risk by means of The 
Modified D'Hoore Co-morbidity Index computations. Logistic regression 
analysis, adjusted for age, race and gender showed that the AACVPR risk 
stratification process and the Modified D'Hoore Co-morbidity Index 
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independently predicted future cardiac events in the short term: AACVPR: 
[OR 1.56,95% Cl 1.14,2.12], Modified D'Hoore Co-morbidity Index: [OR 
1.23,95% Cl 1.03,1.47] amongst study participants. However, prediction 
was better when both tools were used in combination. 
I decided to allocate scores to the patients in my study using the Modified 
D'Hoore Co-morbidity Index for several reasons. Firstly, risk stratification of 
our patients took place at the start of the Phase III exercise component of 
CR, which was similar to the timings reported in Zoghbi's study. Secondly, 
we recorded coronary co-morbid illnesses, such as congestive cardiac failure 
and myocardial infarction, as Zoghbi had done, within the risk stratification 
process during the patient's initial Phase III assessment. Thirdly, because of 
the reduction in the number of categories of co-morbid illness and their 
weightings, scoring was less complicated than with either of the earlier 
indices. A limitation of the Modified D'Hoore Co-morbidity Index was that the 
long term predictive value of this index is unknown, as it has only recently 
been developed. 
8.3.5 Indices of Deprivation 
Socio-economic deprivation is an important consideration in cardiovascular 
outcomes (Tunstall-Pedoe and Woodward 2006). The concept of linking 
deprivation indices to the health services was introduced to explain the socio- 
geographical variations that researchers found in uptake of services and 
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premature mortality. Deprivation measures have been devised over the past 
35 years in an attempt to target health care and reduce health inequalities 
Over time much has been done to improve the original measures as 
deprivation is considered to be "relatively dynamic in nature" (ODPM 2004). 
Over the past 20 years a variety of deprivation indices that linked specifically 
to Health Care have been developed. The Jarman and Townsend (Jarman 
1991; Townsend et al 1985) and the Scottish Deprivation Score, known as 
Carstairs (Morris and Carstairs 1991) are most frequently used within the CR 
setting. Morris and Carstairs examined five indices including the three that 
focused on health care [Table 8: 3]. 
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Table 8: 3 Range of variables in any of the five deprivation indices 
Scottish 
Deprivation 
or Carstairs 
Jarman 
Department 
Townsend of the 
Environment 
Scottish 
Development 
Department 
Index 
Unemployment x xx x 
Youth unemployment x 
No car x x 
Low social class x 
Unskilled x x 
Overcrowding x x xx 
Below occupancy norm x 
Not owner-occupied x 
Lacking amenities x x 
Single parent x x x 
Under age 5 x 
Elderly households x 
Lone pensioners x x 
1-year immigrants x 
Ethnic minorities x x 
Vacant dwellings x 
Level and access (old) x 
Level and access (<5) x 
Permanent sickness x 
Large households x 
Source: (Morris and Carstairs 1991) 
The measure Morris and Carstairs used was found to correlate closely with 
standard mortality rates and was marginally superior to the Townsend score. 
The Jarman index was devised for use in Primary Medical Care and focused 
on general practitioners' workload in order to ascertain resource allocation 
and is therefore not relevant for this research. The indices of Morris and 
Carstairs and Townsend were designed to score material deprivation. It is 
not clear how well either of these perform compared with the new indices that 
have been developed, although Morris and Carstairs has been used recently 
in research on socio-economic deprivation and post-operative cardiovascular 
outcomes (Taylor et al 2003). 
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The Indices of Multiple Deprivation [IMD] were introduced in 2000 (ODPM 
2000) and updated in 2004 (ODPM 2004) and may be a more accurate way 
of scoring deprivation in this study because much of our catchment area lies 
in a rural, as opposed to urban, environment. Neither Townsend nor 
Carstairs accounted for rural deprivation (Jordon 2005). The new and 
revised IMD 2004 version was scored as a Super Output Area and includes a 
range of measures that considers geographical access to a variety of 
services such as health, education and housing. The IMD 2004 comprises 
seven domains, with each domain carrying a percentage weighting, as 
shown in Table 8: 4. 
Table 8: 4 The English Indices of Deprivation 2004: Summary (revised) 
Domain Weights for the IMD 2004 % Domain Weight 
Income Deprivation 22.5 
Employment Deprivation 22.5 
Health Deprivation & disability 13.5 
Education, skills & training Deprivation 13.5 
Barriers to housing & services 9.3 
Crime 9.3 
Living Environment Deprivation 9.3 
Source: Office of the Deputy Prime Minister, 2004 
The geographical catchment area in this research project lies in the south 
east of England, which is one of the least deprived areas in the United 
Kingdom, although much of the area around Basingstoke from which our 
population is drawn may be described as rural. I have chosen to use the 
revised IMD 2004 in my research because I believe it is the best tool for 
providing an overview of rural deprivation. Although rural areas are generally 
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perceived to be idyllic and pleasant places to live, they may also lead to a 
social isolation, with poor access to local services, due to limited transport 
services and inadequate housing. All of these factors account for an 
important type of deprivation, specific to country dwellers. This is shown in 
Table 8: 4 by the weighting of 9.3 for the Living Environment Deprivation 
domain that matches the weighting apportioned to Crime. 
The IMD scores all 998 wards and local authorities in England and in Wales. 
The area of greatest deprivation is in Liverpool with a score or rating of 
86.67. This compares with the area of least deprivation in England, which is 
in Woking in Surrey, and scores 0.59. Within the Basingstoke area, the least 
deprived area also scores 0.59 and is to be found in North Waltham and 
Oakley [Figure 8: 4]. The areas of greatest deprivation in the catchment area 
for my study are in Buckskin scoring 25.99 and Popley East scoring 24.75, 
both in the Basingstoke town centre [Figure 8: 5]. Access and uptake of CR 
from these areas of greater deprivation is generally less. 
204 
N 
cv 
L 
O 
V 
C 
a) 
0 
N 
C 
Co 
Co 
d 
C 
C 
O 
ß 
L 
CL 
a) 
ci 
Co 
a> L 
m 
_ 
U- 
ar 
E 
2 
'0 
5 
C 
t0 
O 
2 
H 
V 
IL 
aý 
0. 
E 
2 
t 
0 
Z 
O 
OC 
O 
C: 
O to 
to *r- >a 
a0 
4) 
ö 
N 
=7 
13 O 
x 
N 
_C 
mw 
CO 
WY 
yC 
IR 
tY= 
1(1 
" 
00 
W 
X 
ff_Zpp 
1N 
LO 
Y MAI 
'hl 
"d 
_ f_ A 0N 1ý N 4/ 4/ 
ý -vo 
Q 
L 
w 
kU 
äý_ ß mä 
10 "1 
äxv$* 
41 F C3 C3 
ct "a 
U. S 
00 
x Jmco 
w. U 
ä 
ýU 
41 o D=Q 
ütpý 
vD 
'C 
c° p u 
"u 
ENo 
41 ID 10 , 
QE 
öd 
o¬a. 
NJN 
ogö 
0 
m 
9 
V 
y7 
ä 
N 
U, 
0 04 
ar 
NX 
ar 
E 
1 
C 
L 
O 
2 
CD 
d L. 
CD 
CD 
C., 
C 
w 
C 
N 
C 
N 
o 
iNo 
Om 
>Q 
C0 
> 
.O 
QOs 
Cl V 
'C O 
=X co 
CY 
NCO 
LCOm 
C) vein 
ý=- ice-X(13 
gO 
Vü 
EtL 
x' °= 
a go 
UL.: 
nýL 
c 
oQ 
Uu 
Ü V1 0 
v 
ýyU 
LcU 
V- C 
Ö0 
f'1 .v 
u öcc 
n¬N 
U !+ 
ö, 
oJ0 
VC 
13 JV 
LL= 
UÖ 
VO 
V'1 ý] 
C 
U 
U 
V 
u 
v 
O 
V 
U 
0 04 
8.3.6 Measuring perception of social support 
Social support is an important dimension of health and quality of life. It is well- 
known that levels of social support are predictive of coronary morbidity (Marmot 
et al 1991; Rosengren et al 2004) and may be associated with coronary heart 
disease severity (Blumenthal et al 2004; Rozanski et al 1999). Nine out of ten 
studies reviewed recently indicated that low levels of social support were a risk 
factor for progression of coronary heart disease with a risk ratio of 3 
(Hemingway and Marmot 1999). The proposed national audit tool for CR 
programmes suggests that psychosocial support should be measured routinely 
as a part of CR patient assessment and outcomes (Lewin et al 2004). Lewin 
and co-authors suggest that the Dartmouth COOP'/woncai' charts (Scholten and 
van Weel 1992) which includes a score for social support, should be used as a 
screening tool for assessing quality of life during attendance at CR. 
Perception of Social Support [Figure 8: 6] is one of the nine domains in the 
Dartmouth COOP charts, which we started to use from April 1996 at the 
beginning and end of the patient's CR course. We were not aware of any other 
measures at that time that were suitable for use in CR settings in terms of being 
both quick to administer and easy to interpret (Turner et al 2003). In a study at 
our centre, we found that the Dartmouth COOP charts and the HADS took our 
patients on average 5.5 minutes to complete and only 30 seconds for CR staff to 
COOP - The Dartmouth Primary Care Cooperative Information Project N wonca - World Organisation of National Colleges Academies and Academic Associations of 
General Practices Organisation/Or Family Physicians 
207 
score. I have described how we used the charts in Chapter 9. In this study I 
decided to consider the level of social support recorded at the start of the 
programme as a baseline demographic measure. 
Figure 8: 7 Perception of Social Support (wonca chart) 
SOCIAL SUPPORT 
During the past 2 weeks........ 
Did you feel someone was available to help you if you 
needed and wanted help? 
Yu, umuch uI ý 
tif 
wanted 
ý 
(ý 
Yaa, gala a bit 
Z 
Ya, aoma 
Ill` 
tF 
Yes, a little 
6 
No, not at all 
8.4 Determining Outcome 
8.4.1 Notification of deaths 
The collection of mortality data for this study has involved the use of two 
different versions of the International Classification of Diseases [ICD]. All death 
certificates use an international system for recording cause of death. The 
International Statistical Classification of Diseases and Related Health Problems 
has been in existence for many years. The original concept of using an 
internationally agreed code for cause of death was designed to enable mortality 
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statistics to be compared across different countries in the world as well as 
facilitating similar methods of collection, processing and presenting mortality 
statistics. As medical conditions are reported to the authorities, they are 
subsequently translated into codes governed by rules laid down by the World 
Health Organisation. In response to developments in medicine over time, the 
original classification of diseases has been updated several times. 
The version in use at the time of writing this thesis is the second edition of the 
tenth revision, known as ICD-10 (WHO 2000). It was published in 1993, and 
used in England and Wales from 1st April 1995, and in Scotland and Northern 
Ireland from 1st April 1996. Mortality coding, however, using ICD-10 as opposed 
to ICD-9 was not introduced until January 2001. ICD-10 (Janisch 1990) is 
considerably different from former versions and far more comprehensive. It is 
published in three volumes and has twice as many categories as ICD-9 (Glattre 
1990). In ICD-10 there have been some radical changes in the grouping of 
diseases. 
Both the ninth and tenth revisions of the ICD use the dagger [t] and asterisk [*j 
system to facilitate coding. A dagger sign denotes the primary code for the 
underlying disease and an asterisk enables an additional code to be added to 
clarify the cause of death. The asterisk must not be used as the sole code. 
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8.4.2 Differences between ICD-9 and ICD-10 
There are several differences between ICD-9 and the ICD-10. ICD-9 has only 
5,000 categories for classifying cause of death and uses a4 digit numeric 
structure. The ICD-10 revision contains a further 3,000 categories and a4 digit 
alphanumeric design enabling future revisions to occur without disruption to the 
coding. Many of the chapters in the newer version have been rearranged, which 
may make comparisons between cause of death difficult for studies such as this 
one, which straddles both ICD-9 and ICD-10. In ICD-9 nearly all the coronary 
heart disease codes fall between numbers 410-414 [Table 8: 5]. 
Table 8: 5 The differences in descriptions between ICD codes 9 and 10 for 
the coronary deaths in the cohort 
ICD-9 Frequency Description ICD-10 Frequency Description 
410 57 Acute myocardial 1219 23 Acute myocardial infarction, 
infarction unspecified 
1249 1 Acute ischaemic heart 
disease, unspecified 
414.1 1 Aneurysm of the heart 
9 Coronary 1251 13 Atherosclerotic heart disease 
414 atherosclerosis 
1 Chronic ischaemic 
414.8 heart disease 
57 Chronic ischaemic 1259 56 Chronic ischaemic heart 
414.9 heart disease NOS* disease, unspecified 
1255 1 Ischaemic cardiomyopathy 
*Not otherwise specified 
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In ICD-10 coronary heart disease is placed under a heading of 'Circulatory 
Diseases'. It is more thorough in its application. For example, an acute 
myocardial infarction is subdivided into six different numerical categories as 
shown in Table 8: 6. According to a recent paper there is a decrease of about 
10% in the number of deaths assigned to acute myocardial infarction with the 
use of ICD-10 in place of ICD-9, although trends in mortality remain unaffected 
by the change in instrument (Griffiths et al 2004). 
Table 8: 6 Subdivisions of the coding for death due to an acute myocardial 
infarction in ICD-10 
ICD-10: Number Acute myocardial infarction: Description 
210 Acute transmural myocardial infarction of anterior wall 
211 Acute transmural myocardial infarction of inferior wall 
212 Acute transmural myocardial infarction of other sites 
213 Acute transmural myocardial infarction of unspecified sites 
214 Acute subendcardial myocardial infarction 
219 Acute myocardial infarction, unspecified 
However, the death certificates for the patients in this study with a primary cause 
of death of a myocardial infarction [n=23] coded with ICD-10, as opposed to 
ICD-9 codes, have all been given the same code, 'I 219'. None of the other 
myocardial infarction codes has been applied. The causes of death by ICD 
code for all the patients in the cohort are illustrated in Table 8: 7 . 
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Table 8: 7 Causes of Death ICD-9 and ICD-10 
ICD Code Frequency Description 
1259 1 Filariasis NOS 
1519 4 Malignant neoplasm stomach 
1520 1 Malignant neoplasm duodenum 
1533 1 Malignant neoplasm sigmoid colon 
1536 1 Malignant neoplasm ascending colon 
1539 1 Malignant neoplasm colon 
1541 1 Malignant neoplasm rectum 
1579 2 Malignant neoplasm pancreas 
1629 9 Malignant neoplasm bronchus/lungs 
1729 1 Malignant melanoma skin 
1749 1 Malignant neoplasm breast 
1830 1 Malignant neoplasm ovary 
185 2 Malignant neoplasm prostate 
1889 3 Malignant neoplasm bladder 
1912 1 Malignant neoplasm temporal lobe 
1990 3 Malignant neoplasm disseminated 
2019 1 Hodgkins disease 
2041 1 Chronic lymphoid leukaemia 
2500 1 Diabetes mellitus uncomplicated 
2506 1 Diabetes with neurological manifestations 
410 57 Acute myocardial infarction 
4140 9 Coronary atherosclerosis 
4141 1 Aneurysm of the heart 
4148 1 Chronic ischaemic heart disease 
4149 57 Chronic ischaemic heart disease NOS 
4151 3 Pulmonary embolus/infarct 
4241 1 Aortic valve disease 
4281 1 Left heart failure 
4289 1 Heart failure NOS 
430 1 Subarachnoid haemorrhage 
4340 1 Cerebral thrombosis 
436 6 Cerebrovascular accident 
4379 2 Cerebrovascular disease 
4411 1 Ruptured thoracic aneurysm 
4413 2 Ruptured abdominal aneurysm 
4415 1 Ruptured aortic aneurysm 
481 2 Pneumococcal pneumonia 
485 2 Bronchopneumonia 
486 2 Pneumonia 
496 2 Chronic airways disease 
515 1 Post inflammatory pulmonary fibrosis 
585 1 Chronic renal failure 8120 1 Fractured upper end humerus C509 1 Cancer 
C159 4 Cancer 
C160 I Cancer 
C169 2 Cancer 
C180 1 Cancer 
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ICD Code Frequency Description 
C187 I Cancer 
C189 3 Cancer 
C20 2 Cancer 
C220 1 Cancer 
C221 2 Cancer 
C259 2 Cancer 
C349 18 Cancer 
C433 I Cancer 
C439 1 Cancer 
C449 1 Cancer 
C450 1 Cancer 
C459 2 Cancer 
C541 1 Cancer 
C56 1 Cancer 
C61 2 Cancer 
C64 2 Cancer 
C679 3 Cancer 
C719 1 Cancer 
C73 1 Cancer 
C787 1 Cancer 
C80 13 Cancer 
C851 1 Cancer 
C859 3 Cancer 
C911 2 Cancer 
C920 1 Cancer 
C97 3 Cancer 
D430 1 Not cardiovascular 
D591 1 Not cardiovascular 
E149 I Not cardiovascular 
E780 1 Not cardiovascular 
F03 1 Not cardiovascular 
G20 1 Not cardiovascular 
1119 1 Hypertensive heart disease without 
congestive heart failure 
1219 23 Acute myocardial infarction, unspecified 
1249 1 Acute ischaemic heart disease, unspecified 
1251 13 Atherosclerotic heart disease 
1255 1 Ischaemic cardiomyopathy 
1259 56 Chronic ischaemic heart disease, 
unspecified 
1269 1 Pulmonary embolism 
1309 1 Acute pericarditis, unspecified 
1330 1 Acute & subacute infective endocarditis 
1350 1 Aortic (valve) stenosis 
1359 2 Aortic valve disorder, unspecified 
1472 1 Ventricular tachycardia 
148 1 Acute fibrillation and flutter 
1500 2 Congestive heart failure 
1510 1 Cardiac septal defect, acquired 
1516 1 Cardiovascular disease, unspecified 
1609 1 Subarachnoid haemorrhage 
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ICD Code Frequency Description 
1619 1 Intracerebral haemorrhage, unspecified 
1639 1 Cerebral infarction, unspecified 
164 11 Stroke, not specified as haemorrhage or 
infarction (CVA NOS) 
1679 6 Cerebrovascular disease, unspecified 
1713 3 Abdominal aneurysm, ruptured 
1739 1 Peripheral vascular disease, unspecified 
1802 1 Phlebitis & thrombophlebitis of other deep 
vessels of lower extremities 
J180 8 Not cardiovascular 
J182 I Not cardiovascular 
J189 6 Not cardiovascular 
J449 2 Not cardiovascular 
J841 2 Not cardiovascular 
K254 1 Not cardiovascular 
K265 1 Not cardiovascular 
K529 1 Not cardiovascular 
K559 1 Not cardiovascular 
K709 2 Not cardiovascular 
L024 1 Not cardiovascular 
M332 I Not cardiovascular 
N138 I Not cardiovascular 
N179 1 Not cardiovascular 
N19 1 Not cardiovascular 
NODC 4 No death certificates 
R99UC 1 Not cardiovascular 
V435 1 Bladder replacement 
V494 1 Disfigurement of limbs 
X599 3 Not cardiovascular 
Y339 1 Not cardiovascular 
Total 451 
8.4.3 Accuracy of Death Certificates 
There are many reasons why information recorded on death certificates may be 
inaccurate and many researchers internationally have commented on these 
problems. 
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The ICD"9 codes were in use when a survey of coronary heart disease deaths in 
four North American states was performed between 1987 and 1995 (Coady et al 
2001). The researchers collected information about the deaths from a variety of 
sources. They looked at the medical records of the deceased, and conducted 
interviews with coroners and doctors. They compared the data on the death 
certificates with the information they had gathered, in particular from the doctors, 
and identified variations in the accuracy of death certification in the four different 
regions they had surveyed. They found that coronary heart disease deaths had 
been overestimated in about 20% of cases and that one in three deaths 
categorised as coronary heart disease deaths had been incorrectly coded. 
A similar review (Chen et al 2002) suggested that the accuracy of death 
certification worldwide requires improved regulations. The focus of this research 
was on international methods for recording deaths, and the effect that this might 
have on the reporting trends in coronary heart disease mortality. Incorrect 
certification of death was reported to have led to inaccurate use of the ICD 
codes and, as a consequence, miscoding of cardiovascular outcomes. 
Moreover, the volume of errors strongly influenced trends in reported mortality 
from coronary heart disease, a problem that has not yet been resolved (Frasure- 
Smith and Lesperance 2005). 
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Causes of mortality were also misclassified in the WHO-MONICA'', Ghent- 
Charleroi Study (De Henauw et al 1998) according to the researchers who 
validated the coronary heart disease data that were collected during the Belgium 
arm of the MONICA trial. Not only were many of the cases miscoded, but the 
authors also reported a tendency to select to 'other forms of coronary heart 
disease' rather than to select specific diagnoses. 
A further reason for miscoding of death may arise from misdiagnosis. There 
may be an error in diagnosing the cause of death by the physician in attendance 
or incomplete reporting of clinical information about the deceased. A paper 
written for the World Health Organisation (Lozano et al 2001) discusses the 
problems of misclassification of deaths from coronary heart disease. In several 
instances a number of ill-defined cardiovascular codes were identified, [Table 
8: 8] that were being inaccurately assigned to ischaemic coronary deaths. This 
occurred, for example, when the cause of death was misdiagnosed or the 
physician certifying the death received insufficient clinical information about the 
patient. When the Japanese switched from ICD-9 to ICD-10 coding between 
1994 and 1995, mortality rates for coronary disease in that one year rose by 
25% (Lozano et al 2001). 
"'World Health Organisation MONItoring of trends and determinants in CArdiovascular diseases 
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Table 8: 8 Ill-defined cardiovascular codes 
Disease ICD-9 ICD-10 
Paroxysmal ventricular tachycardia 427.1 1472 
Ventricular fibrillation & flutter 427.4 1490 
Cardiac arrest 427.5 1460 
Heart failure 428.0 1500 
Myocarditis, unspecified 429.0 1514 
Myocardial degeneration 429.1 1515 
Cardiovascular disease, unspecified 429.2 1516 
Complications of heart disease, unspecified 429.9 1519 
Atherosclerosis, generalised & unspecified 440.9 1709 
Source: (WHO 1992; WHO 1997) 
However, the coding of cause of death in the patients in this study is likely to be 
very reliable since all the people have been under close medical supervision 
during the timeframe of the study, and known individually by me. 
Data from the Office for National Statistics is limited to residents of England and 
Wales who have registered with a general practitioner. Information on some 
patients, for instance those who have moved abroad, those without a fixed 
abode, or those who have failed to register with a general practitioner, will be 
incomplete. Another problem regarding completeness of information occurs in 
death certification for people who die abroad. It is unlikely that information about 
the cause of death will be transferred back to the Office for National Statistics. 
For example, we know via his spouse/widow, of one patient from our cohort who 
died in Germany from a myocardial infarction, yet we have no official information 
from the Office for National Statistics about his death. It may take up to seven 
years to produce a death certificate in special circumstances, such as in 2005 
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following the Tsunami. These issues are unlikely to have an important effect on 
the estimates of mortality in this research. 
8.4.4 Coding errors 
Errors in coding are usually due to inaccurate record-keeping by those who have 
completed the source documentation; for example the physician who certifies 
the death. The National Health Service Information Authority identifies this as 
the main reason behind most of the errors found by audits of clinical coding. It is 
hoped that in future, staff will be trained as coders and be encouraged to 
complete a national clinical coding qualification in order to provide best practice 
in this field and limit coding errors. 
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Chapter 9 
Study Methods 
9.1 Study design and ethical approval 
This study is a single centre, ten-year prospective cohort study of patients 
who have been diagnosed with coronary heart disease. The main outcome 
in this study is mortality, as recorded by the National Health Service Central 
Register. Local ethical approval was granted in 2001 from the North and Mid 
Hampshire Local Research Ethics Committees, for work on this data set. 
However, since the initial ethics approval was granted, the research proposal 
has been further developed. Proposed changes to the study were submitted 
to the local ethics committee once more and approval was received from the 
ethics committee regarding all the changes that were made to the original 
research proposal. Throughout the period of study I have adhered to 
national Data Protection Regulations (Iversen et al 2006). 
9.2 Study Aim 
The aim of the study is to establish whether levels of fitness and levels of 
depression or changes in these levels of cardiac rehabilitation participants 
are associated with survival time. 
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9.3 Study Hypotheses 
The hypotheses are: 
1. The risk of mortality in this coronary population is predicted by: 
i the initial fitness level as measured by peak exercise 
performance on an exercise treadmill or a bicycle ergometer 
ii the level of fitness [as in i] upon completion of Phase III CR 
iii the degree of change in the level of fitness [as in i] during the 
Phase III CR programme. 
2. The risk of mortality in this coronary population is predicted by: 
i the severity of depressive symptoms as measured by the 
Hospital Anxiety and Depression Scale (Zigmond and Snaith 
1983) at the time of entry to Phase III CR 
ii the severity of depressive symptoms [as in 2. i] at the time of 
discharge from Phase III CR 
iii the degree of change in depression scores [as in 2. i] during the 
Phase III CR programme. 
3. The risk of mortality in this coronary population is associated with: 
ia statistically significant interaction between baseline fitness 
and baseline depression scores at the time of assessment for 
the Phase III CR programme 
ii a statistically significant interaction between fitness and 
depression scores at discharge from Phase III CR 
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iii a statistically significant interaction between the change in 
depressive symptoms and change in fitness level during the 
Phase III CR programme. 
9.4 Study Setting 
The study is set in a semi-rural area in Southern England. The Basingstoke 
and Alton CR programme has been in operation since 1976 and provides 
both short term and long term exercise programmes and secondary 
prevention to patients with cardiac illness who live in North Hampshire and 
adjacent counties. The CR programme is now a part of the Cardiology 
Department of the Basingstoke and North Hampshire Hospital NHS 
Foundation Trust in Basingstoke, which was formerly called Basingstoke 
District Hospital. The CR programme is based in the community in a 
purpose-built building at Alton, 16 miles south of Basingstoke. The 
programme also runs at the hospital site and in a community centre at 
Tadley, 9 miles north of the hospital on the A340. 
We receive referrals from cardiologists and general practitioners in 
neighbouring general hospitals and primary care trusts in addition to the routine 
referrals from our own network. The catchment area for our programme 
extends to within a 25-mile radius from our base in Alton [Figure 9: 1]. Exercise 
and health education sessions are offered at three centres: in the hospital 
physiotherapy gymnasium in Basingstoke, a large hall in a community centre 
at Tadley and in Alton, where the major part of the service takes place. 
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There is currently an average of 10 referrals per week. This has increased 
considerably since 1998, when our first interventional cardiologist was 
appointed. 
The CR Programme offers phases I, III and IV of CR to patients and certain 
aspects of the CR programme to spouses or partners as well. I described 
the phases in detail in Chapter 2 page 25. We have never been given 
sufficient resources to provide Phase II rehabilitation, which includes 
following up all newly discharged patients in the interval before they 
commence the exercise programme. The Phase III component lasts 
between six weeks and six months, according to need, and is offered to all 
myocardial infarction patients discharged from the hospital and to all patients 
within our catchment area who are recovering from cardiac surgery or 
revascularisation. 
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Figure 9: 1 The main area served by the Basingstoke & Alton Cardiac 
Rehabilitation programme [from Multimap. com] 
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The rehabilitation programme is a standard, comprehensive course, tailored to 
the individual patient and comprising incremental supervised exercises, home 
exercises, risk factor monitoring, health education, stress management training 
and relaxation sessions (Coats et al 1995; West and Jones 1995). The 
centrepiece is a graduated exercise course lasting six to eight weeks for 
younger, less severely affected patients and up to six months for older and 
sicker patients. 
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All patients are assessed physically and psychologically at the beginning and at 
the end of the Phase III programme, using standardised and validated 
measurements. Some patients are offered the Heart Manual (Lewin et al 
1992), a home programme of exercise and education, as an alternative to 
attending the courses, particularly if they do not wish to socialise or if access to 
one of the venues is difficult. In my study, this applied to only a small group of 
24 patients who received the Heart Manual in lieu of attending the CR 
programme as an out-patient. 
The induction and orientation session at the start of the programme, to which 
partners are invited, helps the patients to be weaned gently into all the aspects 
of the rehabilitation course. Using medical information about the patient from 
the hospital discharge summary, the doctor's clinical examination and the 
exercise test results, the nurses and therapists who supervise this session help 
to formulate an individualised plan for each patient. The format of the course is 
explained to them and they are taught the importance of reporting changes in 
symptoms or anything else that could affect their treatment or progression 
through the course. 
9.4.1 Staffing 
A multidisciplinary team of health care professionals is involved in 
rehabilitating the cardiac patients referred to the programme. Two physicians 
235 
staff on a regular basis. The main referral route is via the Royal Brompton 
Hospital, London but we receive patients from other centres namely St 
George's Hospital and University College Hospital, London and the 
Southampton Group of Hospitals. Private patients are referred into the 
programme from a variety of venues. Ideally surgical patients are referred 
immediately after their discharge from hospital and are given an appointment to 
start their rehabilitation at about six weeks after the date of their operation. 
9.4.3 The Exercise Programme 
The type of exercise performed within the supervised exercise class and at 
home is aerobic. Circuit training is the most convenient and effective style of 
exercise for cardiac patients. Circuit training requires the patient to perform 
various exercises at different stations using a mixture of upper and lower limb 
muscles. These can alternate between pure aerobic exercise and muscle, 
strength and endurance exercises, which act as active recovery exercises, 
allowing the patient to exercise for about 40 minutes in total. The duration of 
each session depends upon the individual's current physical ability. Supervised 
circuit training sessions are performed once or twice weekly, the sicker patients 
being encouraged to attend more often than those with less severe disease. 
Homework is set for the remaining days of the week and includes home circuits 
and brisk walks, where feasible, so that exercises are performed on most if not 
every day each week. 
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9.4.4 The Health Education and Stress Management programmes 
Other components of the programme include education, stress management, 
relaxation training and risk factor monitoring. The health education programme 
consists of a series of lectures that cover various topics such as understanding 
coronary heart disease, cholesterol, healthy eating, blood pressure, the benefits 
of regular physical activity, smoking, cardiac medications, and stress 
management and relaxation techniques. The patients' partners are invited to 
join in this part of the rehabilitation programme. At the start of CR all the 
patients complete two questionnaires to assess their psychosocial condition. 
This helps to identify those patients who present with anxiety or depression and 
who may require extra support whilst they are in the programme, together with 
encouragement to attend the stress management and relaxation sessions. All 
the patients are given their own handheld records, which contain information to 
backup that given in the lectures, as well as their own personalised exercise 
homework diary pages for recording their activities on the five days when they 
performed their exercise routine without medical supervision. 
9.5 Data collection and management 
At the start of the Phase III CR, patients referred to the programme have an 
initial clinical examination, which includes formal exercise testing by either 
treadmill, or bicycle ergometry, with ECG monitoring and measurement of 
estimated peak workload. 
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We also take a full clinical history from the patient and record other baseline 
biological and clinical measurements during the patient's first visit to the Phase 
III programme. This includes taking the pulse to measure a resting heart rate, 
and also measuring the patient's blood pressure. In particular we note any 
relevant co-morbidity that may affect the patient's exercise prescription. For 
example co-morbidity often accompanying diabetes, such as peripheral 
neuropathy or silent ischaemia, may affect the type of exercise programme 
designed for patients with diabetes. 
At this first visit we ask the patients to bring us a list of their current medications 
so that this information can be documented. We also request them to have a 
fasting blood test performed within the following 6-week period to measure lipid 
sub-fractions. The local pathology department is asked to send a copy of the 
test results to the CR Unit to be recorded onto our patient database. 
The information we gather is recorded in each patient's notes and on the 
database and passed on to the rehabilitation team that looks after the patient 
during Phase III. The various components of rehabilitation are tailored to 
meet the individual's requirements. All clinical measurements are repeated 
when the patients finish their programme, and results of blood tests 
discussed with the patient either during the programme or at their final visit. 
Since 1993 the CR Programme has compiled a computerised database of 
patient characteristics and outcomes in a Microsoft Access database file 
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(Microsoft 2000). Initially all information about the patients was recorded in 
paper format. We have retrospectively transferred information from the 
original paper records for each patient into the electronic format in the form of 
a template to facilitate audit and research. An example of the template used 
to record this information is shown in Figure 9: 2. 
Figure 9: 2 The Access Database Template 
PatentlD: 5613 last Name: First Name: Known o: Sea: m 
Tadky: 1.1 NHH: [ Addrert: Age: RItiMate: Etbnldty: a 
Year: 2005 
VWye: GP: Hospit: NHH 
Rehab start; 
Town: Itniingitoke Hop Caen 1)r Hiahopillr thwkmo Source: 
Date Illness: County: Plants Gr. daateDate: PP: HM: r] OP: 
Poet Code: Oct Cadet 
Phone: Mobile: Employment: 
Ref Dbtnoda: Marital statue: 
Other cardiac: Diabstu 
Co-morbidity: Trop on in. 
Tbc: LI 
Clp-b: Clp-aP IYmlly 
HMary: 
Height: Cfp-bbt: 
WORN ArTn Cholesterol: HDL: LDI.: Passt et habit: 
WAIW, Triglyce Idee: BErOU AMR Store: 
BMI: V02-before: after: Sugar Andety: 
Weht :00 TSH: 
1: t, 6NII: W1 after: Depression: 
BP, T4: 
MEDICATION: BEFORE ArMll 
Analogue: 
ecrowr AMA ssroRt AMR eeroac Arne 
Alpiran: Yea 
ACE IaMb: Yes Overall buh: 
FeeBnp: Physical &: 
Betablocker: Yes lAfe In den: Pabdhl ten: Social sup: 
H-blocker figures: 
Statin: Ye, 
And-arrhythmic: Long-term eaerciat 
Thyrodee; 
Additional Infamatbu: 
Ambdarone: 
Dutlaum: 
Hypoglycaemic : 
ETT: E3n: ce ßrnowl 
mine am to heart rate of Borg (Scale 
Current THR: Before 
RHR: After 
Rehab Phase Ill ee dor: Relab Phase IV: ] Home Programme: NSF 
Phase IV eleewfiere: Not known: 
L1 
Smoking: 7 
BMI: 
Weekly at seaeloas: NFRI: (. J NFRI daft; Rik factor score; 
0 
1 year comment: 
Cardlac RIP: duin RIP: Sudden datk: ý_ MI: Heart failure: [ Not owed: 
CofDe. tb: ICD code: 
Duplicates: SNP: 
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For each patient we have collected a range of measures that reflects both 
physical and psychosocial status at the start of and upon completion of 
Phase III CR [Table 9: 1]. 
Table 9: 1 Baseline demographic and outcome measures collected by 
the cardiac rehabilitation programme staff on all the patients enrolled 
into the programme 
1 Name, gender, marital status, age, height and weight 
2 Reason for referral for cardiac rehabilitation 
3 Former exercise habit 
4 Employment status - occupational coding (Standard Occupational Classification, 
2000) 
5 Medication at the start and end of the Phase III exercise programme 
6 Response to electrocardiograph stress test: time on treadmill or bicycle 
ergometer, heart rate, perception of effort rating (Borg 1982) 
7 Before and after measures of physical fitness via an estimated V02 from treadmill 
or bicycle testing, (Astrand and Rhyming 1954) 
8 Anxiety and depression scores using the Hospital Anxiety and Depression scale 
(Zigmond and Snaith 1983) 
9 Quality of life scores using the Dartmouth Coop charts /wonca (van Weel 1993) 
10 Number of supervised exercise sessions attended whilst participating in CR 
11 Adverse events which occurred during CR 
12 Diabetes 
13 Smoking habit 
14 Body mass index 
15 Blood pressure readings 
16 Blood cholesterol and triglyceride levels 
17 Thyroid function test results 
18 Future intentions for long-term exercise habit or arrangements to attend a Phase 
IV cardiac rehabilitation programme 
19 Co-morbidity - details of cardiac and non-cardiac illness, such as diabetes, 
concurrent medical conditions other than index cardiac event that may or may not 
limit ability to participate in CR (Zoghbi et al 2004) 
20 Postal code to be related to an Index of Deprivation (ODPM 2004) 
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9.5.1 Data collection on the fitness levels of the coronary patients 
Measures of fitness are estimated from the exercise tests that the patients 
perform at their initial assessment at the start and on completion of the 
Phase III programme as described in Chapter 8. 
Exercise testing provides the following information: 
" initial fitness level - this helps to decide the level of exercise that can 
be prescribed. It also provides a baseline with which to compare 
fitness at the end of the programme -a measure of the effectiveness 
of the course. 
" heart rate response to exercise - from which exercise heart rate 
targets can be set. 
" ECG changes during exercise - including reversible ischaemia and 
exercise induced arrhythmias. The presence of either affects exercise 
prescription. 
" future risk - exercise test responses such as fitness level, blood 
pressure response and arrhythmias contribute to risk assessment. 
The purpose and value of the risk stratification process in CR is discussed in 
Chapter 8 on page 193. 
9.5.2 Exercise testing of the coronary patients during the study period 
The exercise tests were overseen by one of the two doctors involved with the 
CR programme. They were performed on either a bicycle ergometer or an 
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exercise treadmill. Either system incorporated a facility for monitoring and 
recording a continuous ECG on each patient during the exercise tests. 
The bicycle ergometer used was a Cardionics mechanically-braked bicycle. 
The loads used on the bicycles ranged from 0.25 kilograms and up to 3.00 
kilograms. This equated to workloads of between 12.5 watts and 150 watts. 
The choice of load depended upon the doctor's perception of the patient's 
physical capability at the start of the test, which included accounting for their 
age, the size of the infarction if relevant, and whether or not they had a 
history of angina. The patient pedalled at a constant 50 revolutions per 
minute. A metronome was used to keep the speed of pedalling constant 
throughout the test. The workload on the bicycle ergometer was increased in 
a staged fashion every 5 minutes. The blood pressure was measured to the 
nearest 5mmHg before the test and during the last 30 seconds of each 5 
minute stage of the protocol. The V02peak was predicted from the ergometer 
test from the known energy cost of cycling at the different loads, measured in 
watts and converted to ml/kg/min by dividing predicted oxygen uptake by the 
patient's weight. 
The treadmill used was part of the Marquette Mach 15/17 Electro- 
cardiographic system. Patients were not allowed to support themselves on 
the treadmill bar whilst they performed the test. The exercise test protocol for 
the treadmill tests was either the full Bruce or the modified Bruce protocol. 
(Bruce 1973). These tests are the two most commonly used in the United 
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Kingdom. The modified Bruce was used for frailer patients, as it starts at two 
stages below that of the Bruce and is gentler to perform. 
The Bruce protocol starts with the patient walking at a gradient of 10% at 1.7 
miles per hour (mph). Each stage lasts 3 minutes and rises incrementally to 
a maximum gradient of 22%, a maximum speed of 6mph and a maximum 
duration of 21 minutes. The modified Bruce protocol starts on the flat at 0% 
gradient and a speed of 1.7mph at 2 stages below the full Bruce protocol. 
The stage 3 of the modified Bruce protocol equates with stage 1 of the full 
Bruce protocol [Table 8: 1 ]. 
To measure the change in physical fitness during the CR programme the final 
exercise test was performed at completion of CR, to the same heart rate as the 
initial test. The oxygen uptake V02peak was predicted on the treadmill test on 
the assumption that each minute of the Bruce protocol uses one metabolic 
equivalent known as a 'MET' (3.5ml/kg/min) and the first two stages of the 
modified Bruce protocol use one MET each. For instance, if a patient 
completes 6 minutes of the Bruce protocol an estimated V02peak for the 
patient is calculated as follows: 
The total exercise time completed on the protocol in minutes is multiplied by 
3.5 and then a further 3.5 is added to this figure to represent the resting 
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metabolic rate in millilitres of oxygen for each patient, as shown in the 
following equation: 
estimated V02 . 3.5 (1 +x) 
[where x equals time on treadmill in minutes] 
A patient completing exactly 2 stages or 6 minutes of the Bruce protocol will 
have an estimated V02peak of 24.5m1/kg/min. 
estimated V02 m 3.5 (1 +6)= 24.5 
[where x equals time on treadmill in minutes] 
The tests were terminated when the doctor supervising them noted that 
either the patient had reached 85% of their predicted heart rate maximum for 
their age, or if they developed symptoms, which precluded the test's 
continuation. 
The presence of any of the following signs was also a clinical reason for 
curtailing the exercise tests: 
1. angina pectoris or signs of malignant ischaemia on the 
electrocardiograph 
2. multifocal ventricular ectopic beats on the electrocardiograph or other 
dangerous or compromising cardiac arrhythmias 
3. exhaustion or excessive dyspnoea 
4. orthopaedic limitations. 
Fitness testing is also discussed in Chapter 8, page 186. 
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9.5.3 Data collection on the psychological state of the coronary 
patients 
Questionnaires were used to ascertain the psychological status of all the CR 
patients in the study. From 1st January 1993 all new patients enrolled into 
the programme have been asked to complete the HADS questionnaire as a 
screening tool (Zigmond and Snaith 1983) [Chapter 8 Figure 8: 3] before 
starting the exercise programme and as an outcome measure when they 
graduate from the exercise component of the Phase III programme. 
From April 1996 all patients were also asked to complete six of the nine 
Functional Health Assessment charts known as the Dartmouth Coop/wonca 
Charts (Nelson et al 1987; Scholten and van Weel 1992; van Weel 1993). 
The combination of the HADS and wonca charts was chosen to explore both 
psychological health (the anxiety and depression scores) and perceived 
quality of life (the Dartmouth Coop/wonca charts) during the period of CR. 
The charts are a collection of pictorial questionnaires that focus on domains 
of quality of life. For this study we used six of the domains to assess "overall 
health", "life in general", "feelings", "painful tension", "physical fitness" and 
"social support". Each domain represented by a pictogram is scored 
between 1 and 5 where 1 is equal to a rating of excellent and 5 equals a 
rating of poor. The social support domain was particularly relevant in this 
research because low levels of social support have been shown to be 
associated with depression (Barefoot et al 2003; Grant et al 1988). A copy of 
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the wonca social support chart can be seen in Chapter 8, page 208 [Figure 
8.7]. 
Both the HADS and the Dartmouth charts questionnaire have since been 
incorporated as CR outcome measures in a national CR audit project as part 
of a minimum data set for CR launched early in 2006 (Lewin et al 2004). 
The CR team members supervised the administration of the questionnaires 
in order to ensure consistency. They were also familiar with the scoring 
systems and were able to detect any misinterpretations by the patients as 
they completed them. At the end of the course all finishers were asked to 
complete the same questionnaires once more. 
Methodological issues regarding the use of questionnaires for coronary 
patients are discussed in Chapter 8, page 188. 
9.5.4 Study participants included in the study 
Although we treated a range of cardiac conditions during the study period, 
this research focuses only on the patients with coronary heart disease who 
were enrolled into the CR programme. 
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Table 9: 2 Primary diagnosis and reason for referral to cardiac 
rehabilitation during the study period 
Code Primary Diagnosis 
1 Myocardial Infarction 
8 Myocardial Infarction with Percutaneous Transluminal Coronary 
Angioplasty as a single episode of care 
3 Percutaneous Transluminal Coronary Angioplasty with or without stenting 
2 Coronary Artery Bypass Grafting 
4 Angina Pectoris 
5 Valve Surgery 
6 Other cardiac conditions - such as cardiomyopathy, ischaemic and non- ischaemic heart failure 
7 Non-cardiac conditions 
At their initial assessment we logged all the patients with an entry code 
[Table 9.2] and I removed the cardiac patients who did not have coronary 
disease, for example those who had cardiomyopathy or mitral valve disease 
from the study database, as described later on in this chapter. I selected the 
patients with ischaemic heart failure from entry code 6 to include in the study 
data set. 
All of the patients therefore in this study had a diagnosis of either unstable or 
stable coronary disease as defined by codes from the ninth and tenth 
revisions of the International Classification of Diseases (ICD-9 and ICD-10). 
Briefly this relates to codes 410 - 414 in ICD-9 and all the codes prefixed 
with an 'I' standing for ischaemic in ICD-10. This is better illustrated in 
Chapter 8 [Table 8.5]. Patients in these categories who joined the study 
were followed up for up to 13 years following their initial enrolment. 
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There were 3,732 patients recorded onto our database over the 10-year 
period of the study [Figure 9.3]. These records included patients who had 
more than one episode of care during the study, patients who never turned 
up for their first assessment, and those who were either inappropriately 
referred or misdiagnosed. Following the removal of 768 patients who did not 
have a diagnosis of coronary heart disease, there remained 2,964 coronary 
heart disease patients on the database, of whom 160 did not take up the 
initial invitation to attend CR. In addition, I found three patients whom I 
considered to be outliers because of their extreme presentations. One of 
these was an anorexic with a body mass index of 12. Her myocardial 
infarction may have been secondary to anorexia nervosa. The second 
patient was 18 years old and was possibly a miscode or had an obscure 
genetic condition. These first two observations were excluded from the data 
at this point. The third outlier was a patient with a cholesterol level of 1.9, 
who was taking 80mg. of simvastatin' at the start of CR. Although this dose 
of simvastatin is not unusual now, none of the others in the cohort were on a 
dose of simvastatin greater than 40mg. The majority were taking 10 or 
20mg. tablets once a day. I therefore coded this patient's cholesterol as 
'missing', and he remained in the data set. 
simvastatin -a cholesterol lowering medication 
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Figure 9: 3 Patients recorded onto the Access Database between 
01.01.1993 and 31.12.2002 
Patients without coronary 
heart disease 
N=768 
Never attended 
Cardiac 
Rehabilitation 
N=160 
Patients with coronary 
heart disease 
N= 2964 
Patients with 
extreme 
observations 
N=2 
Patients with a 
fitness 
measurement 
N= 2714 
Patients without 
a fitness 
measurement 
N=88 
There were 2,714 patients who were assessed with a fitness test at the start 
of the programme and 88 who joined the programme for whom we have no 
measure of fitness because they were unable to perform a fitness test. Of 
the 2,714 patients who underwent fitness testing, 2,054 (75.7%) completed 
the CR Phase III programme and 660 (24.3%) patients failed to complete the 
programme. When we knew the reasons for this they were entered in the 
database. Some patients for example were waiting for revascularisation or 
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developed significant co-morbidity that subsequently prevented them from 
continuing to exercise in the Phase III programme. 
Other reasons for leaving the programme included being diagnosed with 
cancer or having an exacerbation of a cancer. Other patients moved away 
from the area and were referred when feasible, to appropriate rehabilitation 
programmes, some died in the period between invitation and attendance, a 
few had difficulty in accessing any of our community venues providing a CR 
service, and some chose not to perform a home-based programme. 
9.5.5 Follow up of the study participants and flagging the data set 
To obtain data on the causes of death we worked with the medical research 
department of the Office for National Statistics, which is based at the General 
Register Office in Southport. We supplied them with a list of the patients in 
the study in an Excel CSV" file. Using an automatic flagging process, and if 
necessary operator tracing and flagging, I was notified every 3 months of 
those patients who had died and sent a copy of their death certificates. This 
allowed me to update the database record at regular intervals. 
This study straddles two versions of The International Statistical 
Classification of Diseases - the 9th and 1Oth Revisions. The problems and 
limitations of applying diagnostic codes and the accuracy of the office for 
CSV = comma separated value 
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National Statistics information are discussed in greater detail in Chapter 8, 
page 210. 
9.5.6 Preparation of the data set and data cleaning 
The following section explains how the raw data from the Access database 
was prepared for analysis. 
Each patient record contained over 100 fields for inputting data. My first task 
was to decide which fields should be exported into an Excel database for 
sorting and initial data checking. At this stage the data was anonymised and 
50 fields were selected for export, although I retained a copy of the Access 
database from which I derived the export query. This was necessary as 
inevitably records required cross checking, even after export. In order to 
check for outliers and operator errors in data handling, each field was sorted 
alphabetically in Excel, as it is not possible to do this within Access. The 50 
fields of raw data were then prepared for export into Intercooled STATA 
Version 9 (STATA 2003) for final cleaning and analysis. STATA only accepts 
Excel files in a CSV format so I adapted some of the fields in order for them 
to be accepted into the STATA programme. 
252 
I made the following adjustments to the data set: 
Blood pressure measurements had been entered into Access as a 
single field. I used an Excel formula to split blood pressure figures into 
separate cells representing systolic and diastolic readings. 
I scored co-morbidity using the Modified D'Hoore Index (Zoghbi et al 
2004) and then added the co-morbidity fields. 
I used an Access query to send the file of postcodes to a public health 
information analyst at The North and Mid Hampshire Health 
Informatics Service who was able to match the pre-calculated Index of 
Multiple Deprivation [IMD] (ODPM 2004) score to each postal code for 
me. All but 121 postal codes were matched in this way and returned 
in Excel format. Postcode linking was complicated by the fact that the 
Royal Mail had made changes to postcodes in our area over the past 
ten years. There were major changes to some of the Basingstoke 
codes in 1995 and some changes to the Alton area codes in 
December 2000. Two patients had postcodes in Wales, and were not 
covered by the IMD. 
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I created a new variable called 'Secondary Prevention' to log whether 
the patients were taking secondary prevention medication or not, ie 
aspirin, aR blockerý'i, ace inhibitor" and a statin. 
I coded smoking habit into the following 5 categories: non-smoker, not 
smoked for more than 10 years, not smoked for between 1-10 years, 
recent quitter of less than one year and current smoker. 
I exported the data from the Excel database into STATA for final preparation 
and carrying out the analyses. Mortality data, previously entered into 
Access, continued to be added to the STATA data set up to 15th November 
2005. The data was rechecked again for outliers and errors and corrected in 
my initial STATA analysis until the data set was accurate. 
9.6 Data analysis 
The statistical analyses were performed using the intercooled STATA version 
9 package. Survival time was defined as the date the participant joined the 
Phase III CR programme, which was usually the day of the first exercise test, 
until the date of death, or 15th November 2005. 
Fitness was treated as a categorical variable. I used the same three cut off 
points of VO2peak as Kavanagh had described in his study of survival in male 
111 ß blocker -a drug that slows the heart rate, reduces blood pressure and protects the heart 
after a myocardial infarction 'v Ace inhibitor -a drug that reduces blood pressure and is also cardio-protective 
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CR participants (Kavanagh et al 2002). These were low fitness which 
equated to a V02peak <15 ml/kg/min, medium fitness V02peak z15 up to 22 
ml/kg/min, and high fitness, which was the referent, as a V02peak > 22 
ml/kg/min. Depression was categorised in a similar way. The referent was no 
depression, which represented a score <8 on the HADS, symptoms 
suggestive of borderline depression z8 and 10, and symptoms suggestive of 
clinical depression for scores > 10. 
For the descriptive analyses the continuous variables were tested to see if 
they were normally distributed by creating histograms. When this was the 
case, the means and standard deviations were calculated for the normally 
distributed variables and T tests were used to compare differences in 
continuous variables by groups of participants. ANOVA tests were used 
when comparing more than two groups. I calculated the median, 10th and 
g0th percentiles with variables that did not appear to be normally distributed 
and used non-parametric tests to test for significance. 
Survival analyses were carried out with V02peak at baseline as the predictor 
variable of interest in relation to both all-cause and cardiovascular mortality. 
The Cox proportional hazards model was fitted and risk factors identified 
from some of the variables as potential confounders of the relationship, were 
entered into the basic model. The method I used to perform this part of the 
analysis and to obtain my fully adjusted model is described in detail in 
Chapter 11. 
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Similar analyses were conducted for V02peak measures at the end of CR and 
for the change measure from baseline to discharge. I repeated the same 
process for the three measures of depression. The interaction of fitness and 
depression was also assessed in the Cox proportional hazards model. This 
interaction term was adjusted for the known risk factors of the disease as 
above. Three survival analyses were performed using the interaction at 
baseline, at discharge and the change from baseline to discharge. 
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Chapter 10 
Results from Descriptive Analyses 
10.1 Introduction 
Data from 2,962 participants were available for analyses of whom 248 did not 
have any fitness data. 
Those participants without fitness data will not be included in the main 
analysis. Table 10: 1 compares those participants with and those without 
fitness data. The participants without fitness data were older, more likely to 
be female, had greater co-morbidity and were less likely to have received any 
form of revascularisation procedure. 
A flowchart [Figure 10.1] shows the study participants with and without 
fitness data during the various stages of the CR programme. For all 
subsequent analyses I used a cohort of the 2,714 study participants, all of 
whom had a recorded level of baseline fitness at the start of CR, because 
one of my hypotheses is based on the prognostic effect of levels of physical 
fitness. 
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Figure 10: 1 Flowchart of study participants with and without exit fitness 
data 
Study participants 
with baseline fitness 
data 
N= 2714 
Completed CR 
N= 2054 
Did not complete CR 
N= 660 
Total with no exit 
fitness data or 
noncomparable data 
N= 1316 
With exit fitness data 
N= 1398 
Without comparable 
fitness data 
N= 656 
10.2 Completeness of data for the study participants 
10.2.1 Missing data 
There were several reasons why data were missing from some of the 
variables. For example, body mass index data, requiring values for height 
and weight, were not routinely recorded until 1998 and were only available 
for 57.2% of participants. Previously participants were weighed but their 
heights were not recorded. Some blood cholesterol test results were 
missing, although every participant was given a blood test form at their first 
assessment and asked to arrange the test. 
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10.2.2 Outcome data 
There were 2,054 participants who completed the CR programme and 660 
who failed to complete the programme [Figure 10: 1]. Table 10: 2 shows a 
comparison between participants who completed CR and those who did not. 
There were significant differences (p<0.001) between several variables. For 
example there were twice as many current smokers in the group who did not 
complete CR. A greater proportion of participants from elementary 
occupations did not complete, and conversely a higher proportion of manager 
and senior officials completed the CR programme (p<0.006). There was also 
a significant difference between the two groups in their perception of the 
amount of social support they were receiving at the time of their first 
assessment. For those who reported that they had no social support at all, 
there was over three times the percentage [4.48%] found in the group that 
did not complete compared with those in the group who did [1.47%] 
(p<0.001). There were differences in baseline fitness levels and 
psychological measures between those who completed and those who did 
not complete CR. Those who did not complete were less fit (p<0.001), more 
anxious, (p<0.001) and more depressed (p<0.001), than those who had 
completed CR. 
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Outcome fitness data recorded at the end of CR and change in fitness from 
start to finish of CR was available for 1,398 [68%] of completers and change 
in depression score data in 1,939 [94.4%] completers. For all the changes in 
values from baseline to outcome there were missing data. There were many 
reasons why outcome data were not available or complete. For example, 
sometimes there was only a baseline value recorded and not an outcome 
value, and conversely on occasions an outcome value had been documented 
but no baseline value. 
I was able to calculate changes in fitness levels for 68.1% of study 
participants. There were several reasons to account for the missing fitness 
data for 31.9% of the cohort. In some cases the results from the first 
exercise test at the start of CR were not comparable with the second test 
performed at the end of the exercise programme. This was because of 
changes in medication, such as ß blocker dosage, between the two tests, 
which altered resting and working heart rate responses. Four low risk and 
fitter participants were referred straight into a Phase IV exercise programme, 
as our Phase III exercise programme would not have been sufficiently 
challenging for them so we did not recall them for a follow-up exercise test. 
Details of the reasons for not having an exit fitness test are shown in Table 
10: 3. 
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Table 10: 3 Reasons behind missing exit exercise test data 
Reasons Frequency Percentage 
Completed the programme but exit exercise 
test was not comparable to the first one for the 
following reasons: 656 49.8 
Taken to different heart rate 481 73.3 
Different ß blocker dose 97 14.8 
Different test protocol 39 5.9 
Not a standardised protocol 23 3.5 
Not possible to retest 5 0.76 
Glyceryl trinitrate used before treadmill 3 0.46 
Retested elsewhere 1 0.15 
Straight to Phase IV 4 0.61 
Transferred to another centre 3 0.46 
Total 656 100 
Elected not to complete the CR programme 245 18.6 
Underwent cardiac surgery 146 11.1 
Became too ill to continue exercise 128 9.73 
programme 
Died 35 2.66 
Moved away, without a transfer 15 1.14 
Came once only, to initial assessment 66 5.02 
No transport available for second test 6 0.46 
Refused a second test 7 0.53 
At work and unable to return for second test 12 0.91 
Total 1316 100 
10.3 Characteristics of the study cohort 
Table 10: 4 shows the demographic, lifestyle and baseline clinical data for the 
participants who completed an exercise test at the start of CR, broken down 
by gender. The mean age of the cohort was 62 years. The females were 
significantly older than the males, with a mean age of 65. One reason for the 
age difference may be because females tend to be protected from 
developing overt coronary disease until the menopause. The majority of 
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study participants were male [79.8%]. The most common reason for referral 
to CR was following a myocardial infarction, with over half [53.5%] of 
participants in this category. The second main reason for referral to CR was 
after coronary artery bypass graft surgery. Angioplasty had only become 
more widely available later on in the study period. Just over 13% had 
undergone angioplasty procedures, some at the same time as the index 
cardiac event, and others electively. 
Almost 9% of participants reported current smoking, a further 30% had given 
up within the previous year, and 30% had never smoked. Over 70% of the 
participants were free from co-morbid conditions, and less than 2% had 
reported severe co-morbid pathology. The majority [64%] felt that they had 
an adequate level of social support, with only 2.2% stating they had no social 
support at all. 
A total of 1,552 participants had a body mass index measurement. The 
median body mass index of males was 26.8kg/m2 and females 27.2kg/m2. 
The females were less fit than the males with a median V02 of 14. Oml/kg/min 
compared to the males at 20.2ml/kg/min. They also had higher median 
anxiety scores of 7 and depression scores of 4 than the males whose median 
anxiety scores were 6 and depression scores 3. 
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Table 10: 5 shows outcome measurements for the cohort at the end of the CR 
programme together with changes in the same measurements, when data 
was available for both before and after measures, since the start of CR. All 
changes were significant (p<0.001). Mean systolic and diastolic blood 
pressure were significantly higher at the end of CR than at the start, which 
was hard to explain, since the expectation would be that with increasing 
fitness the systolic blood pressure would fall. However, anxiety and 
depression scores had significantly decreased by the end of CR. Depression 
scores decreased by a median value of 1 (-5.00,1.00), which translated into 
an improvement of 33%. The estimated V02 increased by a median value of 
3.20, which translated into a significant improvement in fitness of 16.8% 
between the start and end of CR. It was interesting that participants' 
perception of their level of social support had risen significantly by the end of 
CR. Weight and body mass indices between baseline measures and 
completion of CR had also decreased. 
categorised participants' estimated V02 values at the start of their CR 
programme into the 3 groups of low, medium or high fitness. Table 10.8 
shows characteristics of the participants within these three fitness categories. 
There were only three variables, diastolic blood pressure, anxiety score and 
fasting trygliceride level, where the differences between the fitness 
categories did not reach significance. The mean age of the participants in 
the low fitness category [67.7 years] was greater than those in the high 
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fitness category [56.7 years]. Men were significantly more likely to be in the 
high fitness category compared to women. The fitter participants had 
significantly lower systolic blood pressures, a lower body mass index, were 
less likely to be suffering from depression, had little or no concomitant co- 
morbidity, and were more likely to be living in a more affluent part of 
Hampshire (p<0.001). 
The fitter participants were more likely to complete CR than the less fit [Table 
10: 6]. Eighty-two per cent of those in the high fitness category completed the 
programme compared with 66% in the low fitness category. The fittest 
participants were also more likely to have been referred to CR following 
revascularisation procedures with the highest proportion of participants who 
had undergone angioplasty being in the high fitness groups. 
Table 10: 6 Percentage of participants who completed or did not 
complete cardiac rehabilitation by fitness level at baseline 
Baseline Fitness Level 
Referrals to CR Low Medium Iligh 
n=501 n=778 n =775 
Participants who completed 65.8% 76.8% 82.4% 
CR 
Low Medium Iligh 
n= 260 n= 234 n =166 
Participants who did not 34.2% 23.1% 17.6% 
complete CR 
(L; ni square test p<0.001) 
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Those who said they have as much social support as they wanted were most 
predominant in the high fitness group whereas conversely those who thought 
they lacked social support tended to be in the low fitness category. 
There were recorded measures of baseline depression for 2,625 out of the 
2,714 participants in the cohort. Of these, 122 [4.64%] were found to score 
greater than 10 on the HADS, suggestive of clinical depression, with 274 
[10.6%] of the remaining participants in the borderline depression group 
[score of 8-10]. The majority [84.3%] of participants were not depressed at 
baseline. However, considerably more females (16.5%) than males (8.92%) 
were in the borderline depression group. More females (5.68%) were in the 
group with symptoms suggestive of clinical depression than males (4.39%). 
Those with clinical depression were less likely to complete the CR 
programme than those who were not depressed. Forty-two per cent of those 
in the clinically depressed category failed to finish CR compared with 21.7% 
of the non-depressed [Table 10: 7]. 
Table 10: 7 Percentage of participants who completed or did not 
complete cardiac rehabilitation by depression category at baseline 
Baseline 11ADS Depression score 
score 11-21 score 8-10 score 0-7 
Referrals to CR suggests clinical possible borderline no depression depression symptoms 
n=71 n 191 n®1746 
Participants who completed 58.2% 69.7% 78.3% 
CR 
n=51 n=83 n=483 
Participants who did not 41.8% 30.3% 21.7% 
complete CR 
(tni square test p<0.001) 
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The depression score values from the HADS were used to categorise the 
participants into three groups; those with no symptoms of depression [0-<8], 
those exhibiting signs of borderline depression [8-10] and those whose 
symptoms indicate clinical depression [>10]. Table 10: 9 shows the various 
characteristics of the participants within the three depression categories. In 
contrast to the previous table [Table 10: 8] where most of the variables had 
shown a significant association with the levels of fitness, most variables were 
not significantly related to depression. The exceptions to this were being 
female, failing to complete the CR programme, being a current or recent 
smoker, having concomitant co-morbid illness, perceiving a lack of social 
support and being unfit (p<0.001). 
The clinically depressed group contained proportionally more current 
smokers and recent quitters. Sixteen per cent of them reported current 
smoking on the first assessment at CR, compared with 7.9% in the group 
who were not depressed. 
Of the proportion of participants with and without co-morbidity within the three 
depression groups, those with no co-morbidity [71.5% versus 64.8%] were 
more predominant in the group who were not depressed and those with high 
co-morbidity scores were more predominant in the clinically depressed group 
[2.46% versus 1.08%]. The participants who stated that they had as much 
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social support as they needed were in the majority [67.6%] and did not report 
depressive symptoms. This was in contrast to those who felt they had little 
social support and was found predominantly in the groups with borderline or 
clinical depression. 
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Fitness levels were related to depression scores and the participants in the 
clinically depressed group were less fit than their non-depressed 
counterparts (p<0.001) as shown in Table 10: 10. The median estimated V02 
for those reported to be depressed was 16.6m1/kg/min compared with 
17.5ml/kg/min for those who had borderline depression and 19.2ml/kg/min for 
those with no depression. 
Table 10: 10 Depression scores of participants at baseline related to 
fitness category 
BADS Low fitness Medium fitness High fitness 
Depression score n=725 n=981 n=919 
Score 0 -7 78.3% 86.1% 88.8% No depression 
Score 8-10 14.6% 9.89% 7.73% 
possible borderline symptoms 
Score 11-21 7.03% 3.98% 3.48% 
suggests clinical depression 
(t; ni square test p<0.001) 
Having looked at the baseline characteristics of the cohort in relation to both 
fitness and depression as categorical variables, I then examined the changes 
in fitness and depression between initial assessments at the start of CR and 
the outcome assessment at the end of CR with the data that was available 
[Table 10: 11] and compared the numbers of participants in each category of 
fitness or depression at baseline and at the finish of CR [Tables 10: 12 and 
10: 13]. 
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Table 10: 11 Median fitness and depression scores before and 
after cardiac rehabilitation 
Bcforc After 
Cardiac Cardiac p value 
rehabilitation rehabilitation 
Median estimated 
V02 score 19.1 (10.2,28.8) 24.5 (14.0,35.0) <0.001 
101h 90'x' percentiles) 
Median RADS score 
(10`", 90th percentiles) 3.00 (1.00,9.00) 2.00 (0.00,6.00) <0.001b 
("Chi square test ) 
Table 10: 12 Change in fitness category before and after cardiac 
rehabilitation 
V02 Category 
BEFORE 
V02 category 
AFTER 
Total High Fitness Medium Low fitness 
fitness 
High fitness 535 529 6 0 
Medium fitness 539 295 238 6 
Low fitness 324 20 151 153 
Total participants 1398 844 395 159 
(Chi square test p<0.001) 
At the end of the Phase III CR programme nearly half of the 324 participants 
from the low fitness group [151] had moved into the medium group and 20 
participants into the high group. Similarly, just over half of those in the 
medium fitness group [295/539] moved to the high fitness group and very few 
participants had dropped into a lower fitness category. 
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Table 10: 13 Change in depression category before and after cardiac 
rehabilitation 
RADS Depression Score 
BEFORE 
IIADS Depression Score 
AFTER 
Score Score Score 
Total 0-7 8- 10 11-21 
Score 0-7 1690 1658 28 4 
no depression 
Score 8 -10 182 152 21 9 
possible borderline symptoms 
Score 11-21 67 44 14 9 
suggests clinical depression 
Total participants 1939 1854 63 22 
(Chi square test p<0.001) 
There were 67 participants with documented changes in depression scores 
recorded from initial and final assessments whose scores indicated 
symptoms of clinical depression. By the end of the programme nearly three- 
quarters of these [44] moved into the No depression' category, 14 moved 
into the borderline depression category. There were 22 in the clinically 
depressed category; 9 patients who had been depressed at baseline and 13 
patients who had become clinically depressed between the start and end of 
the programme. 
Table 10: 14 shows the change in fitness and depression categories between 
the start and end of the programme. 
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Table 10: 14 Change in fitness and depression categories before and 
after cardiac rehabilitation 
Improved Deteriorated 
p value 
Fitness 33.3% 0.86% 
Category n= 466/1398 n= 12/1398 <0.001 
Depression 10.7% 2.10% 
Category n= 210/1939 n= 41/1939 <0.001b 
"Chi square test 
Out of 1.398 participants with change in fitness data, 33% improved their 
fitness category compared to less than 1% who deteriorated [Table 10: 14]. 
For depression scores, 10.7% of participants showed an improvement 
compared with 2.1% who deteriorated [Table 10: 14]. 
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Chapter 11 
Results from Survival Analyses 
11.1 Survival analyses 
Survival data requires methods of analysis that accommodate the presence 
of censored observations and staggered entry of participants into a study. 
The observational period was calculated from the time the participant began 
CR up to 15th November 2005 or death if earlier. 
I had available almost 13 years, median 6.4 years, of follow-up, and the 
cause of death by three categories: all-cause deaths, cardiovascular deaths 
and deaths specifically from coronary heart disease [Figure 11: 1]. A total of 
451 participants had died which represents 16.6% of the cohort, [16.8% of 
males and 16.1% of females]. There were 277 deaths from cardiovascular 
causes [10.2% of the cohort] and 170 [6.3%] from other causes, mainly 
cancers. As expected, 219 [79.1%] of the cardiovascular deaths were from 
coronary heart disease [Figure 11: 1 and Table 8: 7]. 
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Figure 11: 1 Flow chart of survival outcomes for the study participants 
Study participants 
assessed by exercise 
testing 
N= 2714 
Alive Dead 
N=2263 N=451 
Known to be deceased 
but no death certification 
N=4 
Deaths from 
cardiovascular diseases 
Deaths from coronary 
heart disease 
N=219 
N=277 
Deaths from all other 
causes 
N= 170 
Deaths from non 
coronary causes 
N=58 
There was a total of 18,000 person years of follow-up. Table 11: 1 shows the 
all cause death rate per 1000 person years, Table 11: 2 shows the 
cardiovascular death rate and Table 11: 3 the cardiovascular death rate by 
gender both in the same period. 
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Table 11: 1 All-cause death rate per 1000 person years 
Rate per 95% Confidence Cohort Person years Deaths 1000 person Interval 
years 
Gender 
Male 14439 363 25.1 22.7,27.9 
Female 3561 88 24.7 20.1,30.5 
Total 18000 451 25.1 22.8,27.5 
Age in 10 
year bands 
<50 years 2565 18 7.02 4.42,11.1 
50-59 years 5205 91 17.5 14.2,21.5 
60-69 years 6620 150 22.7 19.3,26.6 
70+ years 3611 192 53.2 46.2,61.3 
Table 11: 2 Cardiovascular death rate per 1000 person years 
Rate per gs% Confidence Cohort Person years Deaths 1000 person Interval 
years 
Gender 
Male 14439 224 15.5 13.6,17.8 
Female 3561 53 14.9 11.4,19.5 
Total 18000 277 15.4 13.7,17.3 
Age in 10 
year bands 
<50 years 2565 14 5.46 3.23,9.25 
50-59 years 5205 53 10.2 7.79,13.4 
60-69 years 6620 95 14.4 11.7,17.5 
70+ years 3611 115 31.9 26.5,38.2 
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Table 11: 3 Cardiovascular death rate per 1000 person years, by gender 
Rate per 95% Confidence Cohort Person years Deaths 1000 person Interval 
years 
Males 
Age in 10 
year bands 
<50 years 2265 11 4.86 2.69,8.77 
50-59 years 4477 49 10.9 8.27,14.5 
60-69 years 5162 74 14.3 11.4,18.0 
70+ years 2535 90 35.5 28.9 43.6 
Total 14439 224 15.5 13.3,17.7 
Females 
Age in 10 
year bands 
<50 years 300 3 10.0 3.32,31.0 
50-59 years 728 4 5.50 2.06,14.6 
60-69 years 1458 21 14.4 9.39,22.1 
70+ years 1075 25 23.3 15.7,34.4 
Total 3561 53 14.9 11.4,19.5 
Low fitness shows an effect on survival. This is illustrated in the Kaplan- 
Meier graph comparing survival times by categories of baseline fitness 
[Figure 11: 2]. Depression scores of greater than 10 at baseline indicate a 
small effect on survival. At this stage, however, I had not considered the 
effect of confounding on these results. 
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Figure 11: 2 Kaplan-Meier survival estimates for baseline fitness 
Kaplan-Meier survival estimates, by fitness categories 1.00 . 
0.75 
0.50 
0.25 
0.001 
0 5 10 
analysis time 
15 
High fitness Medium fitness 
Low fitness 
Figure 11: 3 Kaplan-Meier survival estimates for baseline depression 
Kaplan-Meier survival estimates, by depression category 
1.00 1 
0.75 
0.50 
0.25 
0.00 
05 10 
analysis time 
score 0-7 score 8 -10 
score 11 - 21 (suggests clinical depression) 
15 
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Figure 11: 3 shows the effect of baseline depression scores on survival. The 
two lower categories representing scores 0 to 7 and 8 tolO were very similar. 
I wondered, therefore, if I divided depression into five categories instead of 
three any differences that existed between the two lower categories might 
become apparent. This time I used the lower cut off point of 6, instead of 7. 
This disclosed that there were no participants in this study who had scored 
over 18. Moreover there was only one death from the 15 participants who 
had scored between 15 and 18 on the HADS [Tablel1: 4]. 
Table 11: 4 The number of participants and deaths by baseline 
depression, divided into 5 categories 
Alive Deceased 
_ All cause deaths Cardiovascular deaths 
Baseline Depression level 
Score 0-7 1880 1 349 212 
Score 8-10 228 46 26 
Score 11-14 79 28 19 
Score 15-18 14 1 0 
Score 19-21 00 0 
Total 2201 424 257 
Figure 11: 4 shows that there was no difference in the Kaplan-Meier 
estimates for survival time by depression subdivided into five instead of three 
categories, probably because the number of participants with high 
depression scores was too small. 
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Figure 11: 4 Kaplan-Meier survival estimates, by 5 categories of 
depression at baseline 
Kaplan-Meier survival estimates, by depression categories 
1.00 
0.75 
0.50 
0.25 
0.00 
For all subsequent analyses, I consider firstly the 451 deaths from all causes, 
and secondly the 277 cardiovascular deaths. 
I first assessed the crude estimates of the effects of baseline fitness 
categories and baseline HADS scores on deaths from all causes [Table 11: 5 
and 11: 6] and cardiovascular causes [Tables 11: 7 and 11: 8]. This showed 
the importance of fitness levels (p<0.001) in predicting both all-cause and 
cardiovascular mortality. It also showed the higher risk of all-cause and 
cardiovascular mortality for the top depression category (p=0.091 for deaths 
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05 10 15 
analysis time 
Score 0-7 Score 11-14 
Score 8-10 Score 15-18 
from all causes and p=0.130 for cardiovascular deaths), although this 
association may not be linear. 
Table 11: 5 Deaths from all causes. Hazard ratios using Cox 
proportional hazards regression for baseline fitness 
95% 
Variable Participants Deaths Hazard Confidence p value Ratio Interval 
Baseline Fitness <0.001 
level 
High 941 55 (5.4%) 1.00 
Medium 1012 180(17.8%) 2.73 2.02,3.69 <0.001 
Low 761 216 (28.4%) 5.55 4.13,7.47 <0.001 
Table 11: 6 Deaths from all causes. Hazard ratios using Cox 
proportional hazards regression for baseline depression 
95% 
Variable Participants Deaths Hazard Confidence p value Ratio interval 
Baseline 0.091 
Depression score 
0-7 2229 349 (15.7%) 1.00 
8-10 274 46(16.8%) 1.10 0.81,1.49 0.551 
11-21 122 29(23.8%) 1.56 1.06,2.27 0.022 
Table 11: 7 Deaths from cardiovascular causes. Hazard ratios using 
Cox proportional hazards regression for baseline fitness 
95% 
Variable Participants Deaths Hazard Confidence p value Ratio interval 
Baseline Fitness <0.001 
level 
high 941 24 (2.55%) 1.00 
Medium 1012 107 (10.6%) 3.77 2.42,5.87 <0.001 
Low 761 146 (19.2%) 8.53 5.54,13.1 <0.001 
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Table 11: 8 Deaths from cardiovascular causes. Hazard ratios using 
Cox proportional hazards regression for baseline depression 
95% 
Variable Participants Deaths Hazard Confidence r value Ratio Interval 
Baseline 0.130 
Depression score 
0-7 2229 212(9.51%) 1.00 
8-10 274 26(9.49%) 1.01 0.68,1.53 0.925 
11-21 122 19(15.6%) 1.68 1.05,2.69 0.030 
For subsequent model analyses and after considering various methods, I 
chose to use the model selection method described by David Collett (Collett 
1994). This allowed me to assess which variables were related to outcome 
and needed to be included in the model for all-cause or cardiovascular death 
times. 
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11.2 Strategy for model selection 
11.2.1 Building the model for all-cause mortality with complete 
data 
The process I used for building the model selection is divided into four steps. 
Model selection for all-cause mortality is described in detail in the following 
section of this chapter. I used a similar process to produce the final model 
for cardiovascular deaths. 
Step 1 
I fitted models using each variable one a time from the clinical and 
demographic data as shown in Table 11: 9 to determine which variables on 
their own had a significant effect on mortality. At this point I did not include 
the two exposure variables, fitness and depression as they were the focus of 
my research. I used a specific STATA command to ensure that only cases 
without missing data were included. One of my difficulties was that some 
variables had missing data and it was not possible to choose a model from 
these without losing much data. I started with the variables where there were 
complete data. 
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Step 2 
For the second step of model selection variables, those that appeared to be 
important (p<0.1) from Step 1, were then fitted together into the model. 
These were age, whether the participant completed CR category, diagnosis 
category at referral, family history of coronary heart disease, diagnosis of 
diabetes and co-morbidity score. Variables that appeared important may 
cease to be so in the presence of other variables. I removed each variable 
one by one from the model and assessed the change in model fit. The 
variables that led to a significant increase in the log likelihood ratio were kept 
in the model, and the variables whose removal did not lead to significant 
change in model fit were eliminated. Once a variable was discarded the 
effect of the variables that had been retained were examined again in turn. 
During this process I found two variables that did not reach significance and 
were therefore discarded. These were family history of coronary heart 
disease and a diagnosis of diabetes. 
Step 3 
The third step in the process was to add any variable to the model that had 
formerly not been considered important in Step 2. This was done to check 
whether the variable I had added would become important in the presence of 
other variables. Gender was the only variable with complete data that fitted 
this category. Although not originally significant at Step 1, gender reached 
significance in the presence of the other variables in the model and was thus 
retained. 
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Step 4 
For the fourth and final step of the process, I re-checked to see if any of the 
remaining variables in the model could be discarded by repeating the 
process of dropping them, computing the change with the log likelihood ratio 
test and then reinstating each variable one at a time if the value of the log did 
not increase significantly. At the end of model fitting the best combination 
was a model that included the following variables: age, whether the 
participant completed CR category, diagnosis category at referral, co- 
morbidity score and gender. All these terms had remained significant during 
the model selection process [Table 11: 11 ]. 
11.2.2 Building the model for all-cause mortality using variables 
with complete and missing data 
I then considered building the model by adding the variables where data 
were missing data as well as the variables with complete data. I repeated 
steps 1 to 4. This time the variables I included were age, whether the 
participant completed CR category, diagnosis category at referral, family 
history of coronary heart disease, diagnosis of diabetes, co-morbidity score, 
cholesterol level, deprivation score, baseline body mass index, [which I 
selected in lieu of the weight variable, as weight on its own without a height 
measurement is meaningless] and baseline perception level of social 
support. 
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I discarded each one that did not reach significance at 10%. However none 
of the variables with missing data were significant when added to the model. 
This left me with a model that contained the following variables: age; whether 
the participant completed CR category; diagnosis category at referral and co- 
morbidity score. Next, I added gender to the model, which although not 
significant previously [Table 11: 9], became significant in the presence of the 
other variables. At the end of model fitting the best combination was a model 
[Table 11: 11] that was exactly the same as the one created from the data set 
with complete data. 
11.2.3 Building the model for cardiovascular mortality 
I generated the model for cardiovascular mortality in the same way by firstly 
using a data set with complete data [Table 11.10] and then repeating the 
process with the inclusion of the variables with missing data. The final model 
I selected [Table 11: 11] contained the same variables as the model selection 
for deaths from all causes. 
Finally, I systematically added the fitness and depression variables to the 
models that I had created as shown in Tables 11: 12-11: 21 to assess their 
impact on survival after adjusting for all other variables in the model. 
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Table 11: 11 Deaths from all causes and cardiovascular mortality. 
Hazard ratios for variables included in the final models 
All-cause mortality Cardiovascular mortality 
Participants 2714 Participants 2714 
Deaths 451 Deaths 277 
Variables Hazard 95% p Hazard 95% p 
Ratio Confidence value Ratio Confidence value 
Interval Interval 
Age, in 1 year increase 1.07 1.06,1.08 <0.001 1.07 1.05,1.08 <0.001 
Gender 
Male 
Female 
Referrals to CR 
Completed CR 
Did not complete CR 
Diagnostic category 
MI 
CABG 
PCI 
Angina Pectoris 
Other CHD 
MI + PCI 
Co-morbidity score 
None 
I (least) 
2 
3 
4 (most) 
0.013 0.012 
1.00 1.00 
0.75 0.59,0.94 0.73 0.54,0.99 
<0.001 <0.001 
1.00 1.00 
2.28 1.88,2.76 2.24 1.75,2.86 
<0.001 <0.001 
1.00 1.00 
0.54 0.42,0.70 0.43 0.31,0.62 
0.39 0.23,0.66 0.38 0.19,0.74 
0.70 0.47,1.03 0.67 0.41,1.09 
1.22 0.70,2.13 1.31 0.67,2.56 
0.42 0.17,1.02 0.39 0.12,1.23 
<0.001 0.004 
1.00 1.00 
1.22 0.93,1.61 0.97 0.67,1.41 
1.58 1.23,2.02 1.33 0.96,1.84 
2.63 1.68,4.12 2.41 1.36,4.25 
3.95 2.24,6.97 3.21 1.49,6.93 
The impact of the hazard ratio for age in all the models was constant. 
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Table 11: 12 Deaths from all causes and cardiovascular mortality. 
Hazard ratios with the inclusion of baseline fitness 
All-cause mortality Cardiovascular mortality 
Participants 2714 Participants 2714 
Deaths 451 Deaths 277 
Variables Hazard 95% p Hazard 95% p 
Ratio Confidence value Ratio Confidence value 
Interval Interval 
Age, in 1 year increase 1.05 1.04,1.07 1.04 1.03,1.06 
Gender 
Male 1.00 1.00 
Female 0.61 0.48,0.78 0.53 0.39,0.74 
Referrals to CR 
Completed CR 1.00 1.00 
Did not complete CR 2.06 1.70,2.51 1.92 1.50,2.47 
Diagnostic category 
MI 1.00 1.00 
CABG 0.54 0.42,0.70 0.44 0.31,0.62 
PCI 0.46 0.27,0.79 0.49 0.25,0.96 
Angina Pectoris 0.71 0.48,1.05 0.69 0.42,1.31 
Other CHD 1.28 0.73,2.24 1.38 0.71,2.71 
MI + PCI 0.45 0.18,1.09 0.44 0.14,1.38 
Co-morbidity score 
None 1.00 1.00 
1 (least) 1.14 0.86,1.50 0.87 0.59,1.27 
2 1.43 1.12,1.84 1.14 0.83,1.59 
3 2.07 1.32,3,27 1.69 0.95,3.00 
4 (most) 3.38 1.91,5.98 2.54 1.17,5.51 
Baseline Fitness level <0.001 <0.001 
High 1.00 1.00 
Medium 1.93 1.41,2.63 <0.001 2.95 1.87,4.64 <0.001 
Low 2.83 2.02,3.96 <0.001 5.40 3.36,8.69 <0.001 
The effect of baseline fitness level on mortality was significant. 
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Table 11: 13 Deaths from all causes and cardiovascular mortality. 
Hazard ratios with inclusion of baseline depression 
All-cause mortality Cardiovascular mortality 
Participants 2625 Participants 2625 
Deaths 424 Deaths 257 
Variables Hazard 95% p Hazard 95% p 
Ratio Confidence value Ratio Confidence value 
interval Interval 
Age, in 1 year increase 1.07 1.06,1.08 1.07 1.07,1.09 
Gender 
Male 
Female 
Referrals to CR 
Completed CR 
Did not complete CR 
Diagnostic category 
MI 
CABG 
PCI 
Angina Pectoris 
Other CHD 
MI+PCI 
Co-morbidity score 
None 
I (least) 
2 
3 
4 (most) 
Baseline Depression 
score 
0-<8 (none) 
8-10 
11-21 (suggests 
clinical depression' 
1.00 1.00 
0.71 0.56, 0.91 0.68 0.49, 0.93 
1.00 1.00 
2.28 1.86, 2.78 2.21 1.71, 2.86 
1.00 1.00 
0.53 0.41, 0,69 0.42 0.29, 0.60 
0.39 0.22, 0.68 0.37 0.18, 0.75 
0.68 0.45, 1.02 0.62 0.37, 1.06 
1.12 0.58, 2.19 1.16 0.51, 2.62 
0.43 0.18, 1.05 0.41 0.13, 1.29 
1.00 1.00 
1.18 0.89, 1.57 0.90 0.61, 1.33 
1.55 1.20, 2.01 1.33 0.96, 1.86 
2.46 1.53, 3.95 2.12 1.14, 3.93 
4.17 2.34, 7.43 3.38 1.55, 7.38 
0.076 0.071 
1.00 1.00 
0.98 0.72,1.34 0.893 0.92 0.61,1.39 0.695 
1.60 1.09,2.35 0.017 1.79 1.11,2.87 0.017 
There is evidence that a depression score greater than 10 increases mortality 
for both all-cause deaths and cardiovascular deaths. 
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Table 11: 14 Deaths from all causes and cardiovascular mortality. 
Hazard ratios with inclusion of baseline fitness & baseline depression 
All-cause mortality Cardiovascular mortality 
Participants 2625 Participants 2625 
Deaths 424 Deaths 257 
Variables Hazard 95% p Hazard 95% p 
Ratio Confidence value Ratio Confidence value 
Interval Interval 
Age, in 1 year increase 1.06 1.04,1.07 1.05 1.03,1.06 
Gender 
Male 1.00 1.00 
Female 0.60 0.46,0.77 0.51 0.37,0.71 
Referrals to CR 
Completed CR 1.00 1.00 
Did not complete CR 2.06 1.68,2.53 1.89 1.46,2.46 
Diagnostic category 
MI 1.00 1.00 
CABG 0.53 0.41,0.70 0.42 0.29,0.61 
PCI 0.45 0.26,0.80 0.46 0.22,0.94 
Angina Pectoris 0.69 0.46,1.04 0.64 0.38,1.09 
Other CHD 1.11 0.57,2.17 1.13 0.50,2.56 
MI + PCI 0.44 0.18,1.09 0.43 0.14,1.37 
Co-morbidity score 
None 1.00 1.00 
1 (least) 1.11 0.83,1.47 0.81 0.55,1.20 
2 1.44 1.11,1.86 1.18 0.85,1.65 
3 1.99 1.23,3.22 1.54 0.83,2.88 
4 (most) 3.73 2.09,6.65 2.86 1.31,6.27 
Baseline Fitness level <0.001 <0.001 
High 1.00 1.00 
Medium 1.82 1.32,2.49 <0.00 1 2.63 1.66,4.16 <0.001 
Low 2.66 1.89,3.75 <0.001 4.90 3.03,7.95 <0.001 
Baseline Depression 
score 
0-<8 (none) 1.00 1.00 
8-10 0.93 0.68,1.27 0.633 0.84 0.55,1.27 0.405 
11-21 (suggests 1.45 0.98,2.13 0.061 1.52 0.94,2.45 0.086 
clinical depression) 
The effect of baseline depression was attenuated when added to the model. 
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Table 11: 15 Deaths from all causes and cardiovascular mortality. 
Hazard ratios with the inclusion of fitness level after cardiac 
rehabilitation 
All-cause mortality 
Participants 1398 
Deaths 180 
Cardiovascular mortality 
Participants 1398 
Deaths 106 
Variables Hazard 95% p Hazard 95% p 
Ratio Confidence value Ratio Confidence value 
Interval Interval 
Age, in 1 year increase 1.05 1.03,1.07 1.03 1.01,1.06 
Gender 
Male 1.00 1.00 
Female 0.61 0.41,0.92 0.47 0.27,0.82 
Diagnostic category 
MI 1.00 1.00 
CABG 0.43 0.29,0.64 0.29 0.16,0.54 
PCI 0.25 0.08,0.80 0.28 0.07,1.15 
Angina Pectoris 0.83 0.46,1.51 0.75 0.35,1.64 
Other CHD 2.10 0.92,4.79 2.62 1.05,6.53 
MI + PCI 0.61 0.20,1.85 1.32 0.38,4.57 
Co-morbidity score 
None 1.00 1.00 
I (least) 1.23 0.80,1.88 0.86 0.47,1.59 
2 1.28 0.82,2.00 0.97 0.52,1.80 
3 1.95 0.84,4.51 1.45 0.45,4.70 
4 (most) 6.46 2.53,16.5 1.03 0.12,8.56 
Fitness level after CR <0.001 <0.001 
High 1.00 1.00 
Medium 2.47 1.70,3.58 <0.001 3.68 2.23,6.07 <0.001 
Low 4.23 2.64,6.79 <0.00 1 6.37 3.37,12.0 <0.001 
The effect of adding fitness level after CR was also strongly significant. 
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Table 11: 16 Deaths from all causes and cardiovascular mortality. 
Assessing the effect of fitness levels before cardiac rehabilitation after 
adjusting for fitness levels after cardiac rehabilitation 
All-cause mortality 
Participants 1398 
Deaths 180 
Cardiovascular mortality 
Participants 1398 
Deaths 106 
Variables Hazard 95% p Hazard 95% p 
Ratio Confidence value Ratio Confidence value 
Interval Interval 
Age, in 1 year increase 1.04 1.02,1.06 1.03 1.00,1.05 
Gender 
Male 1.00 1.00 
Female 0.58 0.39,0.87 0.43 0.25,0.75 
Diagnostic category 
MI 1.00 1.00 
CABG 0.42 0.28,0.63 0.29 0.16,0.53 
PCI 0.27 0.08,0.85 0.30 0.07,1.23 
Angina Pectoris 0.83 0.46,1.52 0.76 0.35,1.66 
Other CHD 2.18 0.95,5.00 2.78 1.11,6.94 
MI + PCI 0.66 0.22,2.03 1.50 0.43,5.21 
Co-morbidity score 
None 1.00 1.00 
1 (least) 1.20 0.78,1.85 0.84 0.46,1.55 
2 1.24 0.79,1.94 0.91 0.49,1.69 
3 1.80 0.77,4.16 1.27 0.39,4.11 
4 (most) 5.74 2.24,14.7 0.88 0.11,7.23 
Fitness level after CR 
High 1.00 
Medium 1.72 1.11,2.67 0.016 2.06 1.14,3.73 0.017 
Low 2.53 1.38,4.65 0.003 2.66 1.21,5.87 0.015 
Fitness level before CR <0.001 <0.001 
High 1.00 
Medium 1.86 1.06,3.25 0.030 2.37 1.07,5.27 0.034 
Low 2.53 1.27,5.02 0.008 4.29 1.70,10.8 0.002 
Whilst there is an effect of fitness after CR on survival, even after adjusting 
for this, there is an effect of fitness before CR. 
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Table 11: 17 Deaths from all causes and cardiovascular mortality. 
Hazard ratios with the inclusion of depression score after cardiac 
rehabilitation 
All-cause mortality 
Participants 1965 
Deaths 259 
Cardiovascular mortality 
Participants 1965 
Deaths 156 
Variables Hazard 95% p Hazard 95% p 
Ratio Confidence value Ratio Confidence value 
interval Interval 
Age, in 1 year increase 1.07 1.05,1.08 1.06 1.04,1.08 
Gender 
Male 1.00 1.00 
Female 0.78 0.57,1.08 0.78 0.52,1.18 
Diagnostic category 
MI 1.00 1.00 
CABG 0.41 0.29,0.57 0.30 0.18,0.49 
PCI 0.18 0.07,0.49 0.14 0.03,0.57 
Angina Pectoris 0.79 0.47,1.32 0.77 0.40,1.47 
Other CHD 0.93 0.38,2,27 1.18 0.43,3.24 
MI + PCI 0.40 0.14,1.12 0.54 0.16,1.77 
Co-morbidity score 
None 1.00 1.00 
I (least) 1.22 0.84,1.76 0.85 0.50,1.43 
2 1.30 0.92,1.85 1.01 0.62,1.63 
3 2.80 1.37,5.72 2.02 0.74,5.53 
4 (most) 8.88 3.72,21.2 4.31 0.10,18.6 
Depression level after 0.454 0.116 
CR 
0-<8 (none) 1.00 1.00 
8-10 1.33 0.72,2.44 0.893 1.83 0.93,3.60 0.080 
11-21 (suggests 0.87 0.21,3.54 0.017 0.69 0.10,4.99 0.713 
clinical depression) 
There was no evidence that depression level after CR had an effect on 
survival. 
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Table 11: 18 Deaths from all causes and cardiovascular mortality. 
Hazard ratios for change in fitness levels between baseline and after 
cardiac rehabilitation 
All-cause mortality 
Participants 1398 
Deaths 180 
Cardiovascular mortality 
Participants 1398 
Deaths 106 
Variables Hazard 95% p Hazard 95% p 
Ratio Confidence value Ratio Confidence value 
Interval Interval 
Age, in 1 year increase 1.07 1.05,1.09 1.07 1.04,1.09 
Gender 
Male 1.00 1.00 
Female 0.89 0.61,1.31 0.75 0.44,1.28 
Diagnostic category 
MI 1.00 1.00 
CABG 0.41 0.27,0.61 0.27 0.15,0.50 
PCI 0.20 0.06,0.64 0.21 0.05,0.87 
Angina Pectoris 0.89 0.49,1.61 0.81 0.37,1.78 
Other CHD 2.23 0.97,5.12 . 95 
1.18,7.41 
MI + PCI 0.66 0.23,1.90 1.09 0.33,3.63 
Co-morbidity score 
None 1.00 1.00 
1(least) 1.19 0.78,1.83 0.82 0.44,1.51 
2 1.35 0.87,2.11 1.04 0.56,1.93 
3 2.87 1.25,6.59 2.24 0.70,7.18 
4 (most) 6.69 1.74,16.4 1.38 0.18,10.7 
Change in fitness 0.220 
in ml/kg/min 0.97 0.92,1.02 0.96 0.90,1.03 
0.285 
Table 11: 18 shows the hazard ratios for the incremental change in fitness 
[VO2peak] between the start and end of the CR programme when this variable 
is added to the model. This indicated that an additional increase in fitness of 
1 ml/kg/min is associated with a reduction in risk of 3% for all-cause mortality 
and 4% in cardiovascular mortality, although this was not significant (p=0. 
220 and p= 0.285 respectively). 
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Table 11: 19 Deaths from all causes and cardiovascular mortality. 
Hazard ratios for change in depression score between baseline and 
after cardiac rehabilitation 
All-cause mortality Cardiovascular mortality 
Participants 1939 Participants 1939 
Deaths 252 Deaths 152 
Variables Hazard 95% p Hazard 95% p 
Ratio Confidence value Ratio Confidence value 
Interval Interval 
Age, in 1 year increase 1.07 1.05,1.08 1.06 1.04,1.08 
Gender 
Male 
Female 
Diagnostic category 
MI 
CABG 
PCI 
Angina Pectoris 
Other CHD 
MI + PCI 
Co-morbidity score 
None 
1 (least) 
2 
3 
4 (most) 
Change in depression, 
in single units 
1.00 1.00 
0.81 0.58, 1.12 0.82 0.54, 1.24 
1.00 1.00 
0.40 0.28, 0.57 0.30 0.18, 0.50 
0.19 0.07, 0.50 0.14 0.04, 0.59 
0.78 0.46, 1.33 0.74 0.37, 1.46 
1.17 0.48, 2.87 1.46 0.54, 4.00 
0.42 0.15, 1.20 0.58 0.17, 1.91 
1.00 1.00 
1.25 0.87, 1.81 0.88 0.52, 1.49 
1.32 0.92, 1.88 1.04 0.64, 1.69 
2.78 1.36, 5.69 2.00 0.73, 5.45 
8.73 3.66, 20.8 4.22 0.98, 18.2 
1.03 0.98, 1.09 0.188 1.03 0.97, 1.10 0.318 
When change in depression scores between baseline and exit assessments 
was added to the model this showed that the risk of both all-cause and 
cardiovascular mortality increased by 3% per unit increase on the HADS, 
although this was not found to be significant for either all cause (p=O. 188) or 
for cardiovascular deaths (p= 0.318). 
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Improvement in fitness is intuitively more valuable to people who start from a 
low fitness base rather than for people who are already fit at the start of a 
physical training programme. I therefore decided to repeat the analysis in 
Table 11: 18 to obtain 3 estimates of the change in fitness by the 3 levels of 
fitness category, high, medium and low for all-cause and cardiovascular 
mortality. The results from this analysis are shown in Tables 11: 20 and 
11.21. The effect of change in fitness on mortality varied with the baseline 
fitness level. For those whose baseline fitness levels fell in the high or 
medium categories, change in fitness did not affect either all-cause or 
cardiovascular mortality. However for those who were least fit, with a low 
fitness level at baseline, increasing fitness was associated with a significant 
reduction in mortality, with an effect of an 11% reduction in both all-cause 
and cardiovascular mortality for each increase in fitness of 1 ml/kg/min. 
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Reference: Chapter 11 
Collett D (1994): Modelling survival data in medical research. Texts in 
Statistics Science. London: Chapman & Hall. 
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Chapter 12 
Discussion 
12.1 Overview of this study 
This study reports the long term outcomes for an unselected group of 2,714 
patients with coronary heart disease who enrolled in a CR programme. 
Measures of physical fitness . and depression were compared with prognosis. 
The participants were followed up for nearly 13 years, providing more than 
18,000 person years of observation. 
Between the start and finish of our Phase III programme the mean increase 
in fitness for the cohort was 16.8%. Thirty-three percent of participants 
showed an improvement in their fitness category and less than 1% showed a 
deterioration. The prevalence of symptoms suggestive of clinical depression 
at baseline was less than 5% and this had reduced to 1.13% by the follow-up 
assessment. Fitness levels were significantly related to depression scores; 
the participants who were least fit were more likely to be depressed. 
At the end of the study period 16.6% of the cohort had died. Almost two- 
thirds of the deaths were from cardiovascular causes. The study confirms 
that fitness levels are related to mortality in patients with coronary heart 
disease who have been enrolled in a CR programme. 
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An important finding from this study was that an increase in fitness amongst 
those who were least fit at baseline was associated with an 11 % reduction in 
the risk of cardiovascular mortality for each unit increase in fitness of one 
ml/kg/min. This study, therefore, has shown a significant protective effect of 
improvement in fitness for those in the lowest fitness category at baseline, 
although there was no evidence of survival benefit from improvement in 
fitness in those participants who were in the medium or high fitness 
categories at baseline. 
Results from this study also showed an association at the start of Phase III 
CR between symptoms suggestive of clinical depression [HADS depression 
score <10] and mortality before adjusting for fitness, although there was no 
association evident between depression assessed at the end of the 
programme and mortality. 
As far as I can determine, this study is the only long term observational study 
which has looked at the combined effects of physical fitness and depression 
on mortality in patients with coronary heart disease. It is also the largest 
study to examine the relationship between fitness and mortality, and 
depression and mortality in exercising coronary patients who are enrolled in a 
CR programme. 
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12.2 Strengths of this study 
One of the main strengths of my study is that the participants were not 
selected in any way, but were typical of people with coronary disease 
enrolling in a CR programme in southern England. This gives the study high 
external validity or generalisability (Black 1996). 
With 18,000 person years of follow up, this study was seven times larger than 
the only equivalent observational study of fitness and mortality in CR 
participants (Vanhees et al 1995) and four times larger than the largest 
observational study of depression and mortality in coronary heart disease 
patients (Blumenthal et al 2004). 
The demographic and epidemiological data have been collected consistently 
and systematically. Throughout the study period I oversaw the organisation 
and administration of the CR programme, which included all data collection. 
All the study participants received a similar style and standard of 
individualised intervention for the duration of the study period. 
The long term mortality data on our patients was, as far as I can ascertain, 
complete and reliable, as it was based on the mortality data obtained from 
the Office for National Statistics. 
The majority of the patients referred to Phase III CR are probably stratified as 
low risk and the higher risk patients who have the most to gain are often 
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excluded. Most of the observational studies and randomised controlled trials 
only included participants who were at low risk of succumbing to a further 
cardiovascular event, (Bethell and Mullee 1990; Dugmore et al 1999; Fioretti 
et al 1988; Hofman-Bang et al 1999; Jolliffe et al 2003; Marra et al 1985; 
PRECOR 1991; Taylor et al 2004; Vanhees et al 1995; Vanhees et al 1994; 
Vermeulen et al 1983). This may be because it is perceived as too 
dangerous or too time consuming to include high risk patients in Phase III 
exercise sessions. A further strength in this study is the inclusion of patients 
stratified as high risk, for example those awaiting bypass surgery and those 
with ischaemic heart failure. 
Finally, we recorded information on co-morbidity during the patient's initial 
clinical assessment. I found only two studies that had accounted for the 
shorter term effects of non-cardiovascular co-morbidity on mortality 
(Blumenthal et al 2004; Grace et al 2005) which I discussed in Chapter 7 
page 171 and Chapter 5 page 126, and none which accounted for the longer 
term effect of co-morbidity on outcomes. One reason for this is that early 
research tended to concentrate on a younger male coronary population for 
whom co-morbid illness was relatively uncommon. In this study I built on the 
original research to create an index of co-morbidities specific to CR carried 
out by Zoghbi et al (Zoghbi et al 2004) which I included in my analyses, and 
which proved to be an important aspect of my research. Co-morbidity was 
found to be a significant confounder in prediction of mortality. 
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12.3 Limitations of the study 
The study was limited by 4 main factors. Firstly, the methods we used to 
measure fitness. Secondly, the instruments we used to assess depression. 
Thirdly, the patients we excluded from the analyses and fourthly the stringent 
definition of adequate secondary prevention medication. 
12.3.1 Measuring fitness 
Measuring fitness is difficult in a community venue such as ours, as a Sports 
Centre gymnasium is very different from a controlled laboratory environment. 
We used two methods to measure cardiorespiratory fitness levels: cycle 
ergometry and treadmill testing. For the first part of the study we used a 
cycle ergometer because we did not have access to a treadmill until August 
1995. In August 1995 we obtained a treadmill and thereafter used this 
routinely to assess patients. However, we continued to use cycle ergometry 
for the very few patients who were unable to walk on a treadmill, usually 
because of orthopaedic limitations. 
Exercise testing carried out on a treadmill has an advantage over cycle 
ergometry in that this method measures cardiovascular changes induced by 
a commonly performed exercise - i. e. walking, whereas tests performed on 
cycle ergometers are not usually pertinent to daily activities. For each patient 
we always used the same method for exercise testing at the start and finish 
of the programme. 
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We predicted oxygen uptake [V02peak] from the known oxygen costs of 
bicycling at different workloads or the oxygen uptake per kilogram of body 
weight for different levels of treadmill exercise, as described in Chapter 9 
page 243. Predicted oxygen uptake for both bicycle and treadmill exercise 
differs from measured oxygen uptake. When compared with expired gas 
analysis, cycling overestimates oxygen uptake by about 10% (Shephard 
1979). On the other hand, treadmill exercise underestimates oxygen uptake 
by approximately 5% (Shephard et al 1968). Therefore the participants from 
the earlier years of the study who were tested by cycle ergometry were 
slightly more likely to be included in higher fitness groups. We have no way 
of correcting this small bias. In addition, the changes in physical fitness 
between baseline and follow up, even though they were always measured by 
the same technique, would likewise be subject to a small bias. 
For all but nine months of the study period the same doctor supervised all the 
exercise tests. It is possible that the manner in which a different doctor 
performed the tests in the last nine months differed slightly, although we 
made every effort to ensure that the approach adopted by the two doctors 
was consistent. 
12.3.2 Measuring depression 
We used the HADS depression subscale to measure depression with a 
threshold of 7 for no depression, 8 to 10 for borderline symptoms and a score 
of greater than 10 for symptoms suggestive of clinical depression. 
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The baseline level of depression in this study was lower than in other studies 
using different instruments. The choice of instrument used to detect 
depressive symptoms or depressive disorders may have affected the results I 
obtained. We did not have sufficient resources to use structured interviews, 
considered to be a superior way to assess psychological health. 
A further limitation in my study was the small size of the clinically depressed 
group of patients [67 participants]. I did not have sufficient power therefore to 
show any effect on changes in depression scores between the start and end 
of CR as there were only 29 deaths reported in the clinically depressed 
12.3.3 Participants excluded from analysis 
The cohort for this study consisted of participants for whom we had collected 
fitness data. It was clear from my primary analysis, which compared 
participants with fitness data and those without, that the fitness data group 
was significantly different [Table 10: 1 page 261] from the group without 
fitness data. The participants without fitness data were older, more likely to 
be female, to have enrolled into CR with a myocardial infarction than after 
revascularisation procedures and have greater co-morbid disease (p<0.001). 
12.3.4 The definition of full secondary prevention medication 
In this study I used a very stringent definition of the term `adequate' 
secondary prevention. I had created a new variable called `On Full 
Secondary Prevention' to log whether the patients were taking full secondary 
330 
prevention medication or not, i. e. by combining the 4 standard secondary 
prevention medications: aspirin, aß blocker, an ace inhibitor and a statin into 
a single dichotomous variable. Since statins were not widely available until 
the mid 90s for the patients in this study, and also ace inhibitors were 
similarly less commonly prescribed until midway through the study period this 
is a further limitation of this study. 
12.4 Comparison with previous studies comparing measures 
of fitness and depression with long term mortality 
12.4.1 Age and gender 
The mean age of participants in my study was 62 years. Table 12: 1 shows 
age and gender comparisons between this study and previous research that I 
reviewed in Chapter 4 page 61. The mean age of participants in this study 
was greater than reported in comparable study cohorts. Our patients were 
unselected CR attendees, for whom enrolment had not been limited by either 
age or gender. 
Table 12: 1 Comparisons of age and gender 
Authors, year, 
country of origin 
Mean age, years [±sd] 
Males Females % Female 
Vanhees et al 53 [±8] 0 0 1994, Belgium 
Vanhees et al 53 [±8] 0 0 1995, Belgium 
Kavanagh et al 55 [f9] 0 0 2002 Canada 
Kavanagh et al 59 [t10] 100 2003, Canada 
Awad-Elkarim et al 48 0 2003, UK 18 
This study 61 ±101 65 [±9] 20 
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12.4.2 Smoking habit 
We had recorded data on smoking habit for 99.9% of participants who were 
assessed at the start of Phase III. Nine percent of participants were current 
smokers and 30% had never smoked [Table 10: 4 page 270]. This compares 
with Vanhees' research where 6% of participants were still smoking at 
baseline assessment (Vanhees 1995) and 17% who had no previous history 
of smoking. In Kavanagh's study 16.2% of males (Kavanagh et al 2002) and 
12.5% of females were current smokers and 39% of females had never 
smoked (Kavanagh et al 2003). Kavanagh did not report past smoking 
history for his male cohort. 
The differences in proportion of current smokers in the various studies may 
reflect the background fall in smoking prevalence in North America, parts of 
Europe and the United Kingdom. Kavanagh's studies straddled the late 60s, 
70s and late 80s, Vanhees' study the late 70s and 80s, whereas this study 
was carried out mainly in the nineties through to just beyond the millennium. 
12.4.3 Co-morbidity 
I found that 3.2% of participants reported moderately severe non-cardiac and 
non-psychiatric co-morbid disease and a further 1.2% had severe disease 
[TablelO: 4 page 270]. Thirty percent of participants had no co-morbidity. 
Grace et al's study which I discussed in Chapter 5 page 126 [Table 5: 2] also 
reported that a similar proportion [29%] of acute coronary syndrome survivors 
from their cohort had no co-morbidity at baseline (Grace et al 2005). 
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Little is known about the prevalence of co-morbid illness in the coronary 
population, and particularly those who have attended CR programmes. 
Moreover, the importance of the prognostic effect of non-cardiac co-existing 
illness on outcomes in coronary heart disease patients has rarely been 
considered. Most researchers have accounted only for co-morbidity that 
could have a large effect on survival such as diabetes, heart failure or end 
stage renal disease with the exception of the ENRICHD researchers 
(Berkman et al 2003; Blumenthal et al 2004; Blumenthal et al 1997) who 
used the D'Hoore Co-morbidity Index (D'Hoore et al 1996) to measure co- 
morbidity in their large multicentre clinical trial [Chapter 7 page 171]. There 
are two possible explanations for this. Firstly, patients enrolled in most 
studies have been younger and therefore less likely to have concomitant co- 
morbidity and secondly those with important co-morbidity often fail to be 
referred or enrolled into CR in the first place. 
12.4.4 Fitness 
The median estimated baseline fitness as measured by VO2peak for males in 
this study was 20.2 ml/kg/min., identical to that found by Kavanagh in his 
cohort of younger patients who would therefore be expected to be fitter than 
ours (Kavanagh et al 2002). There are two reasons that may explain why his 
patients were less fit than might be expected. Firstly, in Kavanagh's study 
V02peak was measured by expired gas analysis in laboratory type conditions, 
rather than estimated as we had done. As already mentioned in section 
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12: 3.1 of this chapter it is difficult to directly compare the different methods of 
exercise testing in these instances. Secondly, his patients were tested at 9- 
18 weeks post event compared to our 4-6 weeks. This would give them a 
longer period of physical detraining prior to starting CR. It may be that our 
patients were recruited to CR in an era when patients were mobilised more 
rapidly and therefore when they commenced the Phase III programme were 
fitter compared with Kavanagh's patients, who waited up to 18 weeks to 
begin their supervised exercise. 
The mean V02peak of Vanhees' patients, also measured directly rather than 
estimated (Vanhees 1995), was 23.7 ml/kg/min and this level of fitness was 
greater than our patients, as would be expected from their younger mean 
age. 
The median baseline fitness for females in this study measured by VO2peak 
was 14.0 ml/kg/min as compared with Kavanagh's figure of 15.1 ml/kg/min in 
a rather younger sample. The mean age of our female participants was 65 
years whereas the mean age of Kavanagh's patients was 59 years [Table 
12: 2]. 
Our participants' cardiorespiratory fitness had increased by 16.8% (p<0.001) 
at the second assessment at the end of CR [Table 10: 5 page 275]. Vanhees 
reported an increase in cardiorespiratory fitness of 33% in his younger male 
cohort (Vanhees 1995). One reason for the greater increase in fitness seen 
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in Vanhees' patients may be that they had more supervised training hours 
per week. Our patients usually attended twice weekly exercise classes of 
one hour's duration, whereas Vanhees' patients had received 4 hours of 
supervised physical training each week. 
12.4.5 Depression 
The prevalence of depression in the general population in the United 
Kingdom is 5% (Ohayon et al 1999) which is remarkably similar to the 
baseline level in my cohort. However, in my study the prevalence of clinical 
depression at baseline [n=122/2625] (4.6%) and outcome (-1%) was low 
when compared to levels reported from most other studies of depression and 
coronary heart disease, which I discussed in Chapter 5. There are several 
possible reasons for this. Comparisons between the prevalence of 
depression in this study and other similar study cohorts are shown in Table 
12: 2. At baseline only 4.6% of our participants had symptoms suggestive of 
clinical depression [scoring > 10 on the HADS] and 10.6% were in the 
borderline category [with scores between 8 and 10]. Combining the 
percentages for symptoms suggestive of clinical depression with borderline 
cases gave an overall result of 15.2%. By contrast, van Melle's meta- 
analysis of studies on myocardial infarction survivors, depression and 
cardiovascular prognosis [Chapter 5 page 117] showed a baseline 
prevalence to range from 5 to 47% in the 37 studies he had included (van 
Melle et al 2004). The only other comparable study from the United Kingdom 
that had used the HADS, and had also used the same cut-off points as I 
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have, reported a 7.6% prevalence of in-hospital depression post infarction 
with 9.9% of patients reporting borderline symptoms. This gave an overall 
combination of depression and borderline symptoms of 17.5% (Mayou et al 
2000). Our patients completed baseline psychological assessment at the 
start of Phase III which was about 4-6 weeks later on than Mayou's patients. 
Table 12: 2 Prevalence of baseline depression in selected study 
cohorts 
Authors, year, 
country of origin 
% Baseline Depression 
Depressive Depressive 
symptoms disorders 
Carney, 
17% 1988, USA 
Ahern, 40% 1990, USA 
Ladwig, 
15% 1994, Germany 
Frasure-Smith 
32% 16% 1995,2000, Canada 
Denollet, 41 9% 1996, The Netherlands . 
Barefoot 
11 1% 1996, USA . 
Mayou 7.6% 
2000, UK + borderline symptoms 9.9% 
Penninx 
19 7% 200 1, The Netherlands . 
Connerney 
20 3% 2001, USA . 
Lane 
30% 2002, UK 
Blumenthal 
2003, USA 38% 
Grace 
31 3% 2005, Canada . 
This study 
4.6% 
+ borderline symptoms 10.6% 
This may help to explain the slightly lower prevalence of depression in my 
study. 
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Several researchers have acknowledged that there is no consistency in the 
instruments used to assess depression (Barth et al 2004; Frasure-Smith and 
Lesperance 2005). Some studies used interview techniques whilst others 
use questionnaires or a mix of both. Table 12: 3 shows the different 
instruments used to assess depression in a selection of these studies. 
Results from the studies that used the BDI showed a consistently higher 
prevalence of depression, ranging from 30%-40% when the questionnaire 
was administered within 6-60 days following myocardial infarction (Ahern et 
al 1990; Frasure-Smith et al 2000; Frasure-Smith et al 1995; Grace et al 
2005; Lane et al 2002). 
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Table 12: 3 Depression measures in selected study cohorts 
Authors, year, 
country of origin 
Depression measure 
% Baseline 
depressive 
symptoms 
% Baseline 
depressive 
disorders 
Carney Interview 17% 
1988, USA 
Ahern, BDI 40% 
1990, USA 
Ladwig, Interview 15% 
1994, Germany 
Frasure-Smith BDI and 32% 16% 
1995,2000, Canada Interview 
Denollet, Type D 41.9% 
1996, The Netherlands 
Barefoot Zung 11.1% 
1996, USA 
Mayou HADS 7.6% 
2000, UK 
Penninx CESD 19.7% 
2001, The Netherlands 
Connerney Interview 20.3% 
2001, USA 
Lane BDI 30% 
2002, UK 
Blumenthal CESD 38% 
2003, USA 
Grace BDI 31.3% 
2005, Canada 
This study HADS 4.6% 
The timing of the psychological assessment in relation to a cardiac event or 
procedure may be an important consideration when comparing the 
prevalence rates of depression across different studies. Van Melle's meta- 
analysis showed that there was no uniformity in the timings of psychological 
assessments in the 37 studies he had included (van Melle 2004). For 
example, one study had assessed depression on Day 1 and Day 63 
(Silverstone 1987) whilst approximately a third had measured depression 
within the first week after infarction. Some assessments occurred during 
hospitalisation and others in out patient clinics or during angiography. 
Frasure-Smith also reported similar findings from her more recent systematic 
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review of the literature relating depression and depressive symptoms with 
outcomes in people with coronary heart disease (Frasure-Smith and 
Lesperance 2005). Comparisons between the timings of assessments, 
venues and prevalence of depression are shown in Table 12: 4 
Table 12: 4 Timing, place of assessments and prevalence of depression 
in selected study cohorts 
Authors, year, 
country of origin 
Timing and/or place of 
assessment 
% Baseline 
depressive 
symptoms 
% Baseline 
depressive 
disorder 
Carney Out-patient angiography 17% 
1988, USA 
Ahern, 6-60 days post MI 40% 
1990, USA 
Ladwig, 3 weeks post MI 15% 
1994, Germany 
Frasure-Smith In hospital post MI 32% 16% 
1995,2000, Canada 
Denollet, Out-patient angiography 41.9% 
1996, The Netherlands 
Barefoot Out-patient CHD 11.1% 
1996, USA 
Mayou In hospital post MI 7.6% 
2000, UK 
Penninx Out-patient CHD 19.7% 
2001, The Netherlands 
Connemey In hospital post CABG 20.3% 
2001, USA 
Lane In hospital post MI 30% 
2002, UK 
Blumenthal Day before CABG 38% 
2003, USA 
Grace In hospital post 31.3% 
2005, Canada acute coronary syndrome 
This study 28 - 42 days post MI, post 4.6% 
revascularisation, or with CHD 
In the United Kingdom in particular, little is known about the level of 
depression scores for coronary heart disease patients during Phase III CR 
(Rees et al 2004). Since 1997 The British Association for Cardiac 
Rehabilitation with the British Heart Foundation have circulated all the CR 
programmes within the United Kingdom with an annual questionnaire. This 
339 
questionnaire asks for numbers and diagnoses of the patients treated in the 
CR programmes and outcome data for the patients (Bethell et al 2004). All 
CR programmes in the United Kingdom are encouraged to use the HADS to 
measure psychological state. The annual survey for the year 2001, which 
reflects data collection from the previous year, asked CR co-ordinators about 
the numbers of patients with HADS depression scores of 8 or more i. e. 
combining the symptoms suggestive of borderline and the clinical depression 
categories. This is the only occasion on which the survey requested this 
data. Of the 307 programmes sent a questionnaire for that year, 29 
programmes gave start and finish numbers for patients with depression 
scores of over 8 or more. The results from the survey showed that 885 
[16.7%] of 5299 patients scored 8 or more at the start of CR compared with 
320 [6.0%] at the finish (Evans 2006). However, these data should be 
interpreted with caution. The number of responses was small; the survey did 
not ascertain the timing of assessments; and it is unlikely that baseline 
measures were all collected during the same time frame post event. 
In the current study the proportion of patients with symptoms suggestive of 
either clinical depression or borderline depression at the second 
psychological assessment performed at the end of the Phase III CR 
programme had decreased from 15.2% to 4.4%. Just over 1% remained in 
the clinically depressed category and 3.3% were in the borderline category. 
Changes in depression scores during the CR programme were shown to be 
significant [Table 10: 5 page 275]. Depression scores of participants in this 
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study over a three month period decreased by 33% between the 
assessments at the start and end of CR. 
One other study has looked the effect of depression on morbidity in 
exercising coronary patients (Milani et al 1996) but there is no comparable 
study of the effect on mortality. In Milani's study there is a greater fall [54%] 
in depression over the course of the 3 month CR programme which may be 
explained by the greater number of exercise sessions attended by 
participants and by the fact that he used a different instrument to measure 
depression. 
In common with other researchers I found that the depressed patients were 
less fit, less likely to complete CR, more likely to be smokers and have 
greater co-morbidity [Table 10.9 page 284 ] (Glazer et al 2002; Oldridge et al 
1983; Turner et al 2002). 
12.4.6 Completion Rates 
In the present study there were 660 [24%] participants who failed to complete 
the CR programme [Figure 10: 1 page 261] for a variety of reasons: they 
underwent cardiac surgery, became ill, died, moved house, had transport 
problems, or went back at work. Our non-completion rates were similar to 
the rates of 22% and 25% that have also been reported (Fioretti et al 1988; 
Vanhees et al 1995) but greater than Kavanagh's rates of 4.8% for males 
and 4.3% for females (Kavanagh et al 2002; Kavanagh et al 2003). 
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As was expected, and has been reported previously, the group who did not 
complete our programme was significantly different from the group who did 
[Table 10: 2 page 264]; they were more likely to smoke, were also 
significantly more anxious, more depressed and less fit (p<0.001). They 
were also likely to live in areas of greater deprivation (p<0.001). The 
characteristics of people who do not complete CR have been studied by 
several researchers who have also found that non-completers were more 
anxious, depressed and less fit (Blumenthal et al 1982; Ladwig et al 1994; 
Oldridge et al 1983) and reported that they lived in more deprived areas 
(Lane et al 2001). 
12.4.7 Mortality 
During a follow-up period of almost 13 years [median 6.4 years] there were 
451 deaths out of the 2,714 study participants [16.6% of the cohort], of which 
277 deaths were from cardiovascular causes and 219 of the cardiovascular 
deaths were from coronary heart disease [Figure 11: 1, page 294]. The all- 
cause death rate for females was 24.7 per 1000 person years, very similar to 
that of the males at 25.1 per 1000 person years. This compares with an all- 
cause death rate from Vanhees' younger male cohort of 14.3 per 1000 
person years. For cardiovascular deaths in my study the figures were again 
very similar between the sexes at 14.9 for females and 15.5 for males. 
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12.4.8 Mortality and fitness 
This study has found that an increase in fitness level for those in the lowest 
fitness category was associated with a reduced risk of death. For each one 
ml/kg/min increase in fitness level there was an 11% reduction in 
cardiovascular mortality [Table 11: 21 page 322]. Only one previous 
observational study has assessed the effect of change in fitness level in CR 
on long term mortality (Vanhees et al 1995). Vanhees showed that 
cardiovascular mortality decreased by 2% for each 1% increase in V02peak 
and this was independent of the initial fitness level. This is equivalent to an 
8.4% reduction in cardiovascular mortality for each one ml/kg/min increase in 
fitness. 
One randomised controlled study of physical fitness and survival has also 
examined this relationship (Dorn et al 1999). This study, which I described in 
Chapter 4 page 73 [Tables 4: 4a and 4: 4b], followed up 651 low risk males 
post infarction for 19 years. The researchers reported an 8-14% reduction in 
all-cause mortality for each one MET gained in fitness. This is equivalent to 
a 3% reduction in all-cause mortality for each one ml/kg/min increase in 
fitness. Again, initial fitness level did not influence this finding. 
It is not clear why my findings differed from those reported by both Vanhees 
et al and Dorn et al. For the low fitness group in my study failure to increase 
fitness was associated with greater risk and conversely increasing response 
to exercise was associated with a reduction in mortality. The probable 
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explanation for this was that those with the worse disease were unable to 
exercise sufficiently to increase their fitness level. They were likely to be 
patients who had left ventricular dysfunction and therefore a reduced ability 
to increase their fitness level. 
The mortality rate in those with medium and high fitness levels in my study 
was much lower, indicating that these patients had better left ventricular 
function [Tables 11: 1 and 11: 2 page 294] which may explain why the 
association between mortality and changes in fitness was not seen. 
12.4.9 Mortality and depression 
Over the last 10 years several researchers have examined the effect of 
depression on mortality in people with coronary heart disease. In this study 
the hazard ratios of baseline depression for all-cause deaths [Tables 11: 6 
page 299 and 11: 13 page 313] was 1.56 [95% Cl 1.06,2.27] unadjusted, and 
when adjusted for age, gender, whether the CR was completed or not, the 
reason for referral to CR and co-morbid illness was 1.60 [95% Cl 1.09,2.35]. 
For cardiovascular deaths [Tables 11: 8 page 300 and 11.13 page 313] this 
was 1.68 [95% Cl 1.05,2.69] unadjusted and 1.79 [95% Cl 1.11,2.87] 
adjusted for the same confounders. 
In a meta-analysis Barth et al were the only reviewers to report studies with a 
follow up period beyond 5 years [Chapter 5 page 119] (Barth et al 2004). 
Most of the patients in these studies had suffered an acute myocardial 
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infarction and the majority of patients were male. Mean ages of patients 
ranged from 54 to 74 years, with a minimum age of 19 years and a maximum 
of 90 years. Results for six of the studies with longer follow periods were 
adjusted for a variety of confounders, which included age, gender, smoking, 
hypertension, hyperlipidaemia, diabetes mellitus and body mass index [HR 
1.76 95% Cl 1.27,2.43]. Five of these studies reported cardiovascular as 
opposed to all-cause mortality as an outcome. However, age and gender 
were the only covariates common to both my study and the studies included 
in the meta-analysis. 
Two studies in Barth's meta-analysis had similarities with this study. Both 
were performed in the United Kingdom and followed up hospitalised 
myocardial infarction survivors (Lane et al 2002; Mayou et al 2000). Mayou 
used the HADS with a cut off point of 19 [as opposed to 18 in this study] to 
assess depressive symptoms in 344 patients [mean age 63 years, 27% 
female] who were followed up for 18 months. The odds ratio was reported 
for all-cause deaths but not cardiovascular deaths, OR 1.6 [Cl 0.43,5.95] at 6 
months and OR 1.64 [Cl 0.64,4.20] at 18 months. On the other hand, Lane 
used the BDI to assess depression in 288 participants [mean age 63 years, 
29% female] with a follow up of 3 years and reported an unadjusted odds 
ratio as 1.15 [Cl 0.49,2.70] at the end of the first year of follow-up. The odds 
ratio decreased to 0.84 [Cl 0.3,1.91] by 3 years. 
345 
Neither of these studies showed depressive symptoms to be predictors of 
survival when depression was assessed during the acute phase of a 
myocardial infarction. This differs from my findings where a baseline 
depression score of greater than 10, before adjusting for fitness, was 
associated with an increase in both all-cause and cardiovascular mortality 
when depression was assessed several weeks after the acute event or 
procedure. It may be that in-hospital depression which improves 
spontaneously after discharge is not associated with a worse prognosis while 
persisting depression is. I discuss this point again later in this chapter. The 
follow-up period was also much shorter in these studies than the follow up of 
nearly 13 years in this study, which may also explain the differences between 
the three studies. 
My study did not have sufficient power to show any effect on changes in 
depression scores between the start and end of CR as the depressed group 
of patients was small [67 participants] with just 29 deaths. No other 
observational study has examined the effect of change in depression on 
mortality. 
12.5 Implications for clinicians and policy makers 
There are six findings from this research study which could be used to modify 
policies to improve the outcome for coronary heart disease patients who are 
enrolled in CR programmes. Three of these findings relate to estimated 
levels of cardiorespiratory fitness. Firstly, a higher fitness level [an estimated 
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VO2peak of 15m1/kg/min or more] was associated with improved survival. 
Secondly, improving the fitness level for patients with a low fitness level [an 
estimated VO2peak of less than 15ml/kg/min] was also associated with better 
survival. Thirdly, a low fitness level predicted an increased risk of non- 
completion of the CR programme. 
There are three findings that related to our assessment of depression. The 
patients with scores of over 10 on the HADS depression subscale had overall 
poorer survival than those who scored 10 or below, but this effect was no 
longer significant after controlling for fitness. However, a high HADS 
Depression score also predicted increased risk of non-completion of the CR 
programme. Finally the HADS identified a very low prevalence of depression 
in the cohort in this study. 
12.5.1 Policies related to exercise and fitness testing 
A formal assessment of fitness level should be carried out at the start and the 
finish of the CR programme to enable a level of fitness to be estimated for 
each patient. From an annual BACR survey of CR programmes in the United 
Kingdom we know that few CR programmes measure fitness before CR and 
very few both before and after programme, probably due to the lack of 
financial or staffing resources. In the year 2000,26 [10%] of centres that 
responded to the relevant section of the BACR questionnaire, reported that 
they performed exercise tests before and after CR. Of these only 8 
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programmes were able to provide data supporting this statement (Bethell et 
al 2004). 
Initial fitness testing of coronary patients is important for a number of 
reasons. It acts as a guide to help practitioners individualise the exercise 
prescription. For example patients can be set an appropriately targeted heart 
rate range to achieve whilst exercising and be encouraged to exercise at a 
suitable level commensurate with ability and safety. My research confirms 
that fitness testing performed at entry to CR adds to the process of risk 
stratification for each individual and helps to identify the higher risk patients 
as well as those who are most likely to fail to complete CR. Low fitness level 
patients need more careful monitoring and a more prolonged course of 
exercise in Phase III than their fitter counterparts. This is for two reasons. 
Firstly, they are at higher immediate risk and secondly giving them a longer 
course of exercise should result in greater improvement in exercise tolerance 
and consequently perhaps improve their prognosis. After the finish of the 
programme these patients also need more careful follow up. Their higher 
risk status should be reported back to the general practitioners and 
cardiologists so that more frequent long term monitoring can be used. 
Fitness testing at the end of an exercise programme is also important. It 
measures the overall effectiveness of the exercise programme and provides 
data for audit purposes. For the individual patient it provides a measure of 
the success of their efforts, which may motivate them to continue exercising 
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in the longer term. My study adds to this the finding that those who start with 
low fitness but improve, have a better prognosis than those who do not. 
Repeating the fitness test at the end of the exercise programme therefore 
helps to identify the patients who remain in a higher risk group at the end of 
CR and who may thus require further attention, such as a clinical 
cardiological review, change of treatment, longer medical surveillance or/and 
long term monitoring. 
By spending less Phase III time and fewer resources on the lower risk 
patients with high fitness levels, more time would become available for the 
needful higher risk patients, and the level of provision of CR to include more 
high risk individuals could be developed. 
12.5.2 Policies related to psychological health 
A psychological assessment at the start and end of the CR programme is 
also invaluable. It identifies those patients with an overall worse prognosis 
and those less likely to complete the programme. It provides data for audit of 
the service and may help to monitor the effectiveness of psychological 
components of the CR programme. In a BACR survey of CR programmes in 
the United Kingdom (Bethell et al 2000) only 17% of programmes had 
documented data at baseline on the psychological health of their CR patients 
and even fewer at the end of the Phase III programme. My findings indicate 
that patients with high HADS depression scores should be monitored 
carefully during Phase III. Moreover, after the finish of the Phase III 
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programme, like the low fitness group, they need careful follow up in the long 
term. Their general practitioners should be alerted to their higher risk status 
if they have high depression scores so that appropriate treatment can be 
offered. 
Identification of depression by the HADS depression score indicates a low 
prevalence of depression in this cohort. We did not measure depression until 
the start of Phase III, several weeks after the acute cardiac event or 
procedure. There may be two reasons to explain the low prevalence of 
depression in this study. During Phase 1 we may have simply missed 
inviting some depressed patients to join the programme while others may 
have failed to take up the invitation because of their depression. 
Alternatively, the patients depressed during the early stages of their coronary 
illness may have undergone a spontaneous recovery during the few weeks 
prior to starting their Phase III exercise programme as was found in both the 
ENRICHD (Blumenthal et al 2004) and SADHART studies (Glassman et al 
2002). 
There are two issues concerning psychological assessment. Firstly, which 
type of instrument should be used to measure depression and secondly at 
what stage of the patients' illness is this best done. 
Since the HADS may have been a relatively insensitive measure of 
depression in this cohort of patients consideration should be given to 
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assessing depression with other instruments. The psychometric properties of 
screening instruments vary. The BDI for instance has 7 out of 21 items 
associated with somatic symptoms whereas the HADS has none. This 
means that the assessment with the BDI may pick up symptoms such as 
fatigue or anhedonia which are common to both newly diagnosed myocardial 
infarction patients as well as patients who are depressed. No systematic 
reviews on the psychometric properties of depression screening instruments 
for coronary heart disease cohorts have been published to date (Thombs et 
al 2007). 
The timing of the first psychological assessment and early detection of 
depression when it is present is important (Doyle et al 2006; McGee et al 
2006). Since the HADS may also have been a relatively insensitive measure 
of depression in this study when depression status was measured at the start 
of Phase III, it may be useful to initially assess coronary patients during 
Phase I, in the earlier stages of their illness. Extra effort can then be made to 
ensure that coronary patients found to be depressed during hospitalisation 
are offered treatment for depression to improve quality of life, as well as 
appropriate secondary prevention whether they choose to participate in CR 
or not. 
I discuss both these points again in the following section of this thesis. 
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12.6 Future Research 
12.6.1 The importance of baseline fitness 
Higher fitness even after adjusting for age, gender, reason for referral to CR, 
whether CR was completed or not and co-morbidity is associated with a 
better survival. There are several possible reasons for this. Firstly, the fitter 
patients are likely to have better left ventricular function than the unfit. 
Secondly, they may also have less residual coronary narrowing. Thirdly, they 
may be also less subject to the consequences of ventricular arrhythmias. 
Lastly, those with high fitness levels may be protected because they were 
more physically active and therefore fitter before the index coronary event. 
Unfitness therefore in the coronary patient is a marker for being either very 
sick with poor overall cardiac function or the result of many years of a 
sedentary lifestyle. It is likely that co-morbidity, non-adherence to exercise 
regimes and other preventative measures also contribute to low fitness 
levels. 
There are several components of exercise programmes that influence 
cardiorespiratory fitness. For example the intensity and frequency of the 
prescribed exercise, the duration of the programme, the use of home 
exercise programmes, adherence to prescribed home exercise, the ability to 
perform an adequate exercise prescription and the extent of co-morbid illness 
which may limit the amount of physical activity performed. The latest NICE' 
1 NICE - The National Institute for Health and Clinical Excellence 
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clinical guideline on secondary prevention post myocardial infarction, based 
on the best available evidence, suggests that CR patients should be advised 
to undertake regular activity sufficient to increase exercise capacity. It states 
that patients should be advised by health professionals to increase their 
exercise capacity by exercising for 20-30 minutes regularly at an intensity 
sufficient to bring on mild breathlessness (Cooper et al 2007). 
The average number of supervised exercise sessions undertaken by 
treatment patients in the randomised controlled trials in the Cochrane review 
was 48. Most of the randomised controlled trials reported on patients who 
have attended several sessions of supervised exercise per week (Vanhees et 
al 1995, Milani et al 1996). The weekly frequency of supervised exercise 
may go a long way to increasing the individual's fitness. The National 
Service Framework for Coronary Heart Disease (DOH 2000) recommended 
CR patients attend at least 12 sessions of exercise during Phase III, and the 
SIGN Guideline recommended 16 (SIGN 2002). In practice, many 
programmes in the United Kingdom offer even fewer sessions than this 
(Brodie et al 2006) and little is known about the intensity of individualised 
exercise programmes in routine practice or through research. 
A large scale multicentre cohort study within the United Kingdom is needed 
to monitor fitness levels in CR using measured VO2peak at the start and finish 
of the CR programme. This study could concentrate on the relative 
importance of factors known to influence fitness and prognosis including the 
severity of coronary disease, co-morbid illnesses including the more complex 
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co-morbidities, and the effect of non-adherence on outcomes of all eligible 
CR attendees. It should investigate treatments that are likely to be 
accessible in routine care and therefore helpful to policy makers, as opposed 
to unrealistic treatments that have been available in the various studies 
conducted to date. In addition, it could consider the role of homework, 
individualised goal setting and targets which may be cheaper and effective 
ways to improving fitness than attendances at supervised sessions. The 
outcomes of the shorter programmes versus the longer ones could also be 
compared. 
12.6.2 The importance of baseline depression 
My literature review revealed that most studies of depression and coronary 
heart disease focussed on patients post myocardial infarction. Little is known 
about the natural history of depression in patients who have undergone 
revascularisation procedures. Moreover, different instruments give a 
different prevalence of depression in coronary patients, as does the timing of 
the measurement. An observational study following up patients post 
revascularisation as well as post myocardial infarction, who have been 
assessed with several instruments such as the HADS, the BDI, the Cardiac 
Depression Scale (Hare and Davis 1996) or the Patient Health Questionnaire 
PHQ -9 (Kroenke et al 2001) at different times would identify the instrument 
and timing which gives the most sensitive and specific prediction long term 
prognosis. It would be possible to screen patients initially during the first 
stage of illness to identify depression, and provide more in depth screening 
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with subsequent follow up, monitoring and treatment in the community by 
general practitioners as required for those found to be depressed. 
12.6.3 Treating depression and prognosis 
There have been three studies [Chapter 7] of the effect of antidepressant 
treatments on prognosis following acute coronary events. But these have 
failed to show a benefit in either coronary prognosis or depression status. 
The ENRICHD study (Berkman et al 2003) looked at the effect of treating 
depressed patients with cognitive behavioural therapy or usual care. 
Although depression status was found to improve during the first 6 months of 
the follow up period, this effect was lost by 30 months. There was also no 
difference in event-free survival between the two groups that were studied. 
The SADHART study (Glassman et al 2002) investigated the safety of the 
antidepressant medication sertraline in post myocardial infarction patients. 
Although the intervention group who received sertraline as a treatment rather 
than placebo suffered fewer cardiovascular events, the longer term effect of 
sertraline was not studied. The third study followed up depressed myocardial 
infarction patients who were treated with a variety of antidepressant therapies 
over an 18 month period. It also failed to provide evidence that treating 
depression improved either cardiac prognosis or long term depression for 
either the intervention group or those who had received usual care (van Melle 
et al 2007). 
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However even though depression in acutely ill coronary patients appears to 
resolve spontaneously over time, it is nonetheless important perhaps to 
identify and treat it, in order to improve the quality of life of depressed 
patients during the initial recovery period. Future studies therefore should 
focus on determining which treatments are able to achieve this. Such 
treatments may be different to those known to be effective in people without 
coronary disease. Future challenges for researchers include carrying out 
studies that focus on understanding the mechanisms that give rise to poorer 
prognoses in depressed coronary patients, as well as whether certain 
aspects of depressive illness are more detrimental than others to cardiac 
outcomes. 
12.7 Conclusions 
In summary, this study has shown that initial levels of cardiorespiratory 
fitness and baseline depression scores are associated with prognosis in 
coronary heart disease patients who have attended an exercise-based CR 
programme. It is important that those who care for coronary patients are 
aware of these issues to allow for better targeted treatment for those 
coronary patients who are found to be at highest risk. 
356 
Chapter 12: References 
Ahern DK, Gorkin L, Anderson JL, et al (1990): Biobehavioral variables and 
mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study 
(CAPS). Am J Cardiol 66: 59-62. 
Barth J, Schumacher M, Herrmann-Lingen C (2004): Depression as a risk 
factor for mortality in patients with coronary heart disease: a meta- 
analysis. Psychosom Med 66: 802-13. 
Berkman LF, Blumenthal J, Burg M, et al (2003): Effects of treating 
depression and low perceived social support on clinical events after 
myocardial infarction: the Enhancing Recovery in Coronary Heart 
Disease Patients (ENRICHD) Randomized Trial. JAMA 3106-16. 
Bethell HJ, Mullee MA (1990): A controlled trial of community based coronary 
rehabilitation. British Heart Journal 64: 370-375. 
Bethell HJ, Turner SC, Evans JA, Rose L (2000): BACR database - 
unpublished data. 
Bethell HJN, Turner SC, Evans JA (2004): Cardiac Rehabilitation in the UK 
2000 - can the National Service Framework milestones be attained? 
British Journal Cardiology 11: 162-168. 
Black N (1996): Why we need observational studies to evaluate the 
effectiveness of health care. BMJ 12: 1215-8. 
Blumenthal JA, Babyak MA, Carney RM, et al (2004): Exercise, depression, 
and mortality after myocardial infarction in the ENRICHD trial. Med Sci 
Sports Exerc 36: 746-55. 
357 
Blumenthal JA, O'Connor C, Hinderliter A, et al (1997): Psychosocial factors 
and coronary disease. A national multicenter clinical trial (ENRICHD) 
with a North Carolina focus. NC Med J 58: 440-4. 
Blumenthal JA, Williams RS, Wallace AG, Williams RB, Jr., Needles TL 
(1982): Physiological and psychological variables predict compliance 
to prescribed exercise therapy in patients recovering from myocardial 
infarction. Psychosom Med 44: 519-27. 
Brodie D, Bethell H, Breen S (2006): Cardiac rehabilitation in England: a 
detailed national survey. Eur J Cardiovasc Prev Rehabil 13: 122-8. 
Carney R, Freedland K, Te Velde A (1988): Major Depressive Disorder 
Predicts Cardiac Events with Coronary Artery Disease. Psychosomatic 
Medicine 50: 627 - 633. 
Cooper A, Skinner J, Nherera L, et al (2007): Clinical Guidelines and 
Evidence Review for Post Myocardial Infarction: Secondary 
prevention in primary and secondary care for patients following a 
myocardial infarction. London: National Collaborating Centre for 
Primary Care and Royal College of General Practitioners, pp 40-41. 
D'Hoore W, Bouckaert A, Tilquin C (1996): Practical considerations on the 
use of the Charlson comorbidity index with administrative data bases. 
J Clin Epidemio/49: 1429-33. 
DOH (2000): Coronary Heart Disease: National Service Framework for 
Coronary Heart Disease: modem standards and service models. 
London: Department of Health Crown Copyright. 
358 
Dorn J, Naughton J, Imamura D, Trevisan M (1999): Results of a multicenter 
randomized clinical trial of exercise and long-term survival in 
myocardial infarction patients: the National Exercise and Heart 
Disease Project (NEHDP). Circulation 100: 1764-9. 
Doyle F, McGee HM, De La Harpe D, Shelley E, Conroy R (2006): The 
Hospital Anxiety and Depression Scale depression subscale, but not 
the Beck Depression Inventory-Fast Scale, identifies patients with 
acute coronary syndrome at elevated risk of 1-year mortality. J 
Psychosom Res 60: 461-7. 
Dugmore L, Tipson R, Phillips M, et al (1999): Changes in cardiorespiratory 
fitness, psychological wellbeing, quality of life, and vocational status 
following a 12 month cardiac exercise rehabilitation programme. Heart 
81: 359-366. 
Evans JA (2006): BACR/BHF annual surveys. London: Unpublished data. 
Moretti P, Baardman T, Zwiers G, Brower R, Hugenholtz PG (1988): 
Hemodynamic measurements during the acute phase of myocardial 
infarction: implications for prognosis and cardiac rehabilitation. Journal 
Cardiopulmonary Rehabilitation 8: 265-269. 
Frasure-Smith N, Lesperance F (2005): Reflections on depression as a 
cardiac risk factor. Psychosom Med 67 Suppl 1: S19-25. 
Frasure-Smith N, Lesperance F, Gravel G, et al (2000): Social support, 
depression, and mortality during the first year after myocardial 
infarction. Circulation 101: 1919-24. 
359 
Frasure-Smith N, Lesperance F, Talajic M (1995): Depression and 18-Month 
Prognosis After Myocardial Infarction. Circulation 91: 999-1005. 
Glassman AH, O'Connor CM, Califf RM, et al (2002): Sertraline treatment of 
major depression in patients with acute MI or unstable angina. JAMA 
288: 701-9. 
Glazer KM, Emery CF, Frid DJ, Banyasz RE (2002): Psychological predictors 
of adherence and outcomes among patients in cardiac rehabilitation. J 
Cardiopulm Rehabi/22: 40-6. 
Grace SL, Abbey SE, Kapral MK, Fang J, Nolan RP, Stewart DE (2005): 
Effect of depression on five-year mortality after an acute coronary 
syndrome. Am J Cardiol 96: 1179-85. 
Hare DL, Davis CR (1996): Cardiac Depression Scale: validation of a new 
depression scale for cardiac patients. J Psychosom Res 40: 379-86. 
Hofman-Bang C, Lisspers J, Nordlander R, et al (1999): Two-year results of a 
controlled study of residential rehabilitation for patients treated with 
percutaneous transluminal coronary angioplasty. European Heart 
Journal 20: 1465-1474. 
Jolliffe JA, Rees K, Taylor RS, Thompson D, Oldridge N, Ebrahim S (2003): 
Exercise-based rehabilitation for coronary heart disease. The 
Cochrane Library. 
Kavanagh T, Mertens DJ, Hamm LF, et al (2002): Prediction of long-term 
prognosis in 12 169 men referred for cardiac rehabilitation. Circulation 
106: 666-71. 
360 
Kavanagh T, Mertens DJ, Hamm LF, et al (2003): Peak oxygen intake and 
cardiac mortality in women referred for cardiac rehabilitation. J Am 
Coll Cardiol 42: 2139-43. 
Kroenke K, Spitzer RL, Williams JB (2001): The PHQ-9: validity of a brief 
depression severity measure. J Gen Intern Med 16: 606-13. 
Ladwig KH, Roll G, Breithardt G, Budde T, Borggrefe M (1994): Post- 
infarction depression and incomplete recovery 6 months after acute 
myocardial infarction. Lancet 343: 20-3. 
Lane D, Carroll D, Ring C, Beevers DG, Lip GY (2001): Predictors of 
attendance at cardiac rehabilitation after myocardial infarction. J 
Psychosom Res 51: 497-501. 
Lane D, Carroll D, Ring C, Beevers DG, Lip GY (2002): In-hospital symptoms 
of depression do not predict mortality 3 years after myocardial 
infarction. Int J Epidemiol 31: 1179-82. 
Marra S, Paolillo V, Spadaccini F, Angelino PF (1985): Long-term follow-up 
after a controlled randomized post-myocardial infarction rehabilitation 
programme: effects on morbidity and mortality. European Heart 
Journal 6: 656-663. 
Mayou RA, Gill D, Thompson DR, et al (2000): Depression and anxiety as 
predictors of outcome after myocardial infarction. Psychosom Med 
62: 212-9. 
McGee HM, Doyle F, Conroy RM, De La Harpe D, Shelley E (2006): Impact 
of briefly-assessed depression on secondary prevention outcomes 
361 
after acute coronary syndrome: a one-year longitudinal survey. BMC 
Health Serv Res 6: 9. 
Milani RV, Lavie CJ, Cassidy MM (1996): Effects of cardiac rehabilitation and 
exercise training programs on depression in patients after major 
coronary events. Am Heart J 132: 726-32. 
Ohayon MM, Priest RG, Guilleminault C, Caulet M (1999): The prevalence of 
depressive disorders in the United Kingdom. Biol Psychiatry 45: 300-7. 
Oldridge NB, Donner AP, Buck CW, et al (1983): Predictors of dropout from 
cardiac exercise rehabilitation. Ontario Exercise-Heart Collaborative 
Study. American Journal of Cardiology 51: 70-74. 
PRECOR (1991): Comparison of a rehabilitation programme, a counselling 
programme and usual care after an acute myocardial infarction: 
results of a long-term randomized trial. P. RE. COR. Group. European 
Heart Journal 12: 612-616. 
Rees K, Bennett P, West R, Davey SG, Ebrahim S (2004): Psychological 
interventions for coronary heart disease. Cochrane Database Syst 
Rev: CDO02902. 
Shephard RJ (1979): Recurrence of myocardial infarction in an exercising 
population. Br Heart J 42: 133-8. 
Shephard RJ, Allen C, Benade AJ, et al (1968): The maximum oxygen 
intake. An international reference standard of cardiorespiratory fitness. 
Bull World Health Organ 38: 757-64. 
362 
SIGN (2002): Cardiac Rehabilitation A national clinical guideline. Scottish 
Intercollegiate Guidelines Network. Edinburgh: Royal College of 
Physicians (Scotland). 
Silverstone PH (1987): Depression and outcome in acute myocardial 
infarction. BMJ (Clin Res Ed) 294: 219-20. 
Taylor RS, Brown A, Ebrahim S, et at (2004): Exercise-based rehabilitation 
for patients with coronary heart disease: systematic review and meta- 
analysis of randomized controlled trials. Am J Med 116: 682-92. 
Thombs BD, Magyar-Russell G, Bass EB, et al (2007): Performance 
characteristics of depression screening instruments in survivors of 
acute myocardial infarction: review of the evidence. Psychosomatics 
48: 185-94. 
Turner SC, Bethell HJ, Evans JA, Goddard JR, Mullee MA (2002): Patient 
characteristics and outcomes of cardiac rehabilitation. J Cardiopulm 
Rehabil 22: 253-60. 
van Melle JP, de Jonge P, Honig A, et al (2007): Effects of antidepressant 
treatment following myocardial infarction. BrJ Psychiatry 190: 460-6. 
van Melle JP, de Jonge P, Spijkerman TA, et al (2004): Prognostic 
association of depression following myocardial infarction with mortality 
and cardiovascular events: a meta-analysis. Psychosom Med 66: 814- 
22. 
Vanhees L, Fagard R, Thijs L, Amery A (1995): Prognostic value of training- 
induced change in peak exercise capacity in patients with myocardial 
363 
infarcts and patients with coronary bypass surgery. Am J Cardiol 
76: 1014-9. 
Vanhees L, Fagard R, Thijs L, Staessen J, Amery A (1994): Prognostic 
significance of peak exercise capacity in patients with coronary artery 
disease. J Am Coll Cardiol 23: 358-63. 
Vermeulen A, Lie KI, Durrer D (1983): Effects of cardiac rehabilitation after 
myocardial infarction: changes in coronary risk factors and long-term 
prognosis. American Heart Journal 105: 798-801. 
Zoghbi GJ, Sanderson B, Breland J, Adams C, Schumann C, Bittner V 
(2004): Optimizing risk stratification in cardiac rehabilitation with 
inclusion of a comorbidity index. J Cardiopulm Rehabi! 24: 8-13; quiz 
14-5. 
364 
